1. Cell Cycle/DNA Damage
    Autophagy
    Antibody-drug Conjugate/ADC Related
  2. Topoisomerase
    Autophagy
    ADC Cytotoxin

Doxorubicin hydrochloride (Synonyms: Adriamycin; Hydroxydaunorubicin hydrochloride)

Cat. No.: HY-15142 Purity: 99.47%
Data Sheet SDS Handling Instructions

Doxorubicin hydrochloride is a Topoisomerase II (Top2) catalytic inhibitor, also is a broad spectrum antibiotic used in the treatment of cancers, with IC50 of 374 nM for Hela cells.

For research use only. We do not sell to patients.
Doxorubicin hydrochloride Chemical Structure

Doxorubicin hydrochloride Chemical Structure

CAS No. : 25316-40-9

Size Price Stock Quantity
Free Sample (0.5-1 mg)   Apply now  
10 mM * 1 mL in DMSO $55 In-stock
50 mg $50 In-stock
100 mg $70 In-stock
200 mg $120 In-stock
500 mg $220 In-stock
1 g $395 In-stock
5 g   Get quote  
10 g   Get quote  

* Please select Quantity before adding items.

Other Forms of Doxorubicin hydrochloride:

  • Biological Activity

  • Protocol

  • Technical Information

  • Purity & Documentation

  • References

Description

Doxorubicin hydrochloride is a Topoisomerase II (Top2) catalytic inhibitor, also is a broad spectrum antibiotic used in the treatment of cancers, with IC50 of 374 nM for Hela cells.

IC50 & Target

Topoisomerase II[1]

In Vitro

Combination of Doxorubicin and Simvastatin in the highest tested concentrations (2 μM and 10 μM, respectively) kills 97% of the Hela cells[2].

In Vivo

Mice bearing PC3 xenografts are injected with 2, 4 or 8 mg/kg Doxorubicin and tumor volume is measured over time. A dose of 2 mg/kg does not affect tumor growth while higher dosages delay tumor growth initially (p<0.05 at days 18 and 22), 4 mg/kg or 8 mg/kg Doxorubicin significantly reduces levels of c-FLIP in PC3 xenografts[3]. A single intraperitoneal injection 10 mg/kg (Doxorubicin 1) is administered in rats, 10 daily intraperitoneal injections of 1 mg/kg (Doxorubicin 2), or in 5 weekly intraperitoneal injections of 2 mg/kg (Doxorubicin 3). An 80% mortality rate is observed at day 28 in Doxorubicin 1, whereas Doxorubicin 2 and Doxorubicin 3 reached 80% mortality at days 107 and 98, respectively. Fractional shortening decreased by 30% at week 2 in Doxorubicin DOX1, 55% at week 13 in Doxorubicin 2, and 42% at week 13 in Doxorubicin 3[4].

Clinical Trial
NCT Number Sponsor Condition Start Date Phase
NCT02587169 Broto, Javier Martín, M.D. Retroperitoneal Liposarcoma|Retroperitoneal Leiomyosarcoma|Chondrosarcoma January 2012 Phase 1|Phase 2
NCT00206518 Mothaffar Rimawi|Baylor College of Medicine|Baylor Breast Care Center Breast Cancer September 2004 Phase 2
NCT02471820 Meletios A. Dimopoulos|University of Athens Multiple Myeloma November 2014 Phase 2
NCT03023124 Italian Sarcoma Group Solitary Fibrous Tumors March 2017 Phase 2
NCT00793377 German Breast Group|German Adjuvant Breast Cancer Group Primary Breast Cancer Phase 3
NCT00759824 European Lung Cancer Working Party Small Cell Lung Carcinoma September 2008 Phase 2
NCT00204568 University of Schleswig-Holstein|Arbeitsgemeinschaft fur Internistische Onkologie|German Sarcoma Group|French Sarcoma Group Sarcoma, Soft Tissue August 2004 Phase 2
NCT00669773 National University Hospital, Singapore Breast Cancer February 2007 Phase 2
NCT00283621 M.D. Anderson Cancer Center|Amgen Sarcoma November 2002
NCT00441168 Janssen-Cilag International NV Multiple Myeloma December 2006 Phase 2
NCT01404936 M.D. Anderson Cancer Center|Schering-Plough Lymphoma July 1996 Phase 2
NCT00394251 Celgene Corporation|Celgene Breast Cancer August 2006 Phase 2
NCT00004067 NSABP Foundation Inc|National Cancer Institute (NCI) Breast Cancer February 2000 Phase 3
NCT00087178 NSABP Foundation Inc|National Cancer Institute (NCI) Breast Cancer May 2004 Phase 3
NCT00410488 M.D. Anderson Cancer Center|Eisai Inc. Sarcoma|Nausea|Vomiting December 2006
NCT00001384 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Breast Cancer|Breast Neoplasms May 1994 Phase 2
NCT00538395 King Faisal Specialist Hospital & Research Center Breast Cancer September 2007
NCT00206466 Baylor Breast Care Center|Baylor College of Medicine Breast Cancer April 2002 Phase 2
NCT00204646 University Hospital Tuebingen Sarcoma, Soft Tissue February 1999 Phase 2
NCT00003352 NSABP Foundation Inc|National Cancer Institute (NCI) Breast Cancer June 1998 Phase 2
NCT00215943 H. Lee Moffitt Cancer Center and Research Institute|Novartis Multiple Myeloma June 2003 Phase 3
NCT02623972 Dana-Farber Cancer Institute|Eisai Inc. Inflammatory Breast Cancer|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast December 2015 Phase 2
NCT01534078 Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Dana-Farber Cancer Institute|H. Lee Moffitt Cancer Center and Research Institute|Seattle Genetics, Inc. Hodgkin Lymphoma March 2012 Phase 2
NCT00267046 M.D. Anderson Cancer Center Sarcoma|Oral Mucositis December 2005 Phase 2
NCT02505269 Massachusetts General Hospital|Seattle Genetics, Inc. Hodgkin Lymphoma August 7, 2015 Phase 2
NCT00654732 M.D. Anderson Cancer Center|Genentech, Inc. Hodgkin Lymphoma March 2008 Phase 2
NCT00504504 M.D. Anderson Cancer Center|Genentech, Inc. Lymphoma March 2001 Phase 2
NCT00578864 Baylor College of Medicine|Texas Children's Hospital Neuroblastoma March 2007 Phase 2
NCT00337987 Yale University|Eisai Inc. Peripheral T-Cell Lymphoma November 2005 Phase 2
NCT02298283 The Lymphoma Academic Research Organisation Hodgkin Lymphoma April 2015 Phase 2
NCT00001209 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Neuroectodermal Tumor, Primitive|Neuroepithelioma|Osteosarcoma|Sarcoma|Sarcoma, Ewing's October 1986 Phase 1
NCT01622361 Asan Medical Center|Korean Breast Cancer Study Group Breast Cancer June 2012 Phase 3
NCT00319865 Korean Multiple Myeloma Working Party|Celgene Corporation Multiple Myeloma November 2005 Phase 2
NCT00147875 University of Cologne|German Hodgkin's Lymphoma Study Group|Eli Lilly and Company Hodgkin's Disease March 2004 Phase 1|Phase 2
NCT00147225 M.D. Anderson Cancer Center|Amgen Solid Tumors|Advanced Cancer August 2005 Phase 1|Phase 2
NCT03116984 Shanghai Zhongshan Hospital|Fudan University|Changhai Hospital|Shanghai 10th People's Hospital|First Affiliated Hospital of Zhejiang University|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School|Fujian Cancer Hospital|First Affiliated Hospital of Fujian Medical University|Zhongshan Hospital Xiamen University|The First Affiliated Hospital of Xiamen University|West China Hospital|Beijing Cancer Hospital|Xinqiao Hospital of Chongqing|309th Hospital of Chinese People's Liberation Army|Heilongjiang Provincial Agricultural Reclamation General Hospital|Longyan First Hospital, Affiliated to Fujian Medical University|Peking University First Hospital|The Third Affiliated Hospital of Qiqihar Medical Vniversitiy|Anhui Provincial Hospital|First Affiliated Hospital of Xinjiang Medical University|Qingdao University|The 4th people's hospital of Wuxi City,Affiliated to Jiangnan Universit|Subei People's Hospital of Jiangsu Province,Yangzhou University Hepatocellular Carcinoma May 1, 2017 Phase 3
NCT00591851 Memorial Sloan Kettering Cancer Center|Amgen|Genentech, Inc. Breast Cancer December 2004 Phase 2
NCT00448266 The Netherlands Cancer Institute Breast Cancer May 2007 Phase 2|Phase 3
NCT00736320 University of Cologne Hodgkin Lymphoma November 2009 Phase 3
NCT00083915 University of Arkansas Multiple Myeloma June 2001 Phase 3
NCT00871013 University of Arkansas Myeloma March 2009 Phase 2
NCT00869232 University of Arkansas Multiple Myeloma October 2008 Phase 2
NCT00572169 University of Arkansas Multiple Myeloma November 2006 Phase 3
NCT00352027 St. Jude Children's Research Hospital Hodgkin's Lymphoma July 2006 Phase 2
NCT00038558 M.D. Anderson Cancer Center Hodgkin Disease November 2001 Phase 3
NCT03004833 University of Cologne Classical Hodgkin Lymphoma February 21, 2017 Phase 2
NCT03004287 University of Arkansas|Janssen, LP Multiple Myeloma July 1, 2017 Phase 2
NCT02099188 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|Regione Lombardia Unresectable Sinonasal Tumors November 2013 Phase 2
NCT02099175 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|Regione Lombardia Sinonasal Tumors November 2013 Phase 2
NCT01070862 University Hospital, Caen|Laphal Multiple Myeloma de Novo Treatment May 2003 Phase 3
NCT01356680 University of Cologne Hodgkin Lymphoma December 2011 Phase 3
NCT00136539 Harold J. Burstein, MD, PhD|Dana-Farber Cancer Institute|Genentech, Inc.|Bristol-Myers Squibb|Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Harvard Vanguard Medical Associates|Brigham and Women's Hospital Breast Cancer March 1999 Phase 2
NCT00083538 University of Arkansas Multiple Myeloma February 2001 Phase 2
NCT00265018 University of Cologne Hodgkin´s Lymphoma May 1998 Phase 3
NCT02881086 Johann Wolfgang Goethe University Hospital Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma August 2016 Phase 3
NCT00026208 Stanford University Lymphoma, Hodgkin Disease|Lymphoma|Hodgkin Disease|Lymphoma: Hodgkin June 2001 Phase 2
NCT00408408 NSABP Foundation Inc|National Cancer Institute (NCI) Breast Cancer November 2006 Phase 3
NCT00264953 University of Cologne Hodgkin´s Lymphoma May 1998 Phase 3
NCT00199095 Johann Wolfgang Goethe University Hospital Adult Acute Lymphocytic Leukemia February 1997 Phase 4
NCT00199082 Nicola Goekbuget|Johann Wolfgang Goethe University Hospital Burkitt's Lymphoma|Burkitt's Leukemia|Mediastinal Neoplasms|Lymphoblastic Lymphoma|Large Cell Anaplastic Lymphoma July 2002 Phase 4
NCT00265031 University of Cologne Hodgkin´s Lymphoma January 1999 Phase 3
NCT00165139 Dana-Farber Cancer Institute|Boston Children’s Hospital|Children's Hospital of Philadelphia Neuroblastoma|Ewings Sarcoma|Non-rhabdomyosarcoma Soft Tissue Sarcoma January 1996 Phase 2
NCT00199056 Johann Wolfgang Goethe University Hospital Adult Acute Lymphocytic Leukemia October 1999 Phase 4
NCT00199017 Johann Wolfgang Goethe University Hospital Lymphoma, Lymphoblastic April 2004 Phase 4
NCT00199004 Johann Wolfgang Goethe University Hospital Adult Acute Lymphocytic Leukemia April 2004 Phase 4
NCT00198991 Johann Wolfgang Goethe University Hospital|Deutsche Krebshilfe e.V., Bonn (Germany)|German Federal Ministry of Education and Research Adult Acute Lymphocytic Leukemia April 2003 Phase 4
NCT00199069 Johann Wolfgang Goethe University Hospital|Deutsche Krebshilfe e.V., Bonn (Germany) Adult Acute Lymphocytic Leukemia April 1993 Phase 4
NCT02587169 Broto, Javier Martín, M.D. Retroperitoneal Liposarcoma|Retroperitoneal Leiomyosarcoma|Chondrosarcoma January 2012 Phase 1|Phase 2
NCT00206518 Mothaffar Rimawi|Baylor College of Medicine|Baylor Breast Care Center Breast Cancer September 2004 Phase 2
NCT02471820 Meletios A. Dimopoulos|University of Athens Multiple Myeloma November 2014 Phase 2
NCT03023124 Italian Sarcoma Group Solitary Fibrous Tumors March 2017 Phase 2
NCT00793377 German Breast Group|German Adjuvant Breast Cancer Group Primary Breast Cancer Phase 3
NCT00759824 European Lung Cancer Working Party Small Cell Lung Carcinoma September 2008 Phase 2
NCT00204568 University of Schleswig-Holstein|Arbeitsgemeinschaft fur Internistische Onkologie|German Sarcoma Group|French Sarcoma Group Sarcoma, Soft Tissue August 2004 Phase 2
NCT00669773 National University Hospital, Singapore Breast Cancer February 2007 Phase 2
NCT00283621 M.D. Anderson Cancer Center|Amgen Sarcoma November 2002
NCT00441168 Janssen-Cilag International NV Multiple Myeloma December 2006 Phase 2
NCT01404936 M.D. Anderson Cancer Center|Schering-Plough Lymphoma July 1996 Phase 2
NCT00394251 Celgene Corporation|Celgene Breast Cancer August 2006 Phase 2
NCT00004067 NSABP Foundation Inc|National Cancer Institute (NCI) Breast Cancer February 2000 Phase 3
NCT00087178 NSABP Foundation Inc|National Cancer Institute (NCI) Breast Cancer May 2004 Phase 3
NCT00410488 M.D. Anderson Cancer Center|Eisai Inc. Sarcoma|Nausea|Vomiting December 2006
NCT00001384 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Breast Cancer|Breast Neoplasms May 1994 Phase 2
NCT00538395 King Faisal Specialist Hospital & Research Center Breast Cancer September 2007
NCT00206466 Baylor Breast Care Center|Baylor College of Medicine Breast Cancer April 2002 Phase 2
NCT00204646 University Hospital Tuebingen Sarcoma, Soft Tissue February 1999 Phase 2
NCT00003352 NSABP Foundation Inc|National Cancer Institute (NCI) Breast Cancer June 1998 Phase 2
NCT00215943 H. Lee Moffitt Cancer Center and Research Institute|Novartis Multiple Myeloma June 2003 Phase 3
NCT02623972 Dana-Farber Cancer Institute|Eisai Inc. Inflammatory Breast Cancer|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast December 2015 Phase 2
NCT01534078 Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Dana-Farber Cancer Institute|H. Lee Moffitt Cancer Center and Research Institute|Seattle Genetics, Inc. Hodgkin Lymphoma March 2012 Phase 2
NCT00267046 M.D. Anderson Cancer Center Sarcoma|Oral Mucositis December 2005 Phase 2
NCT02505269 Massachusetts General Hospital|Seattle Genetics, Inc. Hodgkin Lymphoma August 7, 2015 Phase 2
NCT00654732 M.D. Anderson Cancer Center|Genentech, Inc. Hodgkin Lymphoma March 2008 Phase 2
NCT00504504 M.D. Anderson Cancer Center|Genentech, Inc. Lymphoma March 2001 Phase 2
NCT00578864 Baylor College of Medicine|Texas Children's Hospital Neuroblastoma March 2007 Phase 2
NCT00337987 Yale University|Eisai Inc. Peripheral T-Cell Lymphoma November 2005 Phase 2
NCT02298283 The Lymphoma Academic Research Organisation Hodgkin Lymphoma April 2015 Phase 2
NCT00001209 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Neuroectodermal Tumor, Primitive|Neuroepithelioma|Osteosarcoma|Sarcoma|Sarcoma, Ewing's October 1986 Phase 1
NCT01622361 Asan Medical Center|Korean Breast Cancer Study Group Breast Cancer June 2012 Phase 3
NCT00319865 Korean Multiple Myeloma Working Party|Celgene Corporation Multiple Myeloma November 2005 Phase 2
NCT00147875 University of Cologne|German Hodgkin's Lymphoma Study Group|Eli Lilly and Company Hodgkin's Disease March 2004 Phase 1|Phase 2
NCT00147225 M.D. Anderson Cancer Center|Amgen Solid Tumors|Advanced Cancer August 2005 Phase 1|Phase 2
NCT03116984 Shanghai Zhongshan Hospital|Fudan University|Changhai Hospital|Shanghai 10th People's Hospital|First Affiliated Hospital of Zhejiang University|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School|Fujian Cancer Hospital|First Affiliated Hospital of Fujian Medical University|Zhongshan Hospital Xiamen University|The First Affiliated Hospital of Xiamen University|West China Hospital|Beijing Cancer Hospital|Xinqiao Hospital of Chongqing|309th Hospital of Chinese People's Liberation Army|Heilongjiang Provincial Agricultural Reclamation General Hospital|Longyan First Hospital, Affiliated to Fujian Medical University|Peking University First Hospital|The Third Affiliated Hospital of Qiqihar Medical Vniversitiy|Anhui Provincial Hospital|First Affiliated Hospital of Xinjiang Medical University|Qingdao University|The 4th people's hospital of Wuxi City,Affiliated to Jiangnan Universit|Subei People's Hospital of Jiangsu Province,Yangzhou University Hepatocellular Carcinoma May 1, 2017 Phase 3
NCT00591851 Memorial Sloan Kettering Cancer Center|Amgen|Genentech, Inc. Breast Cancer December 2004 Phase 2
NCT00448266 The Netherlands Cancer Institute Breast Cancer May 2007 Phase 2|Phase 3
NCT00736320 University of Cologne Hodgkin Lymphoma November 2009 Phase 3
NCT00083915 University of Arkansas Multiple Myeloma June 2001 Phase 3
NCT00871013 University of Arkansas Myeloma March 2009 Phase 2
NCT00869232 University of Arkansas Multiple Myeloma October 2008 Phase 2
NCT00572169 University of Arkansas Multiple Myeloma November 2006 Phase 3
NCT00352027 St. Jude Children's Research Hospital Hodgkin's Lymphoma July 2006 Phase 2
NCT00038558 M.D. Anderson Cancer Center Hodgkin Disease November 2001 Phase 3
NCT03004833 University of Cologne Classical Hodgkin Lymphoma February 21, 2017 Phase 2
NCT03004287 University of Arkansas|Janssen, LP Multiple Myeloma July 1, 2017 Phase 2
NCT02099188 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|Regione Lombardia Unresectable Sinonasal Tumors November 2013 Phase 2
NCT02099175 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|Regione Lombardia Sinonasal Tumors November 2013 Phase 2
NCT01070862 University Hospital, Caen|Laphal Multiple Myeloma de Novo Treatment May 2003 Phase 3
NCT01356680 University of Cologne Hodgkin Lymphoma December 2011 Phase 3
NCT00136539 Harold J. Burstein, MD, PhD|Dana-Farber Cancer Institute|Genentech, Inc.|Bristol-Myers Squibb|Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Harvard Vanguard Medical Associates|Brigham and Women's Hospital Breast Cancer March 1999 Phase 2
NCT00083538 University of Arkansas Multiple Myeloma February 2001 Phase 2
NCT00265018 University of Cologne Hodgkin´s Lymphoma May 1998 Phase 3
NCT02881086 Johann Wolfgang Goethe University Hospital Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma August 2016 Phase 3
NCT00026208 Stanford University Lymphoma, Hodgkin Disease|Lymphoma|Hodgkin Disease|Lymphoma: Hodgkin June 2001 Phase 2
NCT00408408 NSABP Foundation Inc|National Cancer Institute (NCI) Breast Cancer November 2006 Phase 3
NCT00264953 University of Cologne Hodgkin´s Lymphoma May 1998 Phase 3
NCT00199095 Johann Wolfgang Goethe University Hospital Adult Acute Lymphocytic Leukemia February 1997 Phase 4
NCT00199082 Nicola Goekbuget|Johann Wolfgang Goethe University Hospital Burkitt's Lymphoma|Burkitt's Leukemia|Mediastinal Neoplasms|Lymphoblastic Lymphoma|Large Cell Anaplastic Lymphoma July 2002 Phase 4
NCT00265031 University of Cologne Hodgkin´s Lymphoma January 1999 Phase 3
NCT00165139 Dana-Farber Cancer Institute|Boston Children’s Hospital|Children's Hospital of Philadelphia Neuroblastoma|Ewings Sarcoma|Non-rhabdomyosarcoma Soft Tissue Sarcoma January 1996 Phase 2
NCT00199056 Johann Wolfgang Goethe University Hospital Adult Acute Lymphocytic Leukemia October 1999 Phase 4
NCT00199017 Johann Wolfgang Goethe University Hospital Lymphoma, Lymphoblastic April 2004 Phase 4
NCT00199004 Johann Wolfgang Goethe University Hospital Adult Acute Lymphocytic Leukemia April 2004 Phase 4
NCT00198991 Johann Wolfgang Goethe University Hospital|Deutsche Krebshilfe e.V., Bonn (Germany)|German Federal Ministry of Education and Research Adult Acute Lymphocytic Leukemia April 2003 Phase 4
NCT00199069 Johann Wolfgang Goethe University Hospital|Deutsche Krebshilfe e.V., Bonn (Germany) Adult Acute Lymphocytic Leukemia April 1993 Phase 4
NCT00969462 Meir Medical Center Non-Hodgkin's Lymphoma September 2009 Phase 4
NCT01440088 Threshold Pharmaceuticals|Sarcoma Alliance for Research through Collaboration (SARC) Soft Tissue Sarcoma September 2011 Phase 3
NCT00659178 GlaxoSmithKline Neoplasms, Ovarian June 18, 2008 Phase 1
NCT01095926 University Hospital Muenster Wilms Tumor|Neuroblastoma|Soft Tissue Sarcoma|Acute Lymphoblastic Leukemia May 2010 Phase 2
NCT02475772 Clemens Tempfer|Ruhr University of Bochum Ovarian Cancer November 2016 Phase 1
NCT00878800 Onxeo|Spectrum Pharmaceuticals, Inc Dose Escalation: Solid Tumors|MTD: Soft Tissue Sarcomas December 2006 Phase 1|Phase 2
NCT01227941 Tesaro, Inc. Ovarian Cancer November 2010 Phase 1
NCT01163903 University Health Network, Toronto|Princess Margaret Hospital, Canada Advanced Solid Tumours July 2010 Phase 1
NCT02562378 MedSIR|Roche Pharma AG|Experior Breast Cancer October 2015 Phase 1
NCT00350948 Telik Ovarian Neoplasms May 2006 Phase 3
NCT02192021 University of Pittsburgh Cutaneous T Cell Lymphoma January 2016 Phase 1
NCT00581360 University of Pittsburgh|Millennium Pharmaceuticals, Inc. Adenoid Cystic Carcinoma November 2007 Phase 2
NCT02237690 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Ovarian Cancer September 2014 Phase 1
NCT02420847 M.D. Anderson Cancer Center|Millennium Pharmaceuticals, Inc. Bladder Cancer July 2015 Phase 1|Phase 2
NCT00923936 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Sarcoma, Kaposi April 23, 2009 Phase 2
NCT00949325 Sidney Kimmel Comprehensive Cancer Center|National Comprehensive Cancer Network|Wyeth is now a wholly owned subsidiary of Pfizer Sarcoma September 2009 Phase 1|Phase 2
NCT00720174 National Cancer Institute (NCI) Adult Angiosarcoma|Adult Desmoplastic Small Round Cell Tumor|Adult Epithelioid Sarcoma|Adult Extraskeletal Myxoid Chondrosarcoma|Adult Extraskeletal Osteosarcoma|Adult Fibrosarcoma|Adult Leiomyosarcoma|Adult Liposarcoma|Adult Malignant Mesenchymoma|Adult Malignant Peripheral Nerve Sheath Tumor|Adult Rhabdomyosarcoma|Adult Synovial Sarcoma|Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone|Childhood Angiosarcoma|Childhood Desmoplastic Small Round Cell Tumor|Childhood Epithelioid Sarcom June 2008 Phase 1
NCT00123929 Hospital San Carlos, Madrid|UNC Lineberger Comprehensive Cancer Center Breast Cancer January 2005 Phase 2
NCT00484432 MolMed S.p.A. Ovarian Cancer Metastatic Recurrent November 2008 Phase 2
NCT02261805 Georgetown University|Synta Pharmaceuticals Corp. Cancer|Small Cell Lung Cancer October 2014 Phase 1|Phase 2
NCT00201708 Ohio State University Comprehensive Cancer Center Breast Cancer October 2004 Phase 2
NCT03221881 Hebei Medical University Fourth Hospital Breast Cancer January 2015
NCT01375699 Virginia Commonwealth University Breast Cancer|Gastrointestinal Cancer|Genitourinary Cancer|Sarcoma|Gynecologic Cancer August 11, 2011 Phase 1
NCT00083226 National Cancer Institute (NCI) Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver Cancer March 2004 Phase 2
NCT01815294 Janssen Research & Development, LLC Neoplasms|Neoplasms, Ovarian|Neoplasms, Breast|Advanced or Refractory Solid Malignancies May 2013 Phase 1
NCT01333423 M.D. Anderson Cancer Center|National Institutes of Health (NIH) Breast Cancer September 2012 Phase 1
NCT00516191 University of California, San Francisco Multiple Myeloma October 2004 Phase 1|Phase 2
NCT02758366 Meyer Children's Hospital Glioblastoma (GBM)|DIPG February 2016 Phase 2
NCT00193037 SCRI Development Innovations, LLC|Ortho Biotech, Inc.|Aventis Pharmaceuticals Breast Cancer February 2001 Phase 2
NCT01281943 Washington University School of Medicine Liver Neoplasms June 2011 Phase 2
NCT01490047 Ludwig Institute for Cancer Research|Johns Hopkins University Solid Tumors|Lymphomas January 2013 Phase 1
NCT02753881 Yale University Liver Cancer November 2015 Phase 1
NCT01131364 Philogen S.p.A. Advanced Solid Tumor|Breast Cancer June 2008 Phase 1|Phase 2
NCT00003207 Washington University School of Medicine|National Cancer Institute (NCI) Sarcoma|Unspecified Adult Solid Tumor, Protocol Specific March 1998 Phase 1
NCT00082095 Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA Metastatic Breast Cancer April 2004 Phase 3
NCT00098579 National Cancer Institute (NCI) Gastrointestinal Stromal Tumor|Recurrent Adult Soft Tissue Sarcoma|Stage IV Adult Soft Tissue Sarcoma October 2004 Phase 1
NCT00288431 Merck Sharp & Dohme Corp.|Ariad Pharmaceuticals Cancer|Sarcoma February 2006 Phase 1
NCT01104298 Grupo Espanol de Investigacion en Sarcomas Sarcoma November 2009 Phase 2
NCT00886028 National Institute of Cancerología Malignant Pleural Mesothelioma September 2006 Phase 2
NCT00895414 Masonic Cancer Center, University of Minnesota Breast Cancer April 2009
NCT02527772 Guangxi Medical University Hepatocellular Carcinoma September 2015 Phase 2|Phase 3
NCT00703170 Washington University School of Medicine Resistant Solid Malignancies March 2008 Phase 1
NCT00720096 H. Lee Moffitt Cancer Center and Research Institute|United States Department of Defense Ovarian Cancer July 2008
NCT01767155 AEterna Zentaris Endometrial Cancer April 2013 Phase 3
NCT01537029 Texas Tech University Health Sciences Center|University of Texas Breast Cancer|Obesity February 2012 Phase 4
NCT03111069 M.D. Anderson Cancer Center Malignant Neoplasms of Mesothelial and Soft Tissue|Rhabdomyosarcoma, Pelvic|Rhabdomyosarcoma, Abdominal July 2017 Phase 1
NCT01116635 University of British Columbia Hepatocellular Carcinoma January 2010 Phase 1|Phase 2
NCT00944801 University of Regensburg|Essex Pharma (Schering-Plough) Germany Glioblastoma July 2002 Phase 1|Phase 2
NCT02888665 Fred Hutchinson Cancer Research Center|National Cancer Institute (NCI) Sarcoma December 2016 Phase 1|Phase 2
NCT00305084 MolMed S.p.A. Cancer January 2006 Phase 1
NCT03042819 University Health Network, Toronto|Karyopharm Therapeutics Inc Soft Tissue Sarcoma May 16, 2017 Phase 1
NCT02557854 Theodore Laetsch|University of Texas Southwestern Medical Center Rhabdomyosarcoma|Neuroblastoma|Sarcoma|Sarcoma, Ewing|Osteosarcoma December 2016 Phase 1
NCT00755261 Sidney Kimmel Comprehensive Cancer Center Sarcoma|Soft Tissue Sarcoma September 2008 Phase 2
NCT00530101 University of Miami|Mallinckrodt Breast Cancer July 2004 Phase 1
NCT02260544 Dr. Reddy's Laboratories Limited Ovarian Epithelial Cancer Recurrent July 2014 Phase 1
NCT00815945 AGO Study Group|MSD SHARP & DOHME GmbH (formerly Essex Pharma GmbH) Mesenchymal Tumor|Carcinosarcoma|Leiomyosarcoma June 2008 Phase 2
NCT00770536 Amgen Cancer|Carcinoma|Fallopian Tube Cancer|Gynecological Malignancies|Metastases|Oncology|Ovarian Cancer|Solid Tumors|Tumors January 2009 Phase 1
NCT00068393 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Metastatic Renal Cell Carcinoma|Renal Cell Carcinoma With Sarcomatoid Features December 2003 Phase 2
NCT00004014 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Prostate Cancer April 1999 Phase 2
NCT02790580 National University Hospital, Singapore Breast Cancer May 2016 Phase 2
NCT01840592 Memorial Sloan Kettering Cancer Center|Bayer|National Comprehensive Cancer Network Hepatocellular Carcinoma April 2013 Phase 2
NCT03022123 Hebei Medical University Fourth Hospital Diffuse Large B-cell Lymphoma November 2016
NCT00102609 Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|PharmaMar|PharmaMar S.A.U. Soft Tissue Sarcoma|Sarcoma|Neoplasms, Connective and Soft Tissue|Neoplasms by Histologic Type|Neoplasms April 2005 Phase 1
NCT01872416 The First Affiliated Hospital of Guangzhou Medical University Small Cell Lung Cancer October 2012 Phase 2
NCT00634205 European Lung Cancer Working Party Malignant Mesothelioma July 2006 Phase 2
NCT01669239 SOLTI Breast Cancer Research Group Breast Cancer June 2013 Phase 2
NCT01027910 Massachusetts General Hospital|Dana-Farber Cancer Institute|Brigham and Women's Hospital|Pharmacyclics LLC. Sarcoma February 2009 Phase 1|Phase 2
NCT03009201 OHSU Knight Cancer Institute|National Cancer Institute (NCI) Metastatic Angiosarcoma|Metastatic Epithelioid Sarcoma|Metastatic Fibrosarcoma|Metastatic Leiomyosarcoma|Metastatic Liposarcoma|Metastatic Malignant Peripheral Nerve Sheath Tumor|Metastatic Synovial Sarcoma|Metastatic Undifferentiated Pleomorphic Sarcoma|Myxofibrosarcoma|Pleomorphic Rhabdomyosarcoma|Stage III Soft Tissue Sarcoma|Stage IV Soft Tissue Sarcoma|Undifferentiated (Embryonal) Sarcoma January 2017 Phase 1
NCT00426127 University of Iowa|Aventis Pharmaceuticals Pancreatic Cancer November 2006 Phase 2
NCT00913835 Eli Lilly and Company Ovarian Neoplasms June 2009 Phase 2
NCT00718484 Ziopharm Soft Tissue Sarcoma August 2008 Phase 2
NCT00124956 Boston Children’s Hospital|Glaser Pediatric Research Network|Elizabeth Glaser Pediatric AIDS Foundation Cancer June 2003 Phase 1|Phase 2
NCT00524810 ARCAGY/ GINECO GROUP Metastatic Breast Cancer February 2004 Phase 2
NCT00096291 Massachusetts General Hospital|National Cancer Institute (NCI) Breast Cancer February 2000 Phase 2
NCT00262990 Novartis Pharmaceuticals|Novartis Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Neoplasms November 2005 Phase 3
NCT03000036 University of Campinas, Brazil|Fundação de Amparo à Pesquisa do Estado de São Paulo Breast Cancer Female|Doxorubicin Induced Cardiomyopathy July 2012
NCT00903630 Masonic Cancer Center, University of Minnesota|Celgene Corporation Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer April 2009 Phase 1|Phase 2
NCT02078388 National University Hospital, Singapore Breast Cancer November 2013 Phase 2|Phase 3
NCT01202890 New Mexico Cancer Care Alliance|Celgene Corporation Ovarian Cancer|Epithelial Ovarian Cancer|Fallopian Tube Carcinoma|Primary Peritoneal Carcinoma September 2010 Phase 1
NCT00722293 GlaxoSmithKline Neoplasms, Breast July 2008 Phase 1
NCT01205503 Mara Chambers|University of Kentucky Breast Cancer|Non-Hodgkin's Lymphoma September 2010 Phase 2
NCT00182767 National Cancer Institute (NCI) Fallopian Tube Cancer|Female Reproductive Cancer|Recurrent Breast Cancer|Recurrent Ovarian Epithelial Cancer|Stage III Ovarian Epithelial Cancer|Stage IV Breast Cancer|Stage IV Ovarian Epithelial Cancer January 2006 Phase 1|Phase 2
NCT01010984 Robert C. Martin|University of Louisville|Thomas Jefferson University|M.D. Anderson Cancer Center Stage IV Melanoma September 2009 Phase 1
NCT01272557 PD Dr. med. Matthias Dollinger|Martin-Luther-Universität Halle-Wittenberg Liver Carcinoma December 2010 Phase 2
NCT00165191 Dana-Farber Cancer Institute|Brigham and Women's Hospital|Massachusetts General Hospital Adenocarcinoma of Stomach|Adenocarcinoma of GE Junction|Adenocarcinoma of Esophagus August 1998 Phase 2
NCT01214668 Eli Lilly and Company Solid Tumors January 2009 Phase 1
NCT00179725 Celgene Corporation|Prologue Research International|Celgene Ovarian Cancer November 2005 Phase 1|Phase 2
NCT01168791 Ziopharm Soft Tissue Sarcoma July 2010 Phase 3
NCT01655693 Onxeo Carcinoma, Hepatocellular June 2012 Phase 3
NCT00604968 Merck Sharp & Dohme Corp. Breast Neoplasms February 7, 2007 Phase 4
NCT02076620 Philogen S.p.A. Advanced Solid Tumors Amenable to Anthracycline Therapy|Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer Amenable to Anthracycline Therapy January 2013 Phase 1
NCT02584309 Washington University School of Medicine Sarcoma, Soft Tissue|Soft Tissue Sarcoma|Undifferentiated Pleomorphic Sarcoma|Leiomyosarcoma|Liposarcoma|Synovial Sarcoma|Myxofibrosarcoma|Angiosarcoma|Fibrosarcoma|Malignant Peripheral Nerve Sheath Tumor|Epithelioid Sarcoma February 22, 2016 Phase 2
NCT03056001 Edward Kim|Merck Sharp & Dohme Corp.|Carolinas Healthcare System Soft Tissue Sarcoma, Adult|Soft Tissue Sarcoma, Child May 1, 2017 Phase 2
NCT01514188 CytRx Metastatic Soft Tissue Sarcoma|Locally Advanced Soft Tissue Sarcoma|Unresectable Soft Tissue Sarcoma December 2011 Phase 2
NCT02997358 Gustave Roussy, Cancer Campus, Grand Paris Uterine or Soft Tissue Leiomyosarcoma January 2017 Phase 3
NCT01100944 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Thymoma|Thymic Carcinoma March 2010 Phase 1|Phase 2
NCT00479128 M.D. Anderson Cancer Center|Millennium Pharmaceuticals, Inc. Solid Tumor|Urethral Cancer September 2006 Phase 1
NCT00949182 Rutgers, The State University of New Jersey Liver Cancer July 2009 Phase 2
NCT00484341 MolMed S.p.A. Metastatic Adult Soft Tissue Sarcoma October 2010 Phase 2
NCT00465673 Sidney Kimmel Comprehensive Cancer Center|TTY Biopharm Breast Cancer September 2005 Phase 2
NCT02451943 Eli Lilly and Company Soft Tissue Sarcoma September 2015 Phase 3
NCT00038142 M.D. Anderson Cancer Center Ewing's Sarcoma November 1997 Phase 2
NCT00608803 Ziopharm Advanced Cancer January 2008 Phase 1
NCT01489371 Gynecologic Oncology Group|National Cancer Institute (NCI) Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mixed Epithelial Carcinoma|Ovarian Serous Cystadenocarcinoma|Ovarian Undifferentiated Adenocarcinoma|Recurrent Fallopian Tube Cancer|Recurrent Ovarian Epithelial Cancer|Recurrent Primary Peritoneal Cavity Cancer July 2012 Phase 1
NCT00796120 Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|PharmaMar Sarcoma November 2008 Phase 3
NCT00431795 Hellenic Oncology Research Group|University Hospital of Crete Breast Cancer June 2003 Phase 2
NCT00575952 Gynecologic Oncology Group|National Cancer Institute (NCI) Endometrial Adenosquamous Carcinoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Mixed Adenocarcinoma|Endometrial Serous Adenocarcinoma|Endometrial Squamous Cell Carcinoma|Endometrial Undifferentiated Carcinoma|Recurrent Uterine Corpus Carcinoma|Stage IIIA Uterine Corpus Cancer|Stage IIIC Uterine Corpus Cancer|Stage IVA Uterine Corpus Cancer|Stage IVB Uterine Corpus Cancer January 2008 Phase 1
NCT01970540 PharmaMar Endometrial Adenocarcinomas|Neuroendocrine Tumors|Small-cell Lung Cancer With Less Than 2 Prior Cytotoxic-containing Lines of Therapy May 25, 2011 Phase 1
NCT00004109 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Sarcoma March 1998 Phase 1
NCT00074087 European Organisation for Research and Treatment of Cancer - EORTC Lymphoma October 2003 Phase 2
NCT01746238 Massachusetts General Hospital Sarcoma March 2013 Phase 1
NCT00000996 National Institute of Allergy and Infectious Diseases (NIAID) Sarcoma, Kaposi|HIV Infections Phase 2
NCT02186834 H. Lee Moffitt Cancer Center and Research Institute|Karyopharm Therapeutics Inc Multiple Myeloma September 19, 2014 Phase 1|Phase 2
NCT02394015 Grupo Español de Investigación en Cáncer de Ovario|PharmaMar Ovarian Epithelial Cancer Recurrent March 2015
NCT00563953 SOLTI Breast Cancer Research Group|Schering-Plough Breast Cancer September 2007 Phase 2
NCT00077428 National Cancer Institute (NCI)|Southwest Oncology Group Recurrent Adenoid Cystic Carcinoma of the Oral Cavity|Recurrent Salivary Gland Cancer|Salivary Gland Adenoid Cystic Carcinoma|Stage III Adenoid Cystic Carcinoma of the Oral Cavity|Stage III Salivary Gland Cancer|Stage IV Adenoid Cystic Carcinoma of the Oral Cavity|Stage IV Salivary Gland Cancer June 2004 Phase 2
NCT00088855 National Cancer Institute (NCI) DS Stage I Plasma Cell Myeloma|DS Stage II Plasma Cell Myeloma|DS Stage III Plasma Cell Myeloma June 15, 2004 Phase 2
NCT00079014 National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific January 2004 Phase 1
NCT00933985 National Cancer Institute (NCI) Acute Leukemias of Ambiguous Lineage|Acute Undifferentiated Leukemia|Angioimmunoblastic T-cell Lymphoma|Blastic Phase Chronic Myelogenous Leukemia|Childhood Burkitt Lymphoma|Childhood Chronic Myelogenous Leukemia|Childhood Diffuse Large Cell Lymphoma|Childhood Immunoblastic Large Cell Lymphoma|Childhood Nasal Type Extranodal NK/T-cell Lymphoma|Cutaneous B-cell Non-Hodgkin Lymphoma|Hepatosplenic T-cell Lymphoma|Intraocular Lymphoma|Noncutaneous Extranodal Lymphoma|Peripheral T-cell Lymphoma|Recur June 2009 Phase 1
NCT01498588 Emory University|Eisai Inc. Breast Neoplasms|Breast Cancer|Breast Tumors|Cancer of the Breast|Neoplasms, Breast|Tumors, Breast November 2011 Phase 2
NCT02262455 Santa Maria Biotherapeutics Ovarian Cancer|Fallopian Tube Cancer|Endometrial Cancer|Solid Tumors October 2014 Phase 1
NCT00483509 MolMed S.p.A. Small Cell Lung Cancer December 2006 Phase 2
NCT01227408 University of Southern California|CTI BioPharma Breast Cancer February 2009 Phase 2
NCT02751918 Bayer Ovarian Neoplasms June 8, 2016 Phase 1
NCT00331955 National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific March 2006 Phase 1
NCT00102219 Eli Lilly and Company Breast Cancer October 2004 Phase 2
NCT01670500 Beth Israel Deaconess Medical Center|Dana-Farber Cancer Institute Breast Cancer October 2012 Phase 2
NCT00183742 University of Southern California|Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA Cancer|Carcinoma December 2000 Phase 1
NCT00470067 Roswell Park Cancer Institute Endometrial Cancer February 2007 Phase 2
NCT00478361 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Distal Urethral Cancer|Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter|Proximal Urethral Cancer|Recurrent Bladder Cancer|Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter|Recurrent Urethral Cancer|Regional Transitional Cell Cancer of the Renal Pelvis and Ureter|Stage III Bladder Cancer|Stage IV Bladder Cancer|Transitional Cell Carcinoma of the Bladder|Urethral Cancer Associated With Invasive Bladder Cancer April 2007 Phase 2
NCT00856037 University of Nebraska|National Cancer Institute (NCI) Recurrent Small Cell Lung Carcinoma February 2009 Phase 1
NCT00727961 Merck Sharp & Dohme Corp. Ovarian Neoplasms November 9, 2004 Phase 4
NCT00184002 University of Southern California|Ortho Biotech, Inc. Non-Hodgkin's Lymphoma January 10, 2003 Phase 2
NCT00574236 University of Wisconsin, Madison|National Cancer Institute (NCI)|Millennium Pharmaceuticals, Inc. Metastatic Breast Cancer February 2006 Phase 2
NCT01637532 Leiden University Medical Center|University Medical Center Groningen Recurrent Ovarian Cancer February 2011 Phase 1|Phase 2
NCT00004162 University of Alabama at Birmingham|National Cancer Institute (NCI) Lymphoma June 1997 Phase 1
NCT02953184 Jilin University Antineoplastic Combined Chemotherapy Protocols November 2016 Phase 2
NCT00093444 National Institutes of Health Clinical Center (CC)|National Cancer Institute (NCI) Liver Cancer|Metastatic Cancer September 2004 Phase 1
NCT00255801 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI)|Tibotec Pharmaceutical Limited|M.D. Anderson Cancer Center|New York University School of Medicine|Hackensack University Medical Center|Roswell Park Cancer Institute Lymphoma November 2005 Phase 2
NCT01145430 National Cancer Institute (NCI) Estrogen Receptor Negative|HER2/Neu Negative|Male Breast Carcinoma|Progesterone Receptor Negative|Recurrent Breast Carcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Stage IV Breast Cancer|Triple-Negative Breast Carcinoma June 2010 Phase 1
NCT02326025 Eli Lilly and Company Sarcoma, Soft Tissue January 2015 Phase 1
NCT00080782 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Metastatic Cancer|Prostate Cancer February 2002 Phase 2
NCT00266799 Merck Sharp & Dohme Corp.|Essex Pharma GmbH Breast Cancer January 13, 2006 Phase 3
NCT00687440 Merck Sharp & Dohme Corp.|MDS Pharma Services Breast Neoplasm May 18, 2005 Phase 2
NCT01854255 Ruhr University of Bochum Gastric Cancer November 2013 Phase 2
NCT00507962 M.D. Anderson Cancer Center Advanced Cancer March 2005 Phase 1
NCT02659930 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Kaposi Sarcoma January 4, 2016 Phase 1
NCT01784120 Gachon University Gil Medical Center Metastatic Breast Cancer January 2011 Phase 2
NCT01409733 Heidelberg University|University Hospital Tuebingen|SLK Heilbronn Stage IV Melanoma Patients With Unresectable Liver Metastases June 2010 Phase 1|Phase 2
NCT00531973 Catholic University, Italy|Cephalon Breast Cancer January 2007 Phase 4
NCT00216645 Janssen Pharmaceutical K.K. Ovarian Neoplasms January 2005 Phase 2
NCT00736333 Merck Sharp & Dohme Corp. Breast Neoplasm November 2006
NCT01605526 Hoffmann-La Roche Sarcoma May 2012 Phase 1
NCT01113957 AbbVie (prior sponsor, Abbott)|AbbVie Ovarian Cancer March 2010 Phase 2
NCT00600977 French Innovative Leukemia Organisation Acute Lymphoblastic Leukemia March 2002 Phase 2
NCT01673438 CytRx Advanced Solid Tumor July 2012 Phase 1
NCT00049114 National Cancer Institute (NCI) Inflammatory Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer February 2003 Phase 2
NCT00635193 AbbVie (prior sponsor, Abbott)|Biogen|AbbVie Ovarian Cancer, Primary Peritoneal Cancer July 2007 Phase 1|Phase 2
NCT00248248 Southeastern Gynecologic Oncology|Ortho Biotech, Inc. Ovarian Neoplasm October 2005 Phase 2
NCT00002147 Sequus Pharmaceuticals|NIH AIDS Clinical Trials Information Service Sarcoma, Kaposi|HIV Infections Phase 3
NCT02456857 M.D. Anderson Cancer Center|Novartis Pharmaceuticals Breast Cancer January 2016 Phase 2
NCT01009801 Swiss Group for Clinical Cancer Research Liver Cancer February 2010 Phase 1|Phase 2
NCT01990352 University of Arizona Breast Cancer November 5, 2013 Phase 2
NCT01851733 Washington University School of Medicine Glioblastoma August 13, 2013 Phase 1
NCT01015833 National Cancer Institute (NCI) Adult Hepatocellular Carcinoma|Advanced Adult Hepatocellular Carcinoma|BCLC Stage C Adult Hepatocellular Carcinoma|BCLC Stage D Adult Hepatocellular Carcinoma|Localized Non-Resectable Adult Liver Carcinoma|Recurrent Adult Liver Carcinoma February 2010 Phase 3
NCT01492881 UNC Lineberger Comprehensive Cancer Center|Merck Sharp & Dohme Corp. Multiple Myeloma April 2012 Phase 2
NCT00003350 National Cancer Institute (NCI) AIDS-related Kaposi Sarcoma March 1999 Phase 3
NCT02812654 AC Camargo Cancer Center Sarcoma, Soft Tissue March 2015 Phase 2
NCT02488564 Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori HER-2 Positive Breast Cancer October 2014 Phase 2
NCT00861120 Vejle Hospital Epithelial Ovarian Cancer April 2009 Phase 2
NCT00063934 National Cancer Institute (NCI) Male Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer May 2003 Phase 1|Phase 2
NCT00003034 Alfacell|National Cancer Institute (NCI) Malignant Mesothelioma May 1997 Phase 3
NCT00626704 Amgen Locally Advanced or Metastatic, Unresectable Soft Tissue Sarcoma|Sarcoma|Soft Tissue Sarcoma November 2007 Phase 1|Phase 2
NCT00779285 Merck Sharp & Dohme Corp. Breast Neoplasm February 2006 Phase 4
NCT00744354 UNC Lineberger Comprehensive Cancer Center|Merck Sharp & Dohme Corp.|Millennium Pharmaceuticals, Inc.|Ortho Biotech, Inc. Multiple Myeloma and Plasma Cell Neoplasm October 2008 Phase 1
NCT01485874 Hoosier Cancer Research Network|Boehringer Ingelheim Ovarian Cancer November 2011 Phase 1
NCT00550771 Merck Sharp & Dohme Corp. Breast Neoplasm July 16, 2007 Phase 2
NCT00617591 H. Lee Moffitt Cancer Center and Research Institute|Celgene Corporation|Ortho Biotech Clinical Affairs, L.L.C. Multiple Myeloma January 2008 Phase 2
NCT00043082 Southwest Oncology Group|National Cancer Institute (NCI) Ovarian Cancer|Peritoneal Cavity Cancer August 2002 Phase 3
NCT01541332 Oncotherapeutics|Celgene Corporation Multiple Myeloma February 2012 Phase 1|Phase 2
NCT01170650 Endocyte Ovarian Cancer April 2011 Phase 3
NCT00131963 Duke University|National Cancer Institute (NCI) Breast Cancer October 2003
NCT01328236 Clinical Service, China|Harbin Hematology and Oncology Institute|Shanghai Changzheng Hospital|Chinese PLA General Hospital|307 Hospital of PLA|Wuhan Union Hospital, China|Beijing Chao Yang Hospital|Henan Provincial Hospital|Peking University Third Hospital Plasma Cell Leukemia|Multiple Myeloma September 2010 Phase 2
NCT02536183 AeRang Kim|Children's Research Institute Pediatric Cancer|Solid Tumors|Rhabdomyosarcoma|Ewing Sarcoma|Soft Tissue Sarcomas|Osteosarcoma|Neuroblastoma|Wilms Tumor|Hepatic Tumor|Germ Cell Tumors October 2016 Phase 1
NCT01206881 Herlev Hospital|Rigshospitalet, Denmark|Odense University Hospital|Aarhus University Hospital Breast Cancer March 2009 Phase 2
NCT00502411 M.D. Anderson Cancer Center Soft Tissue Sarcoma January 2003 Phase 1
NCT00103506 Janssen Research & Development, LLC Multiple Myeloma December 2004 Phase 3
NCT00461344 Sanofi Ductal Carcinoma July 2004 Phase 2
NCT00244985 Roswell Park Cancer Institute|Ortho Biotech, Inc. Lymphoma September 2005 Phase 1|Phase 2
NCT00346229 Duke University|National Cancer Institute (NCI) Breast Cancer April 2006 Phase 1
NCT02315196 Rutgers, The State University of New Jersey|National Cancer Institute (NCI)|Rutgers Cancer Institute of New Jersey Estrogen Receptor-negative Breast Cancer|HER2-negative Breast Cancer|Progesterone Receptor-negative Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Triple-negative Breast Cancer December 2014 Phase 2
NCT02414568 The Lymphoma Academic Research Organisation Classical Hodgkin Lymphoma July 2015 Phase 2
NCT00785798 Yale University|Merck Sharp & Dohme Corp. Relapsed Lymphomas|Refractory Lymphomas January 2009 Phase 1|Phase 2
NCT00004123 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Sarcoma July 1997 Phase 1
NCT01666444 VentiRx Pharmaceuticals Inc.|Gynecologic Oncology Group Epithelial Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer October 2012 Phase 2
NCT02255110 Merck KGaA|Threshold Pharmaceuticals Soft Tissue Sarcoma December 2014 Phase 2
NCT00019630 National Cancer Institute (NCI) Childhood Soft Tissue Sarcoma|Childhood Liver Cancer|Bone Cancer|Brain Tumor|Kidney Tumor July 1999 Phase 1
NCT00004930 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Lung Cancer|Metastatic Cancer July 1999 Phase 1
NCT00005800 H. Lee Moffitt Cancer Center and Research Institute|National Cancer Institute (NCI)|Aventis Pharmaceuticals Breast Cancer April 1999 Phase 2
NCT00020124 National Institutes of Health Clinical Center (CC)|National Cancer Institute (NCI) Lung Cancer|Malignant Mesothelioma|Metastatic Cancer June 2000 Phase 1
NCT00960336 ARCAGY/ GINECO GROUP Breast Cancer March 2008 Phase 2
NCT02431559 Ludwig Institute for Cancer Research|MedImmune LLC|VentiRx Pharmaceuticals Inc.|Cancer Research Institute, New York City Ovarian Cancer November 2015 Phase 1|Phase 2
NCT01078441 National Cancer Institute (NCI) Refractory Multiple Myeloma September 2010 Phase 2
NCT00377559 Catharina Ziekenhuis Eindhoven|Cephalon|Sanofi Breast Cancer|Neoplasm Metastasis May 2006 Phase 2
NCT00252889 Christiana Care Health Services|Johnson & Johnson|GlaxoSmithKline Small Cell Lung Cancer|Pancreatic Cancer|Head and Neck Cancer|Gastric Cancer|Esophageal Cancer May 2004 Phase 1
NCT01705158 ARCAGY/ GINECO GROUP Ovarian Cancer October 2012 Phase 1|Phase 2
NCT00543829 German Breast Group Breast Neoplasms April 1998 Phase 2
NCT01887587 Ehab L Atallah|Medical College of Wisconsin Relapsed or Refractory Acute Lymphoblastic Leukemia|Relapsed or Refractory Lymphoblastic Lymphoma|Mixed Phenotype Acute Leukemia October 2013 Phase 1
NCT01294293 Gynecologic Oncology Group|National Cancer Institute (NCI) Malignant Ovarian Mixed Epithelial Tumor|Ovarian Brenner Tumor|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Undifferentiated Ovarian Carcinoma March 2011 Phase 1
NCT01210768 TTY Biopharm Breast Cancer June 2010 Phase 2
NCT01281514 Fox Chase Cancer Center Fallopian Tube Cancer|Peritoneal Cavity Cancer|Recurrent Ovarian Epithelial Cancer December 14, 2010 Phase 1
NCT00176293 University of Kentucky|Ortho Biotech, Inc. Prostate Cancer October 2005 Phase 2
NCT00392340 Children's Cancer and Leukaemia Group|National Cancer Institute (NCI) Neuroblastoma March 2008 Phase 2
NCT00562185 Simmons Cancer Center|National Cancer Institute (NCI) Ovarian Cancer May 2008 Phase 1|Phase 2
NCT00002319 Sequus Pharmaceuticals|NIH AIDS Clinical Trials Information Service Sarcoma, Kaposi|HIV Infections Phase 3
NCT00377780 Laurence J.C. van Warmerdam|Cephalon|Sanofi|Catharina Ziekenhuis Eindhoven Breast Cancer|Neoplasm Metastasis August 2006 Phase 2
NCT01189253 European Organisation for Research and Treatment of Cancer - EORTC|Sarcoma Alliance for Research through Collaboration Sarcoma May 2011 Phase 2|Phase 3
NCT00030472 Gynecologic Oncology Group|National Cancer Institute (NCI) Cervical Cancer December 2001 Phase 2
NCT00189410 AGO Study Group|MedServ. GmbH, Wiesbaden|Essex Pharma GmbH Cancer of the Ovary Treated as 2nd Line Therapy|Muellerian Mixed Tumours|Tumours of the Uterus|Cervical Cancers|Non-Epithelial Ovarian Tumours June 2003 Phase 2
NCT02903524 Hebei Medical University Fourth Hospital Breast Cancer September 2016 Phase 4
NCT01185964 Eli Lilly and Company Sarcoma, Soft Tissue October 2010 Phase 1|Phase 2
NCT02053597 Jules Bordet Institute Breast Cancer October 2014 Phase 2
NCT00484601 Sidney Kimmel Comprehensive Cancer Center Refractory Nasopharyngeal Carcinoma October 2004 Phase 2
NCT00538525 King Faisal Specialist Hospital & Research Center Breast Cancer September 2007
NCT00628251 AstraZeneca Ovarian Neoplasms July 30, 2008 Phase 2
NCT00047229 Princess Margaret Hospital, Canada|National Cancer Institute (NCI) Liver Cancer October 2002 Phase 2
NCT00750815 H. Lee Moffitt Cancer Center and Research Institute|Millennium Pharmaceuticals, Inc.|Ortho Biotech, Inc. Multiple Myeloma September 2008 Phase 1|Phase 2
NCT00331552 University of Washington|National Cancer Institute (NCI) HER2-positive Breast Cancer|Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer February 2006 Phase 1|Phase 2
NCT03161132 Grupo Español de Investigación en Cáncer de Ovario|AstraZeneca Advanced Ovarian Cancer June 2017 Phase 2
NCT00758732 Hellenic Oncology Research Group|University Hospital of Crete Ovarian Cancer October 2005 Phase 2
NCT00005822 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer April 2000 Phase 1
NCT00401804 Austrian Forum Against Cancer Multiple Myeloma|Renal Insuficiency February 2006 Phase 2
NCT00079027 University Hospital Birmingham|National Cancer Institute (NCI) Liver Cancer April 2004 Phase 3
NCT00706953 Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Centocor Ortho Biotech Services, L.L.C. Multiple Myeloma July 2008 Phase 2
NCT00108953 Bayer Carcinoma, Hepatocellular April 2005 Phase 2
NCT00471965 Sanofi Carcinoma, Hepatocellular March 2007 Phase 3
NCT00008073 University of Pittsburgh|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific January 1996 Phase 1
NCT00344422 Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA Multiple Myeloma|Myeloma|M-Protein|Myeloma Proteins October 2000 Phase 3
NCT00061867 Celsion|National Cancer Institute (NCI) Prostate Cancer March 2003 Phase 1
NCT00410462 European Organisation for Research and Treatment of Cancer - EORTC Ovarian Cancer|Sarcoma|Small Intestine Cancer October 2006 Phase 2
NCT00063999 Gynecologic Oncology Group|National Cancer Institute (NCI) Recurrent Uterine Corpus Carcinoma|Stage IIIA Uterine Corpus Cancer|Stage IIIB Uterine Corpus Cancer|Stage IIIC Uterine Corpus Cancer|Stage IVA Uterine Corpus Cancer|Stage IVB Uterine Corpus Cancer August 2003 Phase 3
NCT00779129 Merck Sharp & Dohme Corp.|Princess Margaret Hospital, Canada Breast Neoplasm March 2003 Phase 2
NCT01101594 Immunomedics, Inc. Multiple Myeloma July 2010 Phase 1|Phase 2
NCT02215876 Sidney Kimmel Comprehensive Cancer Center Breast Cancer September 2014 Phase 2
NCT02131480 Gustave Roussy, Cancer Campus, Grand Paris Uterus Leiomyosarcoma|Soft Tissue Leiomyosarcoma June 2010 Phase 2
NCT00036790 University of Wisconsin, Madison|National Cancer Institute (NCI) Breast Cancer|Chronic Myeloproliferative Disorders|Colorectal Cancer|Head and Neck Cancer|Leukemia|Lung Cancer|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic/Myeloproliferative Diseases|Prostate Cancer|Small Intestine Cancer|Unspecified Adult Solid Tumor, Protocol Specific February 2002 Phase 1
NCT00052390 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Sarcoma October 2002 Phase 2
NCT00673179 M.D. Anderson Cancer Center Osteosarcoma May 2008
NCT00245050 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer|Drug/Agent Toxicity by Tissue/Organ|Endometrial Cancer|Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer April 2004 Phase 3
NCT00819221 AstraZeneca Solid Tumors January 5, 2009 Phase 1
NCT00801411 National Cancer Centre, Singapore|National Cancer Institute (NCI) Breast Cancer October 2008 Phase 2
NCT00590785 Memorial Sloan Kettering Cancer Center|Cancer and Leukemia Group B High Risk|Breast Cancer|Positive Nodes|Cyclophosphamide|Doxorubicin August 13, 1996 Phase 3
NCT00536393 French Innovative Leukemia Organisation Lymphoma October 2000 Phase 2|Phase 3
NCT01387932 Merit Medical Systems, Inc. Hepatocellular Carcinoma April 2011 Phase 3
NCT00849251 University of Washington|National Cancer Institute (NCI) Refractory Multiple Myeloma|Stage I Multiple Myeloma|Stage II Multiple Myeloma|Stage III Multiple Myeloma November 2008 Phase 1|Phase 2
NCT00093834 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer January 2004 Phase 1
NCT00002495 Southwest Oncology Group|National Cancer Institute (NCI)|Cancer and Leukemia Group B Lymphoma September 1992 Phase 3
NCT00003212 European Organisation for Research and Treatment of Cancer - EORTC Sarcoma January 1998 Phase 3
NCT00326456 National Cancer Institute, Naples Ovarian Cancer January 2003 Phase 3
NCT01702129 University Hospital, Basel, Switzerland Solid Tumors January 2007 Phase 1
NCT00722592 Endocyte Ovarian Cancer September 2008 Phase 2
NCT00005980 European Organisation for Research and Treatment of Cancer - EORTC Breast Cancer April 2000 Phase 2
NCT00189553 ARCAGY/ GINECO GROUP|Schering-Plough|Arbeitsgemeinschaft Gynaekologische Onkologie Austria|AGO Study Group|ANZGOG|European Organisation for Research and Treatment of Cancer - EORTC|NCIC Clinical Trials Group|NSGO Ovarian Cancer|Fallopian Tube Cancer April 2005 Phase 3
NCT01394354 University Hospital Freiburg|Merck Sharp & Dohme Corp.|Janssen-Cilag Ltd. Multiple Myeloma in Relapse August 2011 Phase 1|Phase 2
NCT01329627 Instituto do Cancer do Estado de São Paulo|Fundação Faculdade de Medicina Locally Advanced HER2-negative Breast Cancer August 2010 Phase 2
NCT00992706 Swiss Group for Clinical Cancer Research Breast Cancer|Palmar-plantar Erythrodysesthesia September 2009 Phase 3
NCT00780039 Merck Sharp & Dohme Corp.|Princess Margaret Hospital, Canada Ovarian Neoplasms October 1, 2003 Phase 2
NCT00293397 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Liver Cancer November 2005 Phase 2
NCT00743431 Merck Sharp & Dohme Corp. Ovarian Neoplasms February 2005
NCT00577798 University of Nebraska|National Cancer Institute (NCI) Cardiac Toxicity|Chemotherapeutic Agent Toxicity|Lymphoma November 2007
NCT00004236 University of Leicester|National Cancer Institute (NCI) Esophageal Cancer|Gastric Cancer August 1998 Phase 2
NCT01396655 Seoul National University Hospital Breast Cancer July 2006 Phase 2
NCT01177683 Sherif Farag, MB, BS|Hoosier Cancer Research Network|Cephalon Multiple Myeloma July 2010 Phase 1|Phase 2
NCT00005861 Gynecologic Oncology Group|National Cancer Institute (NCI) Endometrial Cancer May 2000 Phase 2
NCT01246063 Washington University School of Medicine Multiple Myeloma May 14, 2012 Phase 1|Phase 2
NCT03017404 Hebei Medical University Fourth Hospital Breast Cancer May 2015
NCT00003896 Southwest Oncology Group|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer September 1999 Phase 2
NCT00003038 Mayo Clinic|National Cancer Institute (NCI) Adrenocortical Carcinoma|Breast Cancer|Colorectal Cancer|Prostate Cancer|Unspecified Adult Solid Tumor, Protocol Specific October 1997 Phase 1
NCT00121992 Spanish Breast Cancer Research Group|Sanofi Breast Neoplasms June 1999 Phase 3
NCT00004030 Georgetown University|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific March 1996 Phase 1|Phase 2
NCT00698451 Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Centocor Ortho Biotech Services, L.L.C. Ovarian Neoplasms|Fallopian Tube Neoplasms|Peritoneal Neoplasms August 2008 Phase 2
NCT02488967 NRG Oncology|National Cancer Institute (NCI) Breast Adenocarcinoma|Estrogen Receptor Negative|HER2/Neu Negative|Progesterone Receptor Negative|Stage IB Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIC Breast Cancer|Triple-Negative Breast Carcinoma July 2015 Phase 3
NCT00499122 University of Miami Breast Cancer October 6, 2008 Phase 2
NCT00401635 National Cancer Institute, Naples Endometrial Cancer November 2002 Phase 2
NCT00006125 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lymphoma July 2000 Phase 2
NCT00023855 University of Wisconsin, Madison|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific June 2001 Phase 1
NCT00027989 Pharmatech Oncology|National Cancer Institute (NCI) Breast Cancer December 2001 Phase 2
NCT00032162 AGO Study Group Cervical Cancer|Endometrial Cancer|Fallopian Tube Cancer|Ovarian Cancer|Sarcoma August 2001 Phase 1|Phase 2
NCT01861951 Hannover Medical School Soft Tissue Sarcoma October 2012 Phase 2
NCT00561743 Janssen-Ortho Inc., Canada Multiple Myeloma November 2005 Phase 2
NCT00128778 Spanish Breast Cancer Research Group|Schering-Plough Breast Neoplasms October 2002 Phase 4
NCT00903656 Arbeitsgemeinschaft medikamentoese Tumortherapie|GlaxoSmithKline Metastatic Breast Cancer May 2009 Phase 2
NCT00006235 Gynecologic Oncology Group|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer Phase 1
NCT00589238 National Cancer Centre, Singapore Breast Cancer January 2008 Phase 2
NCT00001339 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Adrenal Cortical Carcinoma August 1993 Phase 2
NCT00016406 Southwest Oncology Group|National Cancer Institute (NCI) Breast Cancer May 2001 Phase 3
NCT01459380 National Cancer Institute (NCI) Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Seromucinous Carcinoma|Ovarian Serous Cystadenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Undifferentiated Ovarian Carcinoma October 11, 2011 Phase 1
NCT00312208 Sanofi|Cancer International Research Group (CIRG) Breast Cancer November 2001 Phase 3
NCT00296010 International Breast Cancer Study Group Breast Cancer August 2005 Phase 3
NCT00002105 Sequus Pharmaceuticals|NIH AIDS Clinical Trials Information Service Sarcoma, Kaposi|HIV Infections Phase 3
NCT00609765 H. Lee Moffitt Cancer Center and Research Institute|Genentech, Inc. Pancreatic Cancer August 2007 Phase 2
NCT01088724 A.O. Ospedale Papa Giovanni XXIII Post-transplant Lymphoproliferative Disease (PTLD)|Non Burkitt February 2002 Phase 4
NCT00523848 Roswell Park Cancer Institute Multiple Myeloma and Plasma Cell Neoplasm June 2006 Phase 2
NCT00003380 Gynecologic Oncology Group|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer May 1998 Phase 1
NCT00303108 US Oncology Research|Ortho Biotech, Inc.|Tibotec Pharmaceutical Limited Metastatic Breast Cancer December 2005 Phase 2
NCT00189137 University of Michigan Cancer Center Sarcoma, Soft Tissue August 2004 Phase 2
NCT00458705 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Multiple Myeloma and Plasma Cell Neoplasm November 2006 Phase 2
NCT03005015 European Organisation for Research and Treatment of Cancer - EORTC Endometrial Neoplasms January 2017 Phase 2
NCT02181075 University of Oxford|Oxford University Hospitals NHS Trust|Celsion Liver Tumour July 2014 Phase 1
NCT00002721 University of New Mexico Prostate Cancer March 1995 Phase 1
NCT00041119 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Breast Cancer May 2002 Phase 3
NCT01697293 Albert Einstein College of Medicine, Inc.|National Cancer Institute (NCI) Breast Adenocarcinoma|Estrogen Receptor Positive|HER2/Neu Negative|Recurrent Breast Carcinoma|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer January 2012 Phase 1|Phase 2
NCT00801580 University of Bologna Lymphoid Leukemia March 2008 Phase 2
NCT02839707 National Cancer Institute (NCI) Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|High Grade Fallopian Tube Serous Adenocarcinoma|High Grade Ovarian Serous Adenocarcinoma|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Seromucinous Carcinoma|Primary Peritoneal High Grade Serous Adenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Undifferentiated Fallopian Tube Carcinoma|Undifferentiated Ovarian Carci May 12, 2017 Phase 2|Phase 3
NCT01464593 Celsion Colon Cancer Liver Metastasis September 2011 Phase 2
NCT00002985 Roswell Park Cancer Institute Sarcoma November 1996 Phase 3
NCT00334932 Herbert Irving Comprehensive Cancer Center|National Cancer Institute (NCI) Multiple Myeloma and Plasma Cell Neoplasm February 2006 Phase 1|Phase 2
NCT00074139 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer September 2003 Phase 1
NCT00193115 SCRI Development Innovations, LLC|Aventis Pharmaceuticals Breast Cancer March 2004 Phase 2
NCT00180908 Gustave Roussy, Cancer Campus, Grand Paris Osteosarcoma|Localised High Grade Osteosarcoma of the Limbs June 1994 Phase 3
NCT00075634 National Cancer Institute (NCI) Recurrent Neuroblastoma|Unspecified Childhood Solid Tumor, Protocol Specific December 2003 Phase 1
NCT03071926 Fudan University Advanced Breast Cancer March 1, 2017 Phase 2
NCT03023046 University of Washington|National Cancer Institute (NCI) Adult Acute Lymphoblastic Leukemia|Adult Lymphoblastic Lymphoma|Philadelphia Chromosome Positive February 23, 2017 Phase 2
NCT01966133 Jia Fan|Fudan University Hepatocellular Carcinoma August 2011 Phase 3
NCT00416533 Wake Forest University Health Sciences|National Cancer Institute (NCI) Prostate Cancer August 2004 Phase 2
NCT00016172 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Lymphoma|Small Intestine Cancer|Unspecified Adult Solid Tumor, Protocol Specific November 2000 Phase 1
NCT00081159 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Metastatic Cancer|Prostate Cancer July 2004 Phase 2
NCT00020449 National Cancer Institute (NCI) Sarcoma January 2001 Phase 2
NCT01100372 Medical University Innsbruck|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer July 2009 Phase 2
NCT00001059 National Institute of Allergy and Infectious Diseases (NIAID)|Sequus Pharmaceuticals|Amgen Sarcoma, Kaposi|HIV Infections Phase 2
NCT01673217 Roswell Park Cancer Institute|National Cancer Institute (NCI)|Eisai Inc. Recurrent Fallopian Tube Cancer|Recurrent Ovarian Epithelial Cancer|Recurrent Primary Peritoneal Cavity Cancer April 2009 Phase 1
NCT00740805 National Cancer Institute (NCI) Solid Neoplasm|Stage III Non-Hodgkin Lymphoma|Stage IV Non-Hodgkin Lymphoma August 18, 2008 Phase 1
NCT01120171 Hellenic Oncology Research Group Breast Cancer September 2009 Phase 2
NCT00433511 National Cancer Institute (NCI)|Cancer and Leukemia Group B|Eastern Cooperative Oncology Group|North Central Cancer Treatment Group Estrogen Receptor Negative|Estrogen Receptor Positive|HER2/Neu Negative|Male Breast Carcinoma|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer December 2009 Phase 3
NCT00513695 University of Washington|National Cancer Institute (NCI) Inflammatory Breast Cancer|Male Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer June 2007 Phase 2
NCT00061984 European Organisation for Research and Treatment of Cancer - EORTC Sarcoma April 2003 Phase 3
NCT01533207 Gynecologic Oncology Group|National Cancer Institute (NCI) Stage I Uterine Sarcoma|Uterine Corpus Leiomyosarcoma June 2012 Phase 3
NCT00366106 Accelerated Community Oncology Research Network|Millennium Pharmaceuticals, Inc. Multiple Myeloma July 2006 Phase 2
NCT01855750 Janssen Research & Development, LLC|Pharmacyclics LLC. Lymphoma September 3, 2013 Phase 3
NCT00006825 New York University School of Medicine|National Cancer Institute (NCI) Breast Cancer July 2000 Phase 1|Phase 2
NCT00006377 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Endometrial Cancer June 2000 Phase 2
NCT02566993 PharmaMar Small-cell Lung Cancer July 2016 Phase 3
NCT00524459 Roswell Park Cancer Institute|National Cancer Institute (NCI) Breast Cancer May 2007 Phase 2
NCT01974440 Janssen Research & Development, LLC|Pharmacyclics LLC. Lymphoma January 31, 2014 Phase 3
NCT00538603 King Faisal Specialist Hospital & Research Center Epithelial Ovarian Cancer June 2005
NCT02538926 University of Washington|National Cancer Institute (NCI) B Acute Lymphoblastic Leukemia|B Lymphoblastic Lymphoma|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent B Lymphoblastic Lymphoma|Recurrent T Lymphoblastic Leukemia/Lymphoma|Refractory B Lymphoblastic Lymphoma|Refractory T Lymphoblastic Lymphoma|T Acute Lymphoblastic Leukemia|T Lymphoblastic Lymphoma July 1, 2017 Phase 2
NCT01090128 University of Utah|Celgene Corporation Stages II-III Breast Cancer September 2008 Phase 1
NCT00856492 Southwest Oncology Group|National Cancer Institute (NCI) Breast Cancer April 2010 Phase 2
NCT00102973 Telik Ovarian Neoplasms December 2004 Phase 3
NCT00005991 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Breast Cancer April 2000 Phase 2
NCT01040871 Millennium Pharmaceuticals, Inc.|Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Diffuse Large B-Cell Lymphoma January 2010 Phase 2
NCT00183976 University of Southern California Non-Hodgkin's Lymphoma|Burkitt Lymphoma|Primary Effusion Lymphomas April 2005 Phase 2
NCT00509665 Medical University of South Carolina Head and Neck Cancer June 2005 Phase 2
NCT00001300 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Sarcoma June 1992 Phase 3
NCT01527149 Roswell Park Cancer Institute|National Cancer Institute (NCI)|National Comprehensive Cancer Network Stage I Mantle Cell Lymphoma|Stage II Contiguous Mantle Cell Lymphoma|Stage II Non-Contiguous Mantle Cell Lymphoma|Stage III Mantle Cell Lymphoma|Stage IV Mantle Cell Lymphoma December 6, 2011 Phase 2
NCT00080847 National Cancer Institute (NCI) Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma March 2004 Phase 2
NCT01100359 Medical University Innsbruck|National Cancer Institute (NCI) Endometrial Cancer November 2007 Phase 2
NCT02648477 City of Hope Medical Center|National Cancer Institute (NCI)|Merck Sharp & Dohme Corp. Estrogen Receptor Negative|Estrogen Receptor Positive|HER2/Neu Negative|Progesterone Receptor Negative|Progesterone Receptor Positive|Stage IV Breast Cancer|Triple-Negative Breast Carcinoma March 4, 2016 Phase 2
NCT02783599 Eli Lilly and Company Soft Tissue Sarcoma October 2016 Phase 1
NCT00030784 European Organisation for Research and Treatment of Cancer - EORTC Sarcoma November 2001 Phase 1
NCT00002318 Sequus Pharmaceuticals|NIH AIDS Clinical Trials Information Service Sarcoma, Kaposi|HIV Infections Phase 3
NCT00005970 National Cancer Institute (NCI)|Cancer and Leukemia Group B|Eastern Cooperative Oncology Group|Canadian Cancer Trials Group|Southwest Oncology Group Breast Adenocarcinoma|HER2 Positive Breast Carcinoma|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer May 19, 2000 Phase 3
NCT00712881 Cephalon|Teva Pharmaceutical Industries Breast Cancer October 2008 Phase 2
NCT00004175 Northwestern University|National Cancer Institute (NCI) Breast Cancer November 1998 Phase 2
NCT01809379 Ruhr University of Bochum Recurrent Ovarian Cancer February 2013 Phase 2
NCT01415336 Peking Union Medical College Hospital Breast Cancer March 2010 Phase 2|Phase 3
NCT00544167 SCRI Development Innovations, LLC|Bayer Breast Cancer May 2007
NCT00312650 Women and Infants Hospital of Rhode Island|Ortho Biotech, Inc. Ovarian Carcinoma April 2006 Phase 2
NCT00883116 R-Pharm Endometrial Cancer August 2009 Phase 3
NCT02735928 Catholic University of the Sacred Heart Ovarian Epithelial Cancer Recurrent|Platinum-resistant January 2016 Phase 1|Phase 2
NCT00261378 Biocompatibles UK Ltd Primary Liver Cancer November 2005 Phase 2
NCT00994968 Yonsei University|National Cancer Institute (NCI) Breast Cancer July 2009 Phase 2
NCT00282087 Sarcoma Alliance for Research through Collaboration Leiomyosarcoma|Uterine Neoplasm January 2006 Phase 2
NCT00006034 Intracel|National Cancer Institute (NCI) Bladder Cancer June 1998 Phase 3
NCT00012324 Eximias Pharmaceutical|National Cancer Institute (NCI) Liver Cancer September 2000 Phase 3
NCT00742404 Oncotherapeutics|National Cancer Institute (NCI) Multiple Myeloma and Plasma Cell Neoplasm July 2008 Phase 2
NCT00691912 Claudia Lorenz-Schlüter|University of Magdeburg Metastatic Breast Cancer December 2006 Phase 2
NCT00003165 University of Glasgow|National Cancer Institute (NCI) Breast Cancer December 1997 Phase 2
NCT00191789 Eli Lilly and Company Breast Cancer February 2003 Phase 2
NCT00789581 SCRI Development Innovations, LLC|Bristol-Myers Squibb Breast Cancer December 2008 Phase 3
NCT00077103 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Head and Neck Cancer November 2003 Phase 1|Phase 2
NCT00730483 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Gastrointestinal Carcinoid Tumor|Islet Cell Tumor|Metastatic Cancer February 2009
NCT00003035 Georgetown University|National Cancer Institute (NCI) Breast Cancer March 1997 Phase 2
NCT02606305 ImmunoGen, Inc. Epithelial Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer|Endometrial Cancer December 2015 Phase 1
NCT01920503 International Group of Endovascular Oncology Cholangiocarcinoma July 2013
NCT01992653 Genentech, Inc. Lymphoma, Non Hodgkin November 29, 2013 Phase 1|Phase 2
NCT00610792 Millennium Pharmaceuticals, Inc. Ovarian Cancer July 2006 Phase 2
NCT00086801 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lymphoma May 2004 Phase 2
NCT02865811 Dana-Farber Cancer Institute|Merck Sharp & Dohme Corp. Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Cancer September 15, 2016 Phase 2
NCT00849472 GlaxoSmithKline|NSABP Foundation Inc Neoplasms, Breast July 2009 Phase 2
NCT02732015 M.D. Anderson Cancer Center|Tesaro, Inc. Sarcoma October 2016 Phase 2
NCT01025089 Memorial Sloan Kettering Cancer Center|Eli Lilly and Company|M.D. Anderson Cancer Center|City of Hope National Medical Center Thymoma|Thymic Carcinoma|Clinical Masaoka Stage II to IVA December 2009 Phase 2
NCT00002837 M.D. Anderson Cancer Center|National Cancer Institute (NCI)|Bristol-Myers Squibb Breast Cancer September 1995 Phase 1|Phase 2
NCT00436709 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Breast Cancer July 2006
NCT01258634 University of Chicago Osteosarcoma|Lung Metastases July 2010 Phase 1
NCT01240629 University of Southern California|National Cancer Institute (NCI)|AEterna Zentaris Prostate Cancer|Hormone-resistant Prostate Cancer|Recurrent Prostate Cancer|Stage IV Prostate Cancer November 2, 2010 Phase 1|Phase 2
NCT00003847 Vertex Pharmaceuticals Incorporated Lung Cancer December 1998 Phase 2
NCT02916316 Fondazione Italiana Linfomi ONLUS Lymphoma|Large B-Cell|Diffuse Large B-Cell January 2014
NCT00258960 Spanish Breast Cancer Research Group|Schering-Plough Breast Cancer February 2006 Phase 2
NCT02428751 Wenqi Jiang|Sun Yat-sen University Lymphoma, Large B-Cell, Diffuse September 2015 Phase 3
NCT00005908 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Breast Cancer|Breast Neoplasm June 2000 Phase 2
NCT01358071 MolMed S.p.A. Ovarian Cancer June 2011 Phase 2
NCT02413320 University of Kansas Medical Center Triple-negative Breast Cancer July 2015 Phase 2
NCT00082472 Zivena NSCLC January 2004 Phase 1|Phase 2
NCT00936689 Rita Golfieri|University of Bologna Carcinoma, Hepatocellular March 2008 Phase 4
NCT00005830 Gynecologic Oncology Group|National Cancer Institute (NCI) Endometrial Adenocarcinoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Serous Adenocarcinoma|Stage III Uterine Corpus Cancer|Stage IV Uterine Corpus Cancer July 2000 Phase 1
NCT00128856 Spanish Breast Cancer Research Group|Eli Lilly and Company|Bristol-Myers Squibb Breast Cancer December 2002 Phase 2
NCT01313884 Stanford University|Amgen Bone Cancer|Ewing's Sarcoma May 2011 Phase 2
NCT00722137 Millennium Pharmaceuticals, Inc.|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Takeda Mantle Cell Lymphoma May 2008 Phase 3
NCT00434031 National Cancer Institute, Naples Breast Cancer September 2007 Phase 2
NCT00278421 German High-Grade Non-Hodgkin's Lymphoma Study Group Lymphoma November 2005 Phase 3
NCT01324180 H. Lee Moffitt Cancer Center and Research Institute|Pediatric Cancer Foundation Acute Lymphoblastic Leukemia July 18, 2011 Phase 1
NCT00636441 Duke University|United States Department of Defense Early-Stage Breast Cancer April 2008 Phase 2
NCT02472353 Avera McKennan Hospital & University Health Center Breast Cancer|Breast Tumors July 2014 Phase 2
NCT02421588 PharmaMar Ovarian Cancer May 2015 Phase 3
NCT00057382 Tularik Hepatocellular Carcinoma March 2003 Phase 2|Phase 3
NCT00494780 GlaxoSmithKline Lymphoma, Follicular June 2007 Phase 2
NCT01489410 Masonic Cancer Center, University of Minnesota Hepatocellular Carcinoma October 2012
NCT00851552 Roswell Park Cancer Institute|Ortho Biotech, Inc. Lymphoma January 2009 Phase 2
NCT00482391 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI)|Dana-Farber Cancer Institute|GlaxoSmithKline Breast Cancer March 2007 Phase 2
NCT00178802 The University of Texas Health Science Center, Houston Breast Neoplasms|Endometrial Neoplasms|Cervix Neoplasms|Ovarian Neoplasms June 1996 Phase 2
NCT00001498 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Breast Cancer|Breast Neoplasms February 1996 Phase 2
NCT00003296 Brown University|National Cancer Institute (NCI) Extrahepatic Bile Duct Cancer|Gallbladder Cancer|Liver Cancer January 1998 Phase 2
NCT00148317 Weill Medical College of Cornell University|Millennium Pharmaceuticals, Inc. Multiple Myeloma June 2005 Phase 2
NCT02377752 Eli Lilly and Company Neoplasm March 23, 2015 Phase 1
NCT00174655 Sanofi Breast Neoplasms June 1998 Phase 3
NCT00004248 Roswell Park Cancer Institute Liver Cancer July 1999 Phase 2
NCT02861222 Central Hospital, Nancy, France Malignant Glioma October 2010 Phase 1
NCT00057720 Telik Ovarian Neoplasms June 2003 Phase 3
NCT00006029 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lymphoma July 2000 Phase 1|Phase 2
NCT00518583 Aptium Oncology Research Network|Ortho Biotech Products, L.P. Breast Cancer October 2006 Phase 2
NCT00004925 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Breast Cancer August 1999 Phase 1|Phase 2
NCT02698891 Dana-Farber Cancer Institute Early Stage Breast Cancer April 2016 Phase 2
NCT01812369 University Hospital, Rouen Bladder Cancer March 2013 Phase 3
NCT00546156 Ian E. Krop, MD, PhD|Genentech, Inc.|Massachusetts General Hospital|Brigham and Women's Hospital|New Hampshire Oncology-Hematology PA|Dana-Farber Cancer Institute Breast Cancer October 2007 Phase 2
NCT00814541 Cancer Trials Ireland Multiple Myeloma and Plasma Cell Neoplasm December 2005 Phase 2
NCT02362165 Sun Yat-sen University Multiple Myeloma April 2015 Phase 3
NCT01172223 Prof Dirk Elling|Sana-Klinikum Lichtenberg Breast Cancer September 2007 Phase 1|Phase 2
NCT00470301 National Cancer Institute (NCI) Breast Cancer|Male Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer April 2007 Phase 1|Phase 2
NCT00365417 NSABP Foundation Inc|Genentech, Inc.|Hoffmann-La Roche|International Drug Development Institute Breast Cancer August 2006 Phase 2
NCT00005643 Gynecologic Oncology Group|National Cancer Institute (NCI) Endometrial Cancer|Sarcoma May 2000 Phase 2
NCT01354522 Peking Union Medical College Hospital Breast Cancer May 2011 Phase 3
NCT00688740 Sanofi|Cancer International Research Group (CIRG) Breast Cancer June 1997 Phase 3
NCT00278408 German High-Grade Non-Hodgkin's Lymphoma Study Group Lymphoma November 2005 Phase 3
NCT03108300 Ain Shams University Malignant Soft Tissue Sarcoma August 30, 2017 Phase 2
NCT00003682 UNICANCER Prostate Cancer October 1998 Phase 3
NCT00352534 Children's Oncology Group|National Cancer Institute (NCI) Stage I Wilms Tumor|Stage II Wilms Tumor|Stage III Wilms Tumor October 2006 Phase 3
NCT00021255 Sanofi|Cancer International Research Group (CIRG) Breast Neoplasms April 2001 Phase 3
NCT00003953 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer February 1999 Phase 2
NCT00003084 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Prostate Cancer December 1997 Phase 2
NCT03220022 National Cancer Institute (NCI) AIDS-Related Lymphoma|CD20 Positive|HIV Positivity|Stage II Diffuse Large B-Cell Lymphoma|Stage III Diffuse Large B-Cell Lymphoma|Stage IV Diffuse Large B-Cell Lymphoma November 1, 2017 Phase 1
NCT02733380 Henan Cancer Hospital Diffuse Large B-cell Lymphoma May 2016 Phase 2
NCT01705691 NSABP Foundation Inc|Eisai Inc. Breast Cancer|HER2-negative Breast Cancer September 2012 Phase 2
NCT00635726 Hellenic Oncology Research Group|University Hospital of Crete Bladder Cancer February 2008 Phase 2
NCT00145639 St. Jude Children's Research Hospital|Immunex/Berlex|National Institutes of Health (NIH) Osteosarcoma May 1999 Phase 2
NCT00003683 UNICANCER|National Cancer Institute (NCI) Kidney Cancer March 1998 Phase 2
NCT00006016 National Cancer Institute (NCI) Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer May 2000 Phase 2
NCT00861705 National Cancer Institute (NCI) Estrogen Receptor Negative|HER2/Neu Negative|Male Breast Carcinoma|Progesterone Receptor Negative|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Triple-Negative Breast Carcinoma May 2009 Phase 2
NCT00052312 European Organisation for Research and Treatment of Cancer - EORTC Endometrial Cancer September 2002 Phase 2
NCT00003088 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Breast Cancer September 1997 Phase 3
NCT01009970 Fondazione Italiana Linfomi ONLUS Diffuse Large B-Cell Lymphoma May 2010 Phase 2
NCT00575406 Arbeitsgemeinschaft medikamentoese Tumortherapie Diffuse Large B-Cell Lymphoma December 2007 Phase 2
NCT00002804 Children's Oncology Group|National Cancer Institute (NCI) Sarcoma September 1996 Phase 2
NCT02986503 Italian Sarcoma Group|Scandinavian Sarcoma Group|Cooperative Osteosarcoma Study Group Spindle Cell Sarcoma of Bone|Osteosarcoma January 2002
NCT01481194 Vejle Hospital|The University of Hong Kong Multiple Myeloma November 2011 Phase 2
NCT00574587 Albert Einstein College of Medicine, Inc.|Merck Sharp & Dohme Corp. Breast Cancer December 2007 Phase 1|Phase 2
NCT00407888 University of Washington|National Cancer Institute (NCI) Estrogen Receptor-positive Breast Cancer|HER2-positive Breast Cancer|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer May 2006 Phase 2
NCT02850419 Celsion Breast Cancer August 2017 Phase 2
NCT00002707 NSABP Foundation Inc|National Cancer Institute (NCI) Breast Cancer December 1995 Phase 3
NCT01110603 Tesaro, Inc. Cancer: Solid Tumors July 2010 Phase 1
NCT00523380 Novo Nordisk A/S Cancer|Ovarian Cancer October 4, 2007 Phase 2
NCT00278109 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer July 2004 Phase 1|Phase 2
NCT00006011 Gynecologic Oncology Group|Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Endometrial Adenocarcinoma|Endometrial Adenosquamous Carcinoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation|Endometrial Serous Adenocarcinoma|Stage III Uterine Corpus Cancer July 2000 Phase 3
NCT00002601 City of Hope Medical Center|National Cancer Institute (NCI) Sarcoma September 1994 Phase 2
NCT01935492 Borstkanker Onderzoek Groep|Roche Pharma AG|Teva Pharma Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|Metastatic Breast Cancer November 2010 Phase 3
NCT00343863 University of Washington|National Cancer Institute (NCI) Male Breast Cancer|Nausea and Vomiting|Stage I Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer January 2006
NCT03123770 Zhejiang University|Second Affiliated Hospital, School of Medicine, Zhejiang University|First Affiliated Hospital of Zhejiang University|Sir Run Run Shaw Hospital|Women's Hospital School Of Medicine Zhejiang University|Zhejiang Cancer Hospital|Zhejiang Provincial People’s Hospital|Zhejiang Provincial Hospital of TCM|First People's Hospital of Hangzhou|Hangzhou Hospital of Traditional Chinese Medicine|First Affiliated Hospital of Wenzhou Medical Univeristy|Ningbo No. 1 Hospital|Jinhua Central Hospital Breast Cancer December 2016 Phase 4
NCT01998906 Hoffmann-La Roche Breast Cancer May 2002 Phase 3
NCT02811523 University Health Network, Toronto Bone Sarcoma|Soft Tissue Sarcoma|Pulmonary Metastases February 2016 Phase 1
NCT01659554 Columbia University Recurrent Ovarian Cancer|Fallopian Tube Cancer March 2012 Phase 2
NCT00777673 University of Tennessee Cancer Institute|National Comprehensive Cancer Network|Celgene Corporation|Genentech, Inc. Breast Cancer October 2008 Phase 2
NCT01527422 Fernando Cabanillas|Genzyme, a Sanofi Company|Auxilio Mutuo Cancer Center Lymphoma|Non Hodgkin's Lymphoma January 2006 Phase 1|Phase 2
NCT00008242 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Multiple Myeloma and Plasma Cell Neoplasm August 2000 Phase 2
NCT03113500 City of Hope Medical Center|National Cancer Institute (NCI) Adult T-Cell Leukemia/Lymphoma|Anaplastic Large Cell Lymphoma, ALK-Negative|Anaplastic Large Cell Lymphoma, ALK-Positive|Angioimmunoblastic T-Cell Lymphoma|CD30-Positive Neoplastic Cells Present|Enteropathy-Associated T-Cell Lymphoma|Hepatosplenic T-Cell Lymphoma|Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma|Peripheral T-Cell Lymphoma, Not Otherwise Specified|Stage III Anaplastic Large Cell Lymphoma|Stage IV Anaplastic Large Cell Lymphoma May 25, 2017 Phase 2
NCT02419742 Hoffmann-La Roche Breast Cancer August 18, 2015 Phase 4
NCT00798252 Bristol-Myers Squibb Advanced Cancer March 2009 Phase 1
NCT00671476 Dr. Susan Love Research Foundation|National Cancer Institute (NCI) Breast Cancer February 2008
NCT00003135 The University of Texas Health Science Center, Houston|National Cancer Institute (NCI) Breast Cancer|Cervical Cancer|Endometrial Cancer|Ovarian Cancer November 1997 Phase 2
NCT02710734 Fox Chase Cancer Center Urothelial Carcinoma of the Bladder February 2016 Phase 2
NCT00191607 Eli Lilly and Company Genital Neoplasms, Female|Fallopian Tube Neoplasms|Ovarian Neoplasms|Pelvic Neoplasms|Peritoneal Neoplasms July 2002 Phase 3
NCT01011010 UNC Lineberger Comprehensive Cancer Center|National Cancer Institute (NCI) Liver Cancer July 2009 Phase 1
NCT00911183 Institut Bergonié|National Cancer Institute (NCI) Lymphoma October 2008 Phase 2
NCT00093795 NSABP Foundation Inc|National Cancer Institute (NCI) Breast Cancer October 2004 Phase 3
NCT00002993 Gynecologic Oncology Group|National Cancer Institute (NCI) Sarcoma August 1997 Phase 2
NCT00254592 University of California, Irvine Breast Cancer October 2005 Phase 2
NCT01639521 University of Southern California|National Cancer Institute (NCI) Anterior Urethral Cancer|Localized Transitional Cell Cancer of the Renal Pelvis and Ureter|Posterior Urethral Cancer|Recurrent Bladder Cancer|Recurrent Urethral Cancer|Regional Transitional Cell Cancer of the Renal Pelvis and Ureter|Stage III Bladder Cancer|Transitional Cell Carcinoma of the Bladder|Ureter Cancer|Urethral Cancer Associated With Invasive Bladder Cancer May 2013 Phase 2
NCT00337194 National Cancer Institute (NCI) Adult Lymphocyte Depletion Hodgkin Lymphoma|Adult Lymphocyte Predominant Hodgkin Lymphoma|Adult Mixed Cellularity Hodgkin Lymphoma|Adult Nodular Sclerosis Hodgkin Lymphoma|Recurrent Adult Hodgkin Lymphoma April 2006 Phase 2
NCT01882816 Memorial Sloan Kettering Cancer Center Thyroid Cancer June 2013 Phase 2
NCT00715208 Millennium Pharmaceuticals, Inc. Relapsed Follicular Lymphoma September 2008 Phase 2
NCT00070018 Southwest Oncology Group|National Cancer Institute (NCI) Lymphoma February 2004 Phase 2
NCT02605915 Hoffmann-La Roche HER2-Positive Metastatic Breast Cancer|HER2-Negative Metastatic Breast Cancer|Locally Advanced or Early Breast Cancer December 31, 2015 Phase 1
NCT00544778 City of Hope Medical Center|National Cancer Institute (NCI) Sarcoma August 2001 Phase 2
NCT01379989 Mario Negri Institute for Pharmacological Research|PharmaMar|Averion International Corporation Ovarian Cancer June 2011 Phase 3
NCT01856192 National Cancer Institute (NCI) CD20 Positive|Stage II Diffuse Large B-Cell Lymphoma|Stage III Diffuse Large B-Cell Lymphoma|Stage IV Diffuse Large B-Cell Lymphoma August 27, 2013 Phase 2
NCT00424203 UNICANCER Breast Cancer|Cognitive/Functional Effects|Depression|Malnutrition|Psychosocial Effects of Cancer and Its Treatment January 2006 Phase 2
NCT00512980 University of Cologne Hodgkin Lymphoma August 2008 Phase 2
NCT00516425 Charing Cross Hospital|National Cancer Institute (NCI) Breast Cancer January 2007 Phase 3
NCT02107378 Sotio a.s. Epithelial Ovarian Carcinoma January 2014 Phase 2
NCT00070564 Southwest Oncology Group|National Cancer Institute (NCI) Breast Cancer November 2003 Phase 3
NCT00875238 Vanderbilt University|National Cancer Institute (NCI) Breast Cancer|Cardiac Toxicity|Cardiovascular Complications June 2008
NCT00944047 University of Kansas Medical Center|Celgene Corporation Breast Cancer July 2009 Phase 2
NCT00988195 Bio-Cancer Treatment International Limited|The University of Hong Kong|Chinese University of Hong Kong Neoplasm|Hepatocellular Carcinoma May 2008 Phase 1
NCT03164993 Oslo University Hospital|Hoffmann-La Roche|Norwegian Cancer Society|St. Olavs Hospital|Helse Stavanger HF|University Hospital of North Norway Cancer, Breast|Triple Negative Breast Cancer June 1, 2017 Phase 2
NCT00107380 Southwest Oncology Group|National Cancer Institute (NCI) Lymphoma November 2005 Phase 2
NCT00404066 George Albert Fisher|GlaxoSmithKline|Sanofi|Stanford University Breast Cancer|Metastatic Breast Cancer October 2006 Phase 2
NCT00003334 New York University School of Medicine|National Cancer Institute (NCI) Endometrial Cancer|Fallopian Tube Cancer|Ovarian Cancer|Sarcoma March 1997 Phase 2
NCT00334854 European Paediatric Soft Tissue Sarcoma Study Group|Italian Association for Pediatric Hematology Oncology|Cooperative Weichteilsarkom Studie|Children's Cancer and Leukaemia Group|Dutch Childhood Oncology Group|National Cancer Institute (NCI) Childhood Malignant Fibrous Histiocytoma of Bone|Sarcoma March 2006 Phase 3
NCT00002608 Ottawa Regional Cancer Centre|National Cancer Institute (NCI) Adrenocortical Carcinoma|Brain and Central Nervous System Tumors|Head and Neck Cancer|Liver Cancer|Malignant Mesothelioma|Pheochromocytoma|Sarcoma May 1994 Phase 2
NCT01324076 University College, London|National Cancer Institute (NCI) Liver Cancer November 2010 Phase 3
NCT00877006 Teva Branded Pharmaceutical Products, R&D Inc.|Teva Pharmaceutical Industries Non-Hodgkin's Lymphoma|Mantle Cell Lymphoma April 30, 2009 Phase 3
NCT00250874 Zeneus Pharma Metastatic Breast Cancer December 2003 Phase 2
NCT00149214 Eli Lilly and Company Breast Cancer September 2005 Phase 2
NCT00354744 Children's Oncology Group|National Cancer Institute (NCI) Sarcoma July 2006 Phase 3
NCT01338753 Clinica Universidad de Navarra, Universidad de Navarra|Roche Farma, S.A Breast Neoplasms October 2009 Phase 2
NCT00770224 Southwest Oncology Group|National Cancer Institute (NCI) Lymphoma April 2009 Phase 2
NCT01672671 Russian Academy of Medical Sciences Early Triple Negative Breast Cancer August 2011 Phase 2
NCT00544219 Swiss Group for Clinical Cancer Research Lymphoma September 2007
NCT02096588 Sidney Kimmel Comprehensive Cancer Center Breast Cancer|Stage I Breast Cancer|Stage II Breast Cancer|Stage III Breast Cancer May 2014 Phase 2
NCT00525642 Fudan University Breast Neoplasms|Adjuvant|Chemotherapy June 2003 Phase 2|Phase 3
NCT00726700 German High-Grade Non-Hodgkin's Lymphoma Study Group|National Cancer Institute (NCI) Lymphoma May 2004 Phase 2
NCT01696032 Astex Pharmaceuticals Ovarian Cancer September 2012 Phase 1|Phase 2
NCT03101748 M.D. Anderson Cancer Center|Puma Biotechnology, Inc. Malignant Neoplasm of Breast August 2017 Phase 1|Phase 2
NCT00516750 Kyoto University|National Cancer Institute (NCI) Bladder Cancer July 2007 Phase 2
NCT00721747 Grupo Oncológico Gallego|Pivotal S.L. Breast Cancer January 2008 Phase 2
NCT02897700 Shanghai Jiao Tong University School of Medicine|Shanghai 10th People's Hospital|China-Japan Union Hospital, Jilin University|Ganzhou City People's Hospital Breast Cancer January 2013 Phase 1|Phase 2
NCT00003691 Gynecologic Oncology Group|National Cancer Institute (NCI) Endometrial Cancer December 1998 Phase 3
NCT01925612 Seattle Genetics, Inc. Lymphoma, B-cell|Lymphoma, Large B-cell, Diffuse August 2013 Phase 2
NCT01008150 NSABP Foundation Inc|Puma Biotechnology, Inc. Breast Cancer October 2010 Phase 2
NCT00436566 Mayo Clinic|National Cancer Institute (NCI) Breast Cancer|Cardiac Toxicity March 2007 Phase 2
NCT00070083 British Columbia Cancer Agency|National Cancer Institute (NCI) Lymphoma July 2003 Phase 1
NCT02792491 Pusan National University Hospital Diffuse Large B-cell Lymphoma August 2012 Phase 2
NCT02055820 Hoffmann-La Roche|AbbVie Lymphoma, Non-Hodgkin November 17, 2013 Phase 1|Phase 2
NCT01918124 Fan Ming|Fudan University Prosthesis Survival January 2008 Phase 2
NCT02448537 Massachusetts General Hospital|Dana-Farber Cancer Institute|PharmaMar Metastatic Sarcoma August 2015 Phase 2
NCT00003493 The Cleveland Clinic|National Cancer Institute (NCI) Multiple Myeloma and Plasma Cell Neoplasm November 1998 Phase 2
NCT00339118 Sheba Medical Center Rhabdomyosarcoma Phase 4
NCT01969032 Russian Academy of Medical Sciences Triple Negative Breast Cancer August 2011 Phase 2
NCT02979522 Millennium Pharmaceuticals, Inc.|Takeda Hodgkin Disease July 18, 2017 Phase 1
NCT00079261 European Organisation for Research and Treatment of Cancer - EORTC Lymphoma|Small Intestine Cancer January 2004 Phase 2
NCT00006372 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific February 2000 Phase 1
NCT00499083 University of Nebraska|National Cancer Institute (NCI) Breast Cancer May 2006 Phase 2
NCT02644278 Vertex Pharmaceuticals Incorporated Advanced Solid Tumor February 2016 Phase 1
NCT00478374 University of Bern Hepatocellular Carcinoma May 2007 Phase 1
NCT00956930 Northwestern University|National Cancer Institute (NCI) Liver Cancer August 2009 Phase 2
NCT03003520 Celgene Lymphoma, Large B-Cell, Diffuse February 28, 2017 Phase 2
NCT00787527 M.D. Anderson Cancer Center|Merck Sharp & Dohme Corp. Lymphoma November 2008 Phase 1|Phase 2
NCT00080795 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter|Urethral Cancer July 2001 Phase 2
NCT00028483 Seattle Genetics, Inc. Breast Cancer October 2000 Phase 2
NCT00003342 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter December 1997 Phase 1
NCT00790244 Oslo University Hospital|Scandinavian Sarcoma Group Soft Tissue Sarcoma|Non Metastatic Disease October 2007 Phase 2
NCT01228331 Universitätsklinikum Hamburg-Eppendorf Leukemia October 2010 Phase 2|Phase 3
NCT00070447 National Cancer Institute (NCI) Lymphoma November 2003 Phase 2
NCT00004888 National Cancer Institute (NCI) Recurrent Breast Cancer|Stage IV Breast Cancer January 2001 Phase 2
NCT00003385 Gynecologic Oncology Group|National Cancer Institute (NCI) Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer March 1999 Phase 1
NCT00194779 University of Washington|National Cancer Institute (NCI) Estrogen Receptor-negative Breast Cancer|Estrogen Receptor-positive Breast Cancer|HER2-positive Breast Cancer|Progesterone Receptor-negative Breast Cancer|Progesterone Receptor-positive Breast Cancer|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer October 2003 Phase 2
NCT00003927 City of Hope Medical Center|National Cancer Institute (NCI) Breast Cancer April 22, 1999
NCT00679029 University of Nebraska|National Cancer Institute (NCI) HER2-negative Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer May 2008 Phase 2
NCT00256243 University of California, Irvine Inflammatory Breast Cancer|Locally Advanced Breast Cancer April 2004 Phase 2
NCT00314977 Radboud University|Sanofi|Amgen Breast Cancer February 2006 Phase 3
NCT00051584 Seattle Genetics, Inc. Ovarian Neoplasms Phase 2
NCT00119262 National Cancer Institute (NCI) Male Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer October 2005 Phase 2
NCT00657878 National Cancer Institute, Naples Ovarian Cancer November 2008 Phase 3
NCT00002493 Gynecologic Oncology Group|National Cancer Institute (NCI) Endometrial Cancer|Psychosocial Effects of Cancer and Its Treatment May 1992 Phase 3
NCT00004048 Garden State Cancer Center at the Center for Molecular Medicine and Immunology Head and Neck Cancer September 1998 Phase 1|Phase 2
NCT00031187 Seattle Genetics, Inc. Prostatic Neoplasms October 2000 Phase 2
NCT01746992 Ruijin Hospital ALK-negative Anaplastic Large Cell Lymphoma|Peripherial T Cell Lymphoma,Not Otherwise Specified|Angioimmunoblastic T Cell Lymphoma|Enteropathy Associated T Cell Lymphoma|Hepatosplenic T Cell Lymphoma|Subcutaneous Panniculitis Like T Cell Lymphoma September 2012 Phase 4
NCT02743065 Fifth Affiliated Hospital, Sun Yat-Sen University|Third Affiliated Hospital, Sun Yat-Sen University Hepatocellular Carcinoma September 2016
NCT03145558 Teclison Ltd. Carcinoma, Hepatocellular October 1, 2017 Phase 2
NCT00310089 National Cancer Institute (NCI) Breast Cancer January 2006
NCT02177695 Southwest Oncology Group|National Cancer Institute (NCI) Bladder Cancer July 2014 Phase 2
NCT02677116 Eli Lilly and Company Neoplasm Metastasis August 2016 Phase 1
NCT00003388 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Lymphoma February 1999 Phase 2
NCT01125020 Shanghai Jiao Tong University School of Medicine|Shanghai Changzheng Hospital Liver Transplantation|Hepatocellular Carcinoma|Tumor Recurrence and Metastasis|Survival|Adjuvant Chemotherapy December 2008
NCT01964755 University of Miami Epstein Barr Virus Associated Non Hodgkin's Lymphoma|Epstein Barr Virus Associated Hodgkin's Lymphoma|Post-Transplant Lymphoproliferative Disease April 21, 2009 Phase 2
NCT00450801 University of Miami Lymphoma April 2004 Phase 2
NCT00506155 M.D. Anderson Cancer Center|Genentech, Inc. Bladder Cancer June 2007 Phase 2
NCT00101010 M.D. Anderson Cancer Center|National Cancer Institute (NCI)|Ortho Biotech, Inc. Lymphoma September 2005 Phase 2
NCT00052936 German High-Grade Non-Hodgkin's Lymphoma Study Group|National Cancer Institute (NCI) Lymphoma January 2001 Phase 3
NCT00059839 Children's Oncology Group|National Cancer Institute (NCI) Lymphoma November 2003 Phase 3
NCT00670358 Mayo Clinic|National Cancer Institute (NCI) Lymphoma August 2008 Phase 1|Phase 2
NCT02855359 Seattle Genetics, Inc. Diffuse, Large B-Cell, Lymphoma|Follicular Lymphoma, Grade 3b|Transformed Lymphoma / DLBCL August 2016 Phase 2
NCT00877071 University of Pittsburgh|Biocompatibles UK Ltd Hepatocellular Carcinoma November 2008 Phase 2
NCT00121199 National Cancer Institute (NCI) Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma June 2005 Phase 2
NCT00878254 University of Miami Mantle-Cell Lymphoma March 25, 2009 Phase 2
NCT00007904 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer July 2000 Phase 2
NCT00346125 Masonic Cancer Center, University of Minnesota Sarcoma April 2006
NCT00003782 NSABP Foundation Inc|National Cancer Institute (NCI) Breast Cancer March 1999 Phase 3
NCT00002772 Southwest Oncology Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group|Cancer and Leukemia Group B Breast Cancer July 1996 Phase 3
NCT01940497 Hoffmann-La Roche Breast Cancer November 16, 2013 Phase 3
NCT01275677 National Cancer Institute (NCI) Estrogen Receptor Negative|Estrogen Receptor Positive|HER2/Neu Positive|Progesterone Receptor Negative|Progesterone Receptor Positive|Recurrent Breast Carcinoma|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIC Breast Cancer January 6, 2011 Phase 3
NCT00336791 M.D. Anderson Cancer Center|Breast Cancer Research Foundation Breast Cancer September 2003 Phase 3
NCT02876107 M.D. Anderson Cancer Center|Amgen Malignant Neoplasm of Breast October 2016 Phase 2
NCT00141648 Trans-Tasman Radiation Oncology Group (TROG)|Australasian Leukaemia and Lymphoma Group|Australasian Radiation Oncology Lymphoma Group|Wesley Research Institute Osteolymphoma September 2000
NCT02838225 Peking Union Medical College Hospital Breast Cancer January 2009 Phase 2
NCT02889523 The Lymphoma Academic Research Organisation|Epizyme, Inc. Lymphoma, Large B-Cell, Diffuse October 2016 Phase 1|Phase 2
NCT00887536 NSABP Foundation Inc|Genentech, Inc.|US Oncology Research Breast Cancer May 2009 Phase 3
NCT02506777 Petrov Research Institute of Oncology Breast Cancer July 2015 Phase 2
NCT00203372 Translational Oncology Research International|Genentech, Inc. Breast Cancer May 2005 Phase 2
NCT02529852 M.D. Anderson Cancer Center|Celgene|Genentech, Inc. Lymphoma November 4, 2015 Phase 1|Phase 2
NCT00001165 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|National Institutes of Health Clinical Center (CC) Islet Cell Adenoma|Neoplasm Metastasis|Zollinger Ellison Syndrome September 1978 Phase 2
NCT02636322 M.D. Anderson Cancer Center|Celgene|Janssen Scientific Affairs, LLC Lymphoma March 2016 Phase 2
NCT02560051 The University of Texas Health Science Center, Houston Prostatic Neoplasms November 2015 Phase 2
NCT01712490 Millennium Pharmaceuticals, Inc.|Seattle Genetics, Inc.|Takeda Hodgkin Lymphoma November 2012 Phase 3
NCT00665457 University of Nebraska|National Cancer Institute (NCI) Breast Cancer April 2004 Phase 2
NCT00510367 M.D. Anderson Cancer Center Breast Cancer|Pregnancy August 2001
NCT01857726 Seoul National University Hospital Hepatocellular Carcinoma July 2013
NCT02631876 ImmunoGen, Inc.|Gynecologic Oncology Group Epithelial Ovarian Cancer|Primary Peritoneal Carcinoma|Fallopian Tube Cancer|Ovarian Cancer November 2016 Phase 3
NCT00115414 Amgen Breast Cancer|Fever|Neutropenia Phase 2
NCT00656669 Indiana University|Pfizer Breast Cancer April 2008
NCT02631109 Beijing Friendship Hospital Hemophagocytic Lymphohistiocytosis December 2015 Phase 3
NCT00859495 Columbia University Pleural Mesothelioma February 2008 Phase 2
NCT02412670 ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group Localized Urothelial Carcinoma of the Renal Pelvis and Ureter|Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter|Regional Urothelial Carcinoma of the Renal Pelvis and Ureter April 2015 Phase 2
NCT01719835 Royal Marsden NHS Foundation Trust|Cancer Research UK Peripheral T-cell Lymphoma NOS|Anaplastic Large Cell Lymphoma, ALK-Negative|Angioimmunoblastic T-cell Lymphoma|Hepatosplenic Gamma/ Delta T-cell Lymphoma March 2012 Phase 2
NCT02359162 Sun Yat-sen University Lymphoma, Extranodal NK-T-Cell May 2015 Phase 3
NCT02734771 Patrick Reagan|Seattle Genetics, Inc.|University of Rochester Diffuse Large B-Cell Lymphoma June 2016 Phase 2
NCT01388621 WiSP Wissenschaftlicher Service Pharma GmbH|ClinAssess GmbH Ovarian Cancer October 2011 Phase 2
NCT03203525 M.D. Anderson Cancer Center|NovoCure Ltd. Liver Cancer August 2017 Phase 1
NCT02427620 M.D. Anderson Cancer Center|Pharmacyclics LLC. Lymphoma June 2015 Phase 2
NCT02958163 Cliniques universitaires Saint-Luc- Université Catholique de Louvain|Erasme University Hospital|Jules Bordet Institute|University Hospital of Liege|Clinique Saint Joseph, Liège|Centre Hospitalier Universitaire Dinant Godinne - UCL Namur Liver Neoplasms|Hepatocellular Cancer February 20, 2017 Phase 2
NCT00044993 Introgen Therapeutics|National Cancer Institute (NCI) Breast Cancer February 2002 Phase 2
NCT02292979 The Lymphoma Academic Research Organisation|Millennium Pharmaceuticals, Inc. Hodgkin Lymphoma March 2015 Phase 2
NCT01014767 Tufts Medical Center Brain Cancer|Choroid Plexus Tumors November 2009 Phase 3
NCT00002878 Eastern Cooperative Oncology Group|National Cancer Institute (NCI)|Southwest Oncology Group|Cancer and Leukemia Group B|NCIC Clinical Trials Group|European Organisation for Research and Treatment of Cancer - EORTC Multiple Myeloma and Plasma Cell Neoplasm March 1997 Phase 3
NCT01678664 Federation Francophone de Cancerologie Digestive Neuroendocrine Tumors|Hepatic Metastases|Metastases October 2012 Phase 2
NCT00990860 Taipei Veterans General Hospital, Taiwan Hepatocellular Carcinoma February 2009 Phase 2
NCT00016276 National Cancer Institute (NCI) Cardiac Toxicity|Inflammatory Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IV Breast Cancer May 2001 Phase 3
NCT00006198 National Center for Research Resources (NCRR) Liver Cancer Phase 2
NCT00651755 M.D. Anderson Cancer Center|Merck Sharp & Dohme Corp. Lymphoma March 2008
NCT01858207 Shi-Ming Lin|Chang Gung Memorial Hospital Hepatocellular Carcinoma January 2012 Phase 2
NCT03188198 Mansoura University Large B Cell Lymphoma June 1, 2016 Phase 2
NCT01831505 Presage Biosciences|National Institutes of Health (NIH)|National Cancer Institute (NCI)|Fred Hutchinson Cancer Research Center Lymphoma November 2012 Phase 1
NCT00014352 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Prostate Cancer|Thromboembolism September 2000 Phase 2
NCT00005960 Amgen|National Cancer Institute (NCI) Pain|Prostate Cancer October 1999 Phase 2
NCT02876302 Dana-Farber Cancer Institute|Incyte Corporation Inflammatory Breast Cancer (IBC) April 26, 2017 Phase 2
NCT00493870 US Oncology Research|Sanofi Breast Cancer May 2007 Phase 3
NCT02298257 The Lymphoma Academic Research Organisation HIV Infection|HIV-associated Hodgkin Lymphoma|Stage III Adult Hodgkin Lymphoma|Stage IV Adult Hodgkin Lymphoma June 2015 Phase 2
NCT00093509 Mark Dewhirst|National Cancer Institute (NCI)|Duke University Sarcoma November 1999 Phase 1|Phase 2
NCT01646034 The Netherlands Cancer Institute Breast Cancer September 2014 Phase 3
NCT02049905 CytRx Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma January 2014 Phase 3
NCT00379574 Asan Medical Center|Janssen Korea, Ltd., Korea Lymphoma, Large-Cell, Diffuse|Lymphoma, B-Cell September 2006 Phase 1|Phase 2
NCT02596971 Hoffmann-La Roche Diffuse Large B-Cell Lymphoma, Lymphoma Follicular December 22, 2015 Phase 1
NCT00094497 Collaborative Group for Adrenocortical Carcinoma Treatment|German Federal Ministry of Education and Research|National Cancer Institute (NCI) Carcinoma, Adrenal Cortical June 2004 Phase 3
NCT00882206 Masonic Cancer Center, University of Minnesota Leukemia|Lymphoma April 2009 Phase 2
NCT00003133 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter September 1997 Phase 1
NCT00002679 Yale University Breast Cancer February 1994 Phase 2
NCT00003696 Commissie Voor Klinisch Toegepast Onderzoek|National Cancer Institute (NCI) Lung Cancer October 1998 Phase 3
NCT00960063 Merck Sharp & Dohme Corp. Neoplasms|Solid Tumors|Bone Cancer|Kidney Tumor|Neuroblastoma November 11, 2009 Phase 1
NCT03211117 Mayo Clinic|National Cancer Institute (NCI) Thyroid Gland Undifferentiated (Anaplastic) Carcinoma July 9, 2017 Phase 2
NCT00003907 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Liver Cancer|Metastatic Cancer August 1999 Phase 2
NCT00002641 European Organisation for Research and Treatment of Cancer - EORTC|NCIC Clinical Trials Group Endometrial Cancer|Kidney Cancer|Ovarian Cancer|Pheochromocytoma|Sarcoma February 1995 Phase 3
NCT00369681 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Lymphoma May 2006 Phase 2
NCT03197935 Hoffmann-La Roche Triple-negative Breast Cancer July 31, 2017 Phase 3
NCT01818063 Sidney Kimmel Cancer Center at Thomas Jefferson University|Susan G. Komen Breast Cancer Foundation|Thomas Jefferson University Estrogen Receptor-negative Breast Cancer|HER2-negative Breast Cancer|Progesterone Receptor-negative Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Triple-negative Breast Cancer April 25, 2013 Phase 2
NCT01897441 Albert Einstein College of Medicine, Inc.|National Cancer Institute (NCI) Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer June 2013
NCT00346164 Children's Oncology Group|National Cancer Institute (NCI) Adult Alveolar Soft-part Sarcoma|Adult Angiosarcoma|Adult Epithelioid Sarcoma|Adult Extraskeletal Chondrosarcoma|Adult Extraskeletal Osteosarcoma|Adult Fibrosarcoma|Adult Leiomyosarcoma|Adult Liposarcoma|Adult Malignant Fibrous Histiocytoma|Adult Malignant Hemangiopericytoma|Adult Malignant Mesenchymoma|Adult Neurofibrosarcoma|Adult Synovial Sarcoma|Childhood Alveolar Soft-part Sarcoma|Childhood Angiosarcoma|Childhood Epithelioid Sarcoma|Childhood Fibrosarcoma|Childhood Leiomyosarcoma|Childhood February 2007 Phase 3
NCT00302003 Children's Oncology Group|National Cancer Institute (NCI) Childhood Favorable Prognosis Hodgkin Lymphoma|Childhood Lymphocyte Depletion Hodgkin Lymphoma|Childhood Mixed Cellularity Hodgkin Lymphoma|Childhood Nodular Sclerosis Hodgkin Lymphoma|Stage I Childhood Hodgkin Lymphoma|Stage II Childhood Hodgkin Lymphoma February 2006 Phase 3
NCT00212082 National University Hospital, Singapore Metastatic Breast Cancer April 2002 Phase 2
NCT01414855 Genentech, Inc. Lymphoma, B-Cell August 31, 2011 Phase 2
NCT02312245 Mayo Clinic|National Cancer Institute (NCI) Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma July 2015 Phase 2
NCT02285062 Celgene Lymphoma, Large B-Cell, Diffuse January 21, 2015 Phase 3
NCT02853500 Dana-Farber Cancer Institute|Surefire Medical, Inc. Liver Cancer July 2016
NCT02641847 Fudan University Triple Negative Breast Cancer|Breast Cancer July 2015 Phase 2|Phase 3
NCT00017160 Radiation Therapy Oncology Group|National Cancer Institute (NCI) Stage III Adult Soft Tissue Sarcoma|Recurrent Adult Soft Tissue Sarcoma|Stage IVA Adult Soft Tissue Sarcoma|Stage IIB Adult Soft Tissue Sarcoma|Stage IIC Adult Soft Tissue Sarcoma Phase 2
NCT00581776 University of Wisconsin, Madison Mantle Cell Lymphoma May 2005 Phase 2
NCT02626455 Bayer Lymphoma, Non-Hodgkin January 6, 2016 Phase 3
NCT00667342 St. Jude Children's Research Hospital|Genentech, Inc. Osteosarcoma|Malignant Fibrous Histiocytoma (MFH) of Bone June 2008 Phase 2
NCT01771107 National Cancer Institute (NCI) AIDS-Related Hodgkin Lymphoma|Classical Hodgkin Lymphoma|HIV Infection|Stage II Hodgkin Lymphoma|Stage IIA Hodgkin Lymphoma|Stage IIB Hodgkin Lymphoma|Stage III Hodgkin Lymphoma|Stage IIIA Hodgkin Lymphoma|Stage IIIB Hodgkin Lymphoma|Stage IV Hodgkin Lymphoma|Stage IVA Hodgkin Lymphoma|Stage IVB Hodgkin Lymphoma March 7, 2013 Phase 1|Phase 2
NCT00107198 Children's Oncology Group|National Cancer Institute (NCI) Childhood Lymphocyte Predominant Hodgkin Lymphoma|Stage I Childhood Hodgkin Lymphoma|Stage II Childhood Hodgkin Lymphoma January 2006
NCT01476410 Northwestern University|Robert H. Lurie Cancer Center|Seattle Genetics, Inc. Adult Lymphocyte Depletion Hodgkin Lymphoma|Adult Lymphocyte Predominant Hodgkin Lymphoma|Adult Mixed Cellularity Hodgkin Lymphoma|Adult Nodular Sclerosis Hodgkin Lymphoma|Stage II Adult Hodgkin Lymphoma|Stage III Adult Hodgkin Lymphoma|Stage IV Adult Hodgkin Lymphoma November 2011 Phase 2
NCT00003376 Eastern Cooperative Oncology Group|National Cancer Institute (NCI)|Cancer and Leukemia Group B Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter|Urethral Cancer September 1998 Phase 3
NCT00089544 National Cancer Institute (NCI) Recurrent Adult Soft Tissue Sarcoma|Stage I Adult Soft Tissue Sarcoma|Stage II Adult Soft Tissue Sarcoma|Stage III Adult Soft Tissue Sarcoma June 2004 Phase 2
NCT00433537 National Cancer Institute (NCI) Contiguous Stage II Mantle Cell Lymphoma|Noncontiguous Stage II Mantle Cell Lymphoma|Stage I Mantle Cell Lymphoma|Stage III Mantle Cell Lymphoma|Stage IV Mantle Cell Lymphoma May 2007 Phase 2
NCT00808899 St. Jude Children's Research Hospital Neuroblastoma December 2008 Phase 2
NCT00002526 Swiss Group for Clinical Cancer Research Ovarian Cancer|Sarcoma January 1993 Phase 2
NCT00194753 University of Washington|Amgen|Bristol-Myers Squibb Breast Neoplasm December 2001 Phase 2
NCT00004125 Eastern Cooperative Oncology Group|National Cancer Institute (NCI)|North Central Cancer Treatment Group|Southwest Oncology Group|Cancer and Leukemia Group B Breast Cancer October 1999 Phase 3
NCT01231906 Children's Oncology Group|National Cancer Institute (NCI) Adult Supratentorial Primitive Neuroectodermal Tumor (PNET)|Childhood Supratentorial Primitive Neuroectodermal Tumor|Ewing Sarcoma of Bone|Extraosseous Ewing Sarcoma|Extraosseous Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Peripheral Primitive Neuroectodermal Tumor of the Kidney|Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor November 2010 Phase 3
NCT00162721 Gustave Roussy, Cancer Campus, Grand Paris Uterine Sarcoma September 2001 Phase 3
NCT01802749 National Cancer Institute, Naples|Mario Negri Institute for Pharmacological Research Recurrent Ovarian Cancer November 2013 Phase 3
NCT01334502 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lymphoma March 2012 Phase 1
NCT00016341 Gynecologic Oncology Group|National Cancer Institute (NCI) Endometrial Cancer May 2001 Phase 3
NCT00003172 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Gastric Cancer December 1997 Phase 2
NCT00003105 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter September 1997 Phase 1|Phase 2
NCT01321008 M.D. Anderson Cancer Center Lymphoma May 2011 Phase 1|Phase 2
NCT02866370 NHS Greater Glasgow and Clyde|Boehringer Ingelheim|Cancer Research UK|European Organisation for Research and Treatment of Cancer - EORTC|Nordic Society for Gynaecologic Oncology|ARCAGY/ GINECO GROUP Ovarian Clear Cell Carcinoma|Endometrial Clear Cell Carcinoma April 2015 Phase 2
NCT02372409 Washington University School of Medicine Glioma|Pilocytic Astrocytoma|Anaplastic Astrocytoma|Glioblastoma|Mixed Oligoastrocytoma|Mixed Glioma|Oligodendroglioma|Optic Glioma|Astrocytoma August 14, 2015 Phase 1
NCT00439296 Therapeutic Advances in Childhood Leukemia Consortium Recurrent Pediatric ALL|Relapsed Pediatric ALL|Acute Lymphoblastic Leukemia|Refractory Pediatric ALL May 2006 Phase 1
NCT00549848 St. Jude Children's Research Hospital|National Cancer Institute (NCI)|Enzon Pharmaceuticals, Inc.|National Institute of General Medical Sciences (NIGMS) Acute Lymphoblastic Leukemia October 29, 2007 Phase 3
NCT00002093 Nexstar Pharmaceuticals|NIH AIDS Clinical Trials Information Service Sarcoma, Kaposi|HIV Infections Phase 3
NCT02293109 University of California, Davis|Amgen Contiguous Stage II Adult Lymphoblastic Lymphoma|Noncontiguous Stage II Adult Lymphoblastic Lymphoma|Stage I Adult Lymphoblastic Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Untreated Adult Acute Lymphoblastic Leukemia December 2015 Phase 1
NCT00002618 Children's Oncology Group|National Cancer Institute (NCI) Lymphoma December 1994 Phase 3
NCT00003667 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Sarcoma September 1998 Phase 2
NCT02912702 Beijing Friendship Hospital Hemophagocytic Lymphohistiocytosis September 2016 Phase 3
NCT00053768 German High-Grade Non-Hodgkin's Lymphoma Study Group|National Cancer Institute (NCI) Lymphoma April 2002 Phase 3
NCT00002466 Memorial Sloan Kettering Cancer Center Kidney Cancer|Sarcoma May 1990 Phase 2
NCT00004906 Hackensack University Medical Center|National Cancer Institute (NCI) Breast Cancer October 1999 Phase 2
NCT00003013 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|National Cancer Institute (NCI) Breast Cancer October 1996 Phase 3
NCT02166463 National Cancer Institute (NCI) Classical Hodgkin Lymphoma|Stage IIB Hodgkin Lymphoma|Stage IIIB Hodgkin Lymphoma|Stage IVA Hodgkin Lymphoma|Stage IVB Hodgkin Lymphoma March 16, 2015 Phase 3
NCT02132949 Hoffmann-La Roche Breast Cancer July 14, 2014 Phase 2
NCT00820690 Barretos Cancer Hospital|University of Sao Paulo Breast Cancer July 2008
NCT00912444 Shanghai Jiao Tong University School of Medicine Breast Cancer July 2009 Phase 3
NCT02541565 University of Washington|National Cancer Institute (NCI) Composite Lymphoma|Grade 3b Follicular Lymphoma|Stage I Diffuse Large B-Cell Lymphoma|Stage I Follicular Lymphoma|Stage II Diffuse Large B-Cell Lymphoma|Stage II Follicular Lymphoma|Stage III Diffuse Large B-Cell Lymphoma|Stage III Follicular Lymphoma|Stage IV Diffuse Large B-Cell Lymphoma|Stage IV Follicular Lymphoma November 24, 2015 Phase 2
NCT00972478 National Cancer Institute (NCI) Stage II Contiguous Adult Diffuse Large Cell Lymphoma|Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma November 2010 Phase 1|Phase 2
NCT01593020 M.D. Anderson Cancer Center|Eisai Inc. Breast Cancer August 2012 Phase 2
NCT01539174 Fox Chase Cancer Center|Genentech, Inc. Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Stage I Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma Phase 2
NCT00841945 French Innovative Leukemia Organisation B Cell Lymphoma April 2005 Phase 3
NCT00088881 National Cancer Institute (NCI) Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Nodal Marginal Zone B-cell Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Splenic Marginal Zone Lymphoma|Stage I Adult Diffuse Large Cell Lymphoma|Testicular Lymphoma|Waldenström Macroglobulinemia December 2004 Phase 2
NCT01004978 National Cancer Institute (NCI) Hepatocellular Carcinoma|Non-Resectable Hepatocellular Carcinoma October 28, 2009 Phase 3
NCT02561273 University of Nebraska|National Cancer Institute (NCI) Anaplastic Large Cell Lymphoma, ALK-Negative|Anaplastic Large Cell Lymphoma, ALK-Positive|Hepatosplenic T-Cell Lymphoma|Peripheral T-Cell Lymphoma, Not Otherwise Specified|Stage II Angioimmunoblastic T-cell Lymphoma|Stage II Enteropathy-Associated T-Cell Lymphoma|Stage III Angioimmunoblastic T-cell Lymphoma|Stage III Enteropathy-Associated T-Cell Lymphoma|Stage IV Angioimmunoblastic T-cell Lymphoma|Stage IV Enteropathy-Associated T-Cell Lymphoma October 2015 Phase 1|Phase 2
NCT01215344 Vanderbilt-Ingram Cancer Center Multiple Myeloma November 2010 Phase 2
NCT00334867 Children's Oncology Group|National Cancer Institute (NCI) Sarcoma December 2005 Phase 3
NCT01775475 AIDS Malignancy Consortium|National Cancer Institute (NCI)|The EMMES Corporation AIDS-related Diffuse Large Cell Lymphoma|AIDS-related Diffuse Mixed Cell Lymphoma|AIDS-related Diffuse Small Cleaved Cell Lymphoma|AIDS-related Immunoblastic Large Cell Lymphoma|AIDS-related Lymphoblastic Lymphoma|AIDS-related Peripheral/Systemic Lymphoma|AIDS-related Small Noncleaved Cell Lymphoma|Stage III AIDS-related Lymphoma|Stage IV AIDS-related Lymphoma September 2016 Phase 2
NCT01057069 The Netherlands Cancer Institute Breast Cancer January 2010 Phase 2|Phase 3
NCT00003912 Societe Internationale d'Oncologie Pediatrique|National Cancer Institute (NCI) Liver Cancer June 1998 Phase 3
NCT00513955 Plymouth Hospitals NHS Trust Lymphoma June 2006 Phase 2
NCT02306161 National Cancer Institute (NCI) Metastatic Ewing Sarcoma|Metastatic Malignant Neoplasm in the Bone|Metastatic Malignant Neoplasm in the Bone Marrow|Metastatic Malignant Neoplasm in the Lung|Metastatic Peripheral Primitive Neuroectodermal Tumor of Bone|Peripheral Primitive Neuroectodermal Tumor of Soft Tissues December 8, 2014 Phase 3
NCT01920932 St. Jude Children's Research Hospital|Seattle Genetics, Inc. Stage II Childhood Hodgkin Lymphoma|Stage III Childhood Hodgkin Lymphoma|Stage IV Childhood Hodgkin Lymphoma August 12, 2013 Phase 2
NCT02213913 University of Chicago|National Cancer Institute (NCI) Adult Grade III Lymphomatoid Granulomatosis|B-cell Chronic Lymphocytic Leukemia|Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Contiguous Stage II Grade 1 Follicular Lymphoma|Contiguous Stage II Grade 2 Follicular Lymphoma|Contiguous Stage II Grade 3 Follicular Lymphoma|Contiguous Stage II Mantle Cell Lymphoma|Conti July 2014 Phase 1|Phase 2
NCT02903004 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Ovarian Neoplasms April 2016 Phase 3
NCT01959490 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer September 2013 Phase 2
NCT00201318 National Health Research Institutes, Taiwan|National Taiwan University Hospital|Mackay Memorial Hospital|National Cheng-Kung University Hospital|Taipei Veterans General Hospital, Taiwan|Chi Mei Medical Hospital Non-Hodgkin's Lymphoma September 2001 Phase 2
NCT02101788 National Cancer Institute (NCI) Low Grade Ovarian Serous Adenocarcinoma|Micropapillary Serous Carcinoma|Ovarian Serous Adenocarcinoma|Primary Peritoneal Serous Adenocarcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma February 27, 2014 Phase 2|Phase 3
NCT00054665 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) B-Cell Lymphoma February 2003 Phase 2
NCT02957968 Virginia Commonwealth University|Merck Sharp & Dohme Corp.|National Cancer Institute (NCI) Locally Advanced Breast Cancer|Invasive Adenocarcinoma of the Breast|Breast Cancer Stage II|Breast Cancer Stage III|Breast Cancer Stage IV January 24, 2017 Phase 2
NCT00304083 Sarcoma Alliance for Research through Collaboration|National Cancer Institute (NCI) Neurofibromatosis Type 1|Sarcoma December 2005 Phase 2
NCT00976911 Hoffmann-La Roche Ovarian Cancer October 2009 Phase 3
NCT00003937 Children's Oncology Group|National Cancer Institute (NCI) Cardiac Toxicity|Sarcoma September 1999 Phase 3
NCT00455533 Bristol-Myers Squibb Breast Cancer October 2007 Phase 2
NCT01279291 Kyowa Hakko Kirin Pharma, Inc.|Kyowa Kirin Pharmaceutical Development, Inc. Neoplasms|Ovarian Neoplasms|Fallopian Tube Neoplasms|Primary Peritoneal Neoplasm January 2011 Phase 1
NCT00000681 National Institute of Allergy and Infectious Diseases (NIAID) Sarcoma, Kaposi|HIV Infections Phase 1
NCT00000954 National Institute of Allergy and Infectious Diseases (NIAID)|Novum|Bristol-Myers Squibb Sarcoma, Kaposi|HIV Infections Phase 1
NCT00144807 Lymphoma Study Association Diffuse Large Cell Lymphoma December 2003 Phase 2
NCT00092222 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Lymphoproliferative Disorder|HHV-8|Malignancy|HIV September 17, 2004 Phase 2
NCT01147016 Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) Breast Cancer July 2010 Phase 2
NCT02685657 Russian Academy of Medical Sciences|Russian Society of Clinical Oncology Triple Negative Breast Cancer September 2016 Phase 2
NCT00486668 NSABP Foundation Inc|GlaxoSmithKline Invasive Breast Cancer July 2007 Phase 3
NCT00014534 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Bladder Cancer March 2004 Phase 3
NCT00002492 University of Miami Sarcoma November 1991 Phase 2
NCT00006184 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Multiple Myeloma August 2000 Phase 2
NCT00524316 Roswell Park Cancer Institute Liver Cancer April 2007 Phase 2
NCT00808639 Dana-Farber Cancer Institute|Beth Israel Deaconess Medical Center|Brigham and Women's Hospital|Amgen Bladder Cancer|Muscle-invasive Bladder Cancer December 2008 Phase 2
NCT01516567 Gustave Roussy, Cancer Campus, Grand Paris|Children's Oncology Group Primary Mediastinal Large B Cell Lymphoma December 2011 Phase 2
NCT00477412 M.D. Anderson Cancer Center|Millennium Pharmaceuticals, Inc. Mantle Cell Lymphoma|Lymphoma April 2007 Phase 1
NCT00499616 Children's Oncology Group|National Cancer Institute (NCI) Neuroblastoma October 2007 Phase 3
NCT00586846 Memorial Sloan Kettering Cancer Center Osteosarcoma July 2003 Phase 2
NCT00290498 M.D. Anderson Cancer Center|Genentech, Inc. Lymphoma August 2005 Phase 2
NCT00060346 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Lymphoma June 2004 Phase 2
NCT00501826 M.D. Anderson Cancer Center|Novartis Leukemia|Lymphoblastic Lymphoma|Leukemia, Lymphoblastic, Acute July 11, 2007 Phase 2
NCT00003679 Scottish Cancer Therapy Network|National Cancer Institute (NCI) Breast Cancer November 1998 Phase 3
NCT01468740 Harlachinger Krebshilfe e.V.|Deutsche AIDS Gesellschaft e.V. HIV-associated Hodgkin Lymphoma March 2004 Phase 2
NCT01099436 Borstkanker Onderzoek Groep|Dutch Cancer Society|Amgen|Sanofi|Novartis Breast Cancer April 2010 Phase 3
NCT00825149 Hoffmann-La Roche Non-Hodgkin's Lymphoma February 2009 Phase 1
NCT01516580 Gustave Roussy, Cancer Campus, Grand Paris|Children's Oncology Group B-cell Non Hodgkin Lymphoma|Mature B-cell Leukemia Burkitt-type December 2011 Phase 3
NCT02637375 University of Chicago Breast Cancer May 2016
NCT00000801 National Institute of Allergy and Infectious Diseases (NIAID) Lymphoma, Non-Hodgkin|HIV Infections Phase 2
NCT00187161 St. Jude Children's Research Hospital Non-Hodgkin Lymphoma|Acute Lymphoblastic Leukemia, Mature B-Cell November 1994 Phase 2
NCT02446600 National Cancer Institute (NCI)|AstraZeneca Deleterious BRCA1 Gene Mutation|Deleterious BRCA2 Gene Mutation|Endometrial Undifferentiated Carcinoma|Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Transitional Cell Carcinoma|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Tumor|Ovarian Seromucinous Carcinoma|Ovarian Serous Tumor|Ovarian Transitional Cell Carcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Undifferentiated Fallopian Tube Carcinoma|Undifferentiated Ova February 4, 2016 Phase 3
NCT00795678 Case Comprehensive Cancer Center|United States Department of Defense|National Cancer Institute (NCI) Breast Cancer|Metastatic Cancer September 2008
NCT01606878 Children's Oncology Group|National Cancer Institute (NCI) Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Neuroblastoma|Unspecified Childhood Solid Tumor, Protocol Specific March 2013 Phase 1
NCT02181738 Bristol-Myers Squibb Hodgkin Disease July 2014 Phase 2
NCT00005867 Lymphoma Trials Office|National Cancer Institute (NCI) Lymphoma January 1998 Phase 3
NCT00365274 National Cancer Institute (NCI) Anaplastic Large Cell Lymphoma August 2006 Phase 2
NCT00217425 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Lymphoma July 2006 Phase 2
NCT01969578 European Organisation for Research and Treatment of Cancer - EORTC Salivary Gland Cancer February 2015 Phase 2
NCT00945724 International Extranodal Lymphoma Study Group (IELSG) Large B-cell Diffuse Lymphoma of Testis April 2009 Phase 2
NCT02364713 Mayo Clinic|National Cancer Institute (NCI) Fallopian Tube Transitional Cell Carcinoma|Malignant Ovarian Clear Cell Tumor|Malignant Ovarian Endometrioid Tumor|Malignant Ovarian Serous Tumor|Ovarian Seromucinous Carcinoma|Ovarian Transitional Cell Carcinoma|Primary Peritoneal Serous Adenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Undifferentiated Fallopian Tube Carcinoma|Undifferentiated Ovarian Carcinoma March 2015 Phase 2
NCT01490060 M.D. Anderson Cancer Center|Merck Sharp & Dohme Corp. Sarcoma|Chemotherapy-induced Nausea and Vomiting|Effects of Chemotherapy|Adverse Effects of Medical Drugs May 2012
NCT02331251 Western Regional Medical Center Advanced Cancer|Breast Cancer|Sarcoma|Pancreatic Cancer|Small Cell Lung Cancer|Ovarian December 2014 Phase 1|Phase 2
NCT01251107 Fondazione Michelangelo Hodgkin Lymphoma March 2000 Phase 3
NCT02180867 National Cancer Institute (NCI) Adult Fibrosarcoma|Alveolar Soft Part Sarcoma|Angiomatoid Fibrous Histiocytoma|Atypical Fibroxanthoma|Clear Cell Sarcoma of Soft Tissue|Epithelioid Malignant Peripheral Nerve Sheath Tumor|Epithelioid Sarcoma|Extraskeletal Myxoid Chondrosarcoma|Extraskeletal Osteosarcoma|Fibrohistiocytic Neoplasm|Glomus Tumor of the Skin|Inflammatory Myofibroblastic Tumor|Intimal Sarcoma|Leiomyosarcoma|Liposarcoma|Low Grade Fibromyxoid Sarcoma|Low Grade Myofibroblastic Sarcoma|Malignant Cutaneous Granular Cell Tu July 11, 2014 Phase 2|Phase 3
NCT00389818 AIDS Malignancy Consortium|National Cancer Institute (NCI)|The EMMES Corporation Lymphoma January 2007 Phase 2
NCT00000626 National Institute of Allergy and Infectious Diseases (NIAID)|Amgen HIV Infections|Hodgkin's Disease Phase 2
NCT00002557 National Cancer Institute (NCI) Lymphoma June 1993 Phase 2
NCT00542191 Leo W. Jenkins Cancer Center Breast Cancer July 2007 Phase 2
NCT01159236 M.D. Anderson Cancer Center Breast Cancer September 2010
NCT02858804 Institute of Hematology & Blood Diseases Hospital Mantle Cell Lymphoma January 2016 Phase 4
NCT01287741 Hoffmann-La Roche|Fondazione Italiana Linfomi ONLUS Diffuse Large B-Cell Lymphoma July 2011 Phase 3
NCT02098343 Aprea Therapeutics AB Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53 March 2014 Phase 1|Phase 2
NCT00450385 University of Miami Lymphoma April 24, 2007 Phase 2
NCT03108248 Zhongda Hospital HCC|Portal Vein Tumor Thrombosis January 1, 2011
NCT02617485 Mabion SA Diffuse Large B-Cell Lymphoma December 2015 Phase 3
NCT00365365 Sanofi Breast Cancer August 2006 Phase 2
NCT02724540 Abramson Cancer Center of the University of Pennsylvania Adults With Unresectable Liver-dominant Neuroendocrine Tumor Metastases That Are Are Symptomatic, Progressive, or Involve 25% of the Liver Volume March 2016 Phase 3
NCT02199184 M.D. Anderson Cancer Center Leukemia January 2015 Phase 2
NCT00038610 M.D. Anderson Cancer Center|Novartis Pharmaceuticals Leukemia March 2001 Phase 2
NCT00690560 Centre Antoine Lacassagne Lymphoma May 2007 Phase 2
NCT03159897 Fondazione Italiana Linfomi ONLUS Hodgkin Lymphoma June 2017 Phase 3
NCT00002576 Cancer Research Campaign Clinical Trials Centre|National Cancer Institute (NCI) Lymphoma November 1992 Phase 3
NCT02877303 M.D. Anderson Cancer Center|Amgen Leukemia|Acute Lymphoblastic Leukemia November 2016 Phase 2
NCT01704716 St. Anna Kinderkrebsforschung Neuroblastoma February 2002 Phase 3
NCT02420717 M.D. Anderson Cancer Center|Incyte Corporation Leukemia July 2015 Phase 2
NCT01547741 NSABP Foundation Inc|National Cancer Institute (NCI) Breast Cancer April 2012 Phase 3
NCT00101101 H. Lee Moffitt Cancer Center and Research Institute|National Cancer Institute (NCI)|Lymphoma Research Foundation|Novartis Lymphoma July 2004 Phase 2
NCT03018626 Nanfang Hospital of Southern Medical University Lymphoma, Large B-Cell, Diffuse February 2017 Phase 3
NCT00039481 National Cancer Institute (NCI) Cardiac Toxicity|Unspecified Childhood Solid Tumor, Protocol Specific November 2002 Phase 1
NCT02398240 Mitchell Cairo|New York Medical College Hodgkin Lymphoma May 2015 Phase 2
NCT00169130 Lymphoma Study Association|Fondation ARC Lymphoma, Large-Cell, Diffuse October 1999 Phase 2|Phase 3
NCT02379585 Western Regional Medical Center Breast Cancer January 2013 Phase 1|Phase 2
NCT00671658 M.D. Anderson Cancer Center Leukemia|Acute Lymphoblastic Leukemia November 2002 Phase 2
NCT02449278 Wuhan University Diffuse Large B-cell Lymphoma October 2015 Phase 3
NCT02449265 Wuhan University Diffuse Large B-cell Lymphoma October 2015 Phase 3
NCT00719472 Genentech, Inc. Non-Hodgkin's Lymphoma July 2008 Phase 3
NCT01777152 Seattle Genetics, Inc.|Millennium Pharmaceuticals, Inc. Anaplastic Large-Cell Lymphoma|Non-Hodgkin Lymphoma|T-Cell Lymphoma January 2013 Phase 3
NCT00025363 National Cancer Institute (NCI) Alveolar Childhood Rhabdomyosarcoma|Embryonal Childhood Rhabdomyosarcoma|Embryonal-botryoid Childhood Rhabdomyosarcoma|Previously Treated Childhood Rhabdomyosarcoma|Recurrent Childhood Rhabdomyosarcoma November 2001 Phase 2
NCT00169156 Lymphoma Study Association|Hoffmann-La Roche Untreated T-cell Angioimmunoblastic Lymphoma December 2005 Phase 2
NCT03023358 Nanfang Hospital of Southern Medical University Peripheral T Cell Lymphoma February 2017 Phase 3
NCT00968253 M.D. Anderson Cancer Center|Novartis Leukemia|Acute Lymphocytic Leukemia November 2009 Phase 1|Phase 2
NCT00276705 Children's Cancer and Leukaemia Group|National Cancer Institute (NCI) Liver Cancer June 2005 Phase 2
NCT00866749 M.D. Anderson Cancer Center Lymphoblastic Leukemia|Lymphoblastic Lymphoma September 2006 Phase 2
NCT00931918 Millennium Pharmaceuticals, Inc.|Takeda Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL) October 2009 Phase 2
NCT00225173 Stanford University|National Cancer Institute (NCI) Hodgkin Disease October 2001 Phase 2
NCT02349958 Bay Area Gynecology Oncology Ovarian Cancer|Peritoneal Cancer|Fallopian Tube Cancer|Uterine Cancer|Mesotheliomas|Gastrointestinal Cancers|Cervical Cancer September 2006 Phase 2
NCT00043979 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Sarcoma September 19, 2002 Phase 2
NCT00209222 European Mantle Cell Lymphoma Network|German Low Grade Lymphoma Study Group|Lymphoma Study Association Lymphoma, Mantle-Cell July 2004 Phase 3
NCT01670084 Mayo Clinic B-cell Adult Acute Lymphoblastic Leukemia|Blastic Phase Chronic Myelogenous Leukemia|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia|Untreated Adult Acute Lymphoblastic Leukemia December 2012 Phase 2
NCT00645632 Mayo Clinic|National Cancer Institute (NCI) Sarcoma November 1990
NCT00580333 Massachusetts General Hospital|Dana-Farber Cancer Institute|Beth Israel Deaconess Medical Center|Brigham and Women's Hospital|Genentech, Inc. Breast Cancer September 2007 Phase 2
NCT01622439 Lund University Hospital|Valcuria Diffuse Large B-cell Lymphoma June 2012 Phase 1|Phase 2
NCT02116530 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Hematopoietic/Lymphoid Cancer|Nausea and Vomiting|Unspecified Adult Solid Tumor, Protocol Specific August 2014 Phase 3
NCT00002696 Grupo Oncologico Cooperativo del Sur|National Cancer Institute (NCI) Breast Cancer October 1995 Phase 3
NCT02419495 M.D. Anderson Cancer Center|Karyopharm Therapeutics Inc Advanced Cancers June 26, 2015 Phase 1
NCT03036904 Weill Medical College of Cornell University|Genentech, Inc.|Massachusetts General Hospital|M.D. Anderson Cancer Center Diffuse Large B-Cell Lymphoma|High Grade B-Cell Lymphoma February 6, 2017 Phase 1
NCT01204996 Centocor, Inc. Cancer May 2010 Phase 1
NCT01358877 Hoffmann-La Roche|Genentech, Inc.|Breast International Group Breast Cancer November 8, 2011 Phase 3
NCT00003519 Eastern Cooperative Oncology Group|National Cancer Institute (NCI)|Southwest Oncology Group|North Central Cancer Treatment Group|Cancer and Leukemia Group B Breast Cancer August 1998 Phase 3
NCT00301821 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lymphoma January 2006 Phase 2
NCT00084838 Dana-Farber Cancer Institute|National Cancer Institute (NCI) Central Nervous System Tumor, Pediatric February 2003 Phase 2
NCT00929591 Southwest Oncology Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group|North Central Cancer Treatment Group|Cancer and Leukemia Group B|NCIC Clinical Trials Group Breast Cancer May 1989 Phase 3
NCT01889069 Hoffmann-La Roche Lymphoma July 31, 2013 Phase 3
NCT01455532 Sanofi Neoplasm Malignant November 2011 Phase 1
NCT02494713 The University of Texas Health Science Center, Houston Prostate Cancer October 2015 Phase 2
NCT01319981 M.D. Anderson Cancer Center|Spectrum Pharmaceuticals, Inc Leukemia March 2013 Phase 2
NCT00471484 National Cancer Centre, Singapore|National Cancer Institute (NCI) Liver Cancer March 2007 Phase 2
NCT01424982 M.D. Anderson Cancer Center|Ariad Pharmaceuticals Leukemia October 2011 Phase 2
NCT00140595 Lymphoma Study Association|Amgen Diffuse Large-Cell Lymphoma December 2003 Phase 3
NCT02797717 GALIA AVRAHAMI|University of Giessen|Rabin Medical Center Classical Hodgkins Lymphoma in Children and Adolescents. November 2015
NCT00928200 Therapeutic Advances in Childhood Leukemia Consortium Relapsed Acute Lymphoblastic Leukemia|Allergy to PEG e.Coli Asparaginase|Allergy to Native e.Coli Asparaginase May 2009 Phase 1
NCT02406092 Hoffmann-La Roche Non-Hodgkin Lymphoma October 13, 2015 Phase 3
NCT00634179 Emory University|Millennium Pharmaceuticals, Inc. Lymphoma, B-Cell|Follicular Lymphoma February 2008 Phase 1|Phase 2
NCT01964391 Hoffmann-La Roche Breast Cancer February 21, 2014 Phase 3
NCT01060904 Seattle Genetics, Inc.|Millennium Pharmaceuticals, Inc. Disease, Hodgkin January 2010 Phase 1
NCT00209209 European Mantle Cell Lymphoma Network|German Low Grade Lymphoma Study Group|Lymphoma Study Association|HOVON - Dutch Haemato-Oncology Association|Nordic Lymphoma Group Lymphoma, Mantle-Cell January 14, 2004 Phase 3
NCT00000689 National Institute of Allergy and Infectious Diseases (NIAID) Lymphoma, Non-Hodgkin|HIV Infections Phase 1
NCT03225924 The Lymphoma Academic Research Organisation DLBCL July 2017 Phase 1|Phase 2
NCT01864109 Memorial Sloan Kettering Cancer Center Newly Diagnosed Ewing Sarcoma May 2013 Phase 2
NCT02125344 German Breast Group|Amgen|Roche Pharma AG|TEVA|Vifor Pharma Tubular Breast Cancer Stage II|Tubular Breast Cancer Stage III|Mucinous Breast Cancer Stage II|Breast Cancer Female NOS|Invasive Ductal Breast Cancer|HER2 Positive Breast Cancer|Inflammatory Breast Cancer December 2014 Phase 3
NCT02029430 CytRx Kaposi's Sarcoma|HIV+|HIV Positive|AIDS January 2014 Phase 2
NCT00290667 German High-Grade Non-Hodgkin's Lymphoma Study Group Lymphoma February 2004 Phase 2
NCT00022945 Corixa Corporation Mantle Cell Lymphoma Phase 2
NCT00363090 Toronto Sunnybrook Regional Cancer Centre|National Cancer Institute (NCI) Lymphoma September 2006 Phase 1|Phase 2
NCT01966471 Hoffmann-La Roche Breast Cancer January 31, 2014 Phase 3
NCT01523977 Dana-Farber Cancer Institute|Novartis Acute Lymphoblastic Leukemia November 2011 Phase 1
NCT00973752 Massachusetts General Hospital|Dana-Farber Cancer Institute|Beth Israel Deaconess Medical Center|Enzon Pharmaceuticals, Inc.|Genzyme, a Sanofi Company Acute Lymphoblastic Leukemia August 2009 Phase 2
NCT00896519 French Innovative Leukemia Organisation|National Cancer Institute (NCI) Lymphoma March 2009 Phase 2
NCT01042041 Abramson Cancer Center of the University of Pennsylvania Hepatocellular Carcinoma|Liver Cancer|Localized Unresectable Liver Cancer September 2009 Phase 1
NCT00186849 St. Jude Children's Research Hospital|National Institutes of Health (NIH) Neuroblastoma October 1997 Phase 2
NCT01849783 University of Iowa|National Cancer Institute (NCI) Extramedullary Plasmacytoma|Isolated Plasmacytoma of Bone|Light Chain Deposition Disease|Primary Systemic Amyloidosis|Stage I Multiple Myeloma|Stage II Multiple Myeloma|Stage III Multiple Myeloma April 2013 Phase 2
NCT01200758 Hoffmann-La Roche Non-Hodgkin's Lymphoma February 15, 2011 Phase 3
NCT01359592 Southwest Oncology Group|National Cancer Institute (NCI) Lymphoma September 2011 Phase 2
NCT02449252 Wuhan University Follicular Lymphoma October 2015 Phase 3
NCT00061893 Children's Oncology Group|National Cancer Institute (NCI) Sarcoma April 2004 Phase 2
NCT02753647 Ruijin Hospital Diffuse Large B-cell Lymphoma April 2016 Phase 2
NCT01548573 University of Iowa|National Cancer Institute (NCI) Multiple Myeloma May 2012 Phase 2
NCT00324831 Favrille|National Cancer Institute (NCI) Lymphoma Phase 3
NCT01847001 Columbia University Locally Advanced Malignant Neoplasm|Breast Cancer October 2012 Phase 2
NCT00801281 Polish Lymphoma Research Group Follicular Lymphoma|Marginal Zone Lymphoma|Small Lymphocytic Lymphoma|Lymphoplasmacytic Lymphoma February 2007 Phase 3
NCT01779050 Washington University School of Medicine Breast Neoplasms December 19, 2013 Phase 2
NCT00003992 National Cancer Institute (NCI) Breast Cancer August 1999 Phase 2
NCT01055301 Southwest Oncology Group|National Cancer Institute (NCI) Multiple Myeloma|Plasma Cell Myeloma July 2011 Phase 2
NCT00577629 Duke University|GlaxoSmithKline Lymphoma, B-Cell June 18, 2005 Phase 2
NCT02822157 Universitaire Ziekenhuizen Leuven|AstraZeneca Ovarian Epithelial Cancer August 2016 Phase 2
NCT00000658 National Institute of Allergy and Infectious Diseases (NIAID)|Schering-Plough Lymphoma, Non-Hodgkin|HIV Infections Phase 3
NCT00390793 M.D. Anderson Cancer Center|Bristol-Myers Squibb Acute Lymphoblastic Leukemia|Leukemia September 2006 Phase 2
NCT00217503 National Cancer Institute (NCI) Lymphoma July 2005 Phase 2
NCT00135135 St. Jude Children's Research Hospital|AstraZeneca|National Institutes of Health (NIH) Neuroblastoma August 2005 Phase 2
NCT02559154 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Multiple Myeloma July 2010 Phase 4
NCT01000285 Washington University School of Medicine Leukemia-Lymphoma, Adult T-Cell September 2010 Phase 1|Phase 2
NCT01970722 City of Hope Medical Center|National Cancer Institute (NCI) Recurrent Uterine Corpus Cancer|Recurrent Fallopian Tube Cancer|Recurrent Ovarian Cancer|Recurrent Primary Peritoneal Cancer|Stage IIIA Uterine Corpus Cancer|Stage IIIA Fallopian Tube Cancer|Stage IIIA Ovarian Cancer|Stage IIIA Primary Peritoneal Cavity Cancer|Stage IIIB Uterine Corpus Cancer|Stage IIIB Fallopian Tube Cancer|Stage IIIB Ovarian Cancer|Stage IIIB Primary Peritoneal Cavity Cancer|Stage IIIC Uterine Corpus Cancer|Stage IIIC Fallopian Tube Cancer|Stage IIIC Ovarian Cancer|Stage IIIC May 2014
NCT01868451 Memorial Sloan Kettering Cancer Center|Seattle Genetics, Inc.|University of Rochester|City of Hope Medical Center|Stanford University Hodgkin Lymphoma May 2013
NCT01193842 National Cancer Institute (NCI) AIDS-Related Diffuse Large Cell Lymphoma|AIDS-Related Plasmablastic Lymphoma|AIDS-Related Primary Effusion Lymphoma|Grade 3b Follicular Lymphoma|HIV Infection|Plasmablastic Lymphoma|Primary Effusion Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Stage I Adult Diffuse Large Cell Lymphoma|Stage I Grade 3 Follicular Lymphoma|Stage II Contiguous Adult Diffuse Large Cell Lymphoma|Stage II Grade 3 Contiguous Follicular Lymphoma|Stage II Grade 3 Non-Contiguou October 6, 2010 Phase 1|Phase 2
NCT02228772 Massachusetts General Hospital|Millennium Pharmaceuticals, Inc. Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma|B-cell Adult Acute Lymphoblastic Leukemia|T-cell Adult Acute Lymphoblastic Leukemia December 2014 Phase 1
NCT02228512 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease|Primary Effusion Lymphoma August 15, 2014 Phase 1|Phase 2
NCT01005914 OHSU Knight Cancer Institute|National Cancer Institute (NCI) Leukemia June 2009 Phase 2
NCT02073097 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Stage I Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma October 2014 Phase 1|Phase 2
NCT00005089 Southwest Oncology Group|National Cancer Institute (NCI) Lymphoma April 2000 Phase 2
NCT01946529 St. Jude Children's Research Hospital|University of Tennessee Health Science Center|University of Florida|Nemours Children's Clinic Desmoplastic Small Round Cell Tumor|Ewing Sarcoma of Bone or Soft Tissue|Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor November 2013 Phase 2
NCT00000987 National Institute of Allergy and Infectious Diseases (NIAID) Sarcoma, Kaposi|HIV Infections Phase 1
NCT00002827 Children's Oncology Group|National Cancer Institute (NCI)|Children's Cancer Group Cardiac Toxicity|Lymphoma October 1996 Phase 3
NCT01769209 Stanford University|National Cancer Institute (NCI) B-cell Adult Acute Lymphoblastic Leukemia|Ph Positive Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Lymphoblastic Leukemia|T-cell Adult Acute Lymphoblastic Leukemia March 2013 Phase 2
NCT00669877 M.D. Anderson Cancer Center Burkitt's Lymphoma|Burkitt'S-like Lymphoma August 2002 Phase 2
NCT02661503 University of Cologne Classical Hodgkin Lymphoma July 2016 Phase 3
NCT01055314 National Cancer Institute (NCI) Adult Rhabdomyosarcoma|Childhood Alveolar Rhabdomyosarcoma|Childhood Embryonal Rhabdomyosarcoma|Metastatic Childhood Soft Tissue Sarcoma|Stage IV Adult Soft Tissue Sarcoma|Untreated Childhood Rhabdomyosarcoma January 2010 Phase 2
NCT00098839 Children's Oncology Group|National Cancer Institute (NCI) Recurrent Childhood Acute Lymphoblastic Leukemia February 2005 Phase 1|Phase 2
NCT00890656 M.D. Anderson Cancer Center|Enzon Pharmaceuticals, Inc. Acute Lymphoblastic Leukemia June 2003 Phase 2
NCT00003389 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Lymphoma April 1999 Phase 3
NCT01121406 Boehringer Ingelheim Ovarian Neoplasms April 2010 Phase 2
NCT00004010 Children's Oncology Group|National Cancer Institute (NCI) Lymphoma October 1999 Phase 2
NCT02767674 The First Affiliated Hospital with Nanjing Medical University Diffuse Large B Cell Lymphoma May 2016 Phase 3
NCT00004031 Southwest Oncology Group|National Cancer Institute (NCI)|Cancer and Leukemia Group B|Eastern Cooperative Oncology Group|NCIC Clinical Trials Group Lymphoma July 1997 Phase 3
NCT00039195 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI)|Bristol-Myers Squibb|Genentech, Inc. Lymphoma November 2006 Phase 2
NCT01848132 Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea|Janssen-Cilag, S.A. Diffuse, Large B-Cell, Lymphoma October 3, 2013 Phase 2
NCT02670616 Samsung Medical Center Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma May 2016 Phase 2
NCT01464606 Children's Hospitals and Clinics of Minnesota Pleuropulmonary Blastoma September 2011
NCT02951728 Ruijin Hospital Diffuse Large B Cell Lymphoma October 2016 Phase 1|Phase 2
NCT00005964 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lymphoma May 2000 Phase 2
NCT00109837 Southwest Oncology Group|National Cancer Institute (NCI) Leukemia April 2005 Phase 2
NCT03036488 Merck Sharp & Dohme Corp. Triple Negative Breast Neoplasms March 7, 2017 Phase 3
NCT00983944 Kristie Blum|Ohio State University Comprehensive Cancer Center Lymphoma September 2009 Phase 2
NCT01979536 National Cancer Institute (NCI) Anaplastic Large Cell Lymphoma, ALK-Positive|CD30-Positive Neoplastic Cells Present|Stage II Childhood Anaplastic Large Cell Lymphoma|Stage III Childhood Anaplastic Large Cell Lymphoma|Stage IV Childhood Anaplastic Large Cell Lymphoma November 8, 2013 Phase 2
NCT00011986 Gynecologic Oncology Group|Southwest Oncology Group|Medical Research Council|National Cancer Institute (NCI) Primary Peritoneal Carcinoma|Stage III Ovarian Cancer|Stage IV Ovarian Cancer January 2001 Phase 3
NCT00005090 Southwest Oncology Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group|Cancer and Leukemia Group B Lymphoma April 2000 Phase 3
NCT00024167 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Prostate Cancer April 2002 Phase 3
NCT00126191 Dana-Farber Cancer Institute|Beth Israel Deaconess Medical Center|Brigham and Women's Hospital Burkitt Lymphoma|Non-Hodgkins Lymphoma|Atypical Burkitt Lymphoma July 2005 Phase 2
NCT02481310 Northwestern University|National Cancer Institute (NCI)|Millennium Pharmaceuticals, Inc. Adult Burkitt Lymphoma|B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma|Diffuse Large B-Cell Lymphoma|MYC Gene Mutation|Plasmablastic Lymphoma September 2015 Phase 1|Phase 2
NCT00039130 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Leukemia|Lymphoma May 2002 Phase 2
NCT01698281 AEterna Zentaris Breast Cancer December 2012 Phase 2
NCT00274924 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Lymphoma April 2006 Phase 2
NCT00577993 M.D. Anderson Cancer Center|Genentech, Inc. Lymphoma March 1998 Phase 3
NCT00002764 European Organisation for Research and Treatment of Cancer - EORTC|Eastern Cooperative Oncology Group|Scandinavian Sarcoma Group|Southwest Oncology Group Endometrial Cancer|Kidney Cancer|Metastatic Cancer|Ovarian Cancer|Pheochromocytoma|Sarcoma April 1996 Phase 3
NCT02784015 Samsung Medical Center Unresectable Localized Soft Tissue Sarcoma May 2016 Phase 2
NCT01332968 Hoffmann-La Roche|German Low Grade Lymphoma Study Group|Institute of Cancer Research, United Kingdom Non-Hodgkin's Lymphoma August 1, 2011 Phase 3
NCT02531308 Rush University Medical Center Diffuse Large B-Cell Lymphoma July 2015 Phase 2
NCT02771743 Samsung Medical Center Newly Diagnosed High Risk Neuroblastoma April 2015 Phase 2
NCT00002539 European Organisation for Research and Treatment of Cancer - EORTC|Medical Research Council Sarcoma August 1993 Phase 3
NCT00003595 National Cancer Institute (NCI) Lymphoma January 1999 Phase 3
NCT00005578 Children's Oncology Group|National Cancer Institute (NCI) Cardiac Toxicity|Lymphoma March 1997 Phase 3
NCT00028964 University of California, San Francisco|National Cancer Institute (NCI) Breast Cancer|Drug/Agent Toxicity by Tissue/Organ February 2001 Phase 1|Phase 2
NCT00002855 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Prostate Cancer August 1996 Phase 3
NCT01746173 Dana-Farber Cancer Institute|Massachusetts General Hospital|Beth Israel Deaconess Medical Center T-cell Non-Hodgkin Lymphoma February 2013 Phase 2
NCT00118209 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Large B Cell Lymphoma May 2005 Phase 3
NCT01857934 St. Jude Children's Research Hospital|Cookies for Kids' Cancer|CURE Childhood Cancer, Inc. Neuroblastoma July 5, 2013 Phase 2
NCT02337985 City of Hope Medical Center|National Cancer Institute (NCI) AIDS-Related Burkitt Lymphoma|AIDS-Related Diffuse Large B-cell Lymphoma|AIDS-Related Plasmablastic Lymphoma|AIDS-Related Primary Effusion Lymphoma|HIV Infection|AIDS Related Non-Hodgkin Lymphoma August 3, 2015
NCT01230983 Children's Oncology Group|National Cancer Institute (NCI) Cardiac Toxicity|Leukemia|Lymphoma June 1996 Phase 3
NCT00004188 Children's Oncology Group|National Cancer Institute (NCI) Neuroblastoma February 2001 Phase 3
NCT00002571 Southwest Oncology Group|National Cancer Institute (NCI) Lymphoma June 1994 Phase 2
NCT00006734 Children's Oncology Group|National Cancer Institute (NCI)|Southwest Oncology Group Sarcoma May 2001 Phase 3
NCT02419469 M.D. Anderson Cancer Center|Jazz Pharmaceuticals Leukemia|Precursor-B Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma|Lymphoma November 13, 2015 Phase 2
NCT02032277 AbbVie|US Oncology Research|NSABP Foundation Inc|Alliance for Clinical Trials in Oncology|German Breast Group|Grupo Español de Investigación del Cáncer de Mama Triple Negative Breast Cancer April 2, 2014 Phase 3
NCT00041132 Southwest Oncology Group|National Cancer Institute (NCI) Lymphoma September 2002 Phase 2
NCT00058422 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Lymphoma February 2003 Phase 2
NCT01056679 University of Cologne Hodgkin Lymphoma April 2010 Phase 1
NCT01593228 Sanofi Solid Tumors May 2012 Phase 3
NCT00866307 Children's Oncology Group|National Cancer Institute (NCI) B-cell Adult Acute Lymphoblastic Leukemia|B-cell Childhood Acute Lymphoblastic Leukemia|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia February 2009
NCT01451515 St. Jude Children's Research Hospital|National University, Singapore Lymphoblastic Lymphoma May 25, 2012 Phase 2
NCT00295893 City of Hope Medical Center|National Cancer Institute (NCI) Breast Cancer September 2005 Phase 2
NCT02918747 Hunan Cancer Hospital Lymphoma September 2016 Phase 3
NCT00165087 Dana-Farber Cancer Institute|Boston Children’s Hospital Acute Lymphoblastic Leukemia January 1996 Phase 3
NCT00006721 Southwest Oncology Group|National Cancer Institute (NCI)|Cancer and Leukemia Group B|Eastern Cooperative Oncology Group Lymphoma March 2001 Phase 3
NCT01798004 Children's Oncology Group|National Cancer Institute (NCI) Disseminated Neuroblastoma|Localized Resectable Neuroblastoma|Localized Unresectable Neuroblastoma|Regional Neuroblastoma|Stage 4S Neuroblastoma April 2013
NCT01760226 Baylor College of Medicine|National Cancer Institute (NCI)|Texas Children's Hospital Diffuse Large B Cell Lymphoma|Post Transplant Lymphoproliferative Disorder|Primary Mediastinal (Thymic) Large B-cell Lymphoma January 2013
NCT01148446 Fondazione Italiana Linfomi ONLUS Elderly Patients (>65 Years)|Diffuse Large B Cell Lymphoma (DLBCL) January 2003 Phase 3
NCT02200757 CytRx Metastatic Small Cell Lung Cancer September 2014 Phase 2
NCT00446030 Sanofi Breast Neoplasms March 2007 Phase 2
NCT00004092 City of Hope Medical Center|National Cancer Institute (NCI) Breast Cancer May 1999 Phase 2
NCT01446809 University of Washington|National Cancer Institute (NCI) Stage IIA Adult Soft Tissue Sarcoma|Stage III Adult Soft Tissue Sarcoma|Stage IV Adult Soft Tissue Sarcoma April 2012
NCT00134030 Children's Oncology Group|National Cancer Institute (NCI)|University College London Hospitals Localized Osteosarcoma|Metastatic Osteosarcoma November 2005 Phase 3
NCT02419755 St. Jude Children's Research Hospital Mixed Lineage Acute Leukemia|Acute Myeloid Leukemia|Acute Lymphoid Leukemia April 2015 Phase 2
NCT02483247 Boston Biomedical, Inc Cancer September 2015 Phase 1|Phase 2
NCT00002803 Children's Hospital Medical Center, Cincinnati|National Cancer Institute (NCI) Neuroblastoma July 1995 Phase 2
NCT02994251 Yale University Unresectable Intrahepatic Cholangiocarcinoma December 2016 Phase 2
NCT00002565 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Lymphoma May 1994 Phase 3
NCT00304070 Children's Oncology Group|National Cancer Institute (NCI) Stage I Adrenocortical Carcinoma|Stage II Adrenocortical Carcinoma|Stage III Adrenocortical Carcinoma|Stage IV Adrenocortical Carcinoma September 2006 Phase 3
NCT00002477 Medical Research Council|National Cancer Institute (NCI) Ovarian Cancer April 1991 Phase 3
NCT00235235 Hoosier Cancer Research Network|United States Department of Defense|Indiana University School of Medicine|Walther Cancer Institute Breast Cancer September 2005
NCT00187070 St. Jude Children's Research Hospital Lymphoma, Large Cell|Lymphoma, Non-Hodgkin December 1997
NCT02499367 The Netherlands Cancer Institute|Bristol-Myers Squibb Breast Cancer August 2015 Phase 2
NCT03033914 Memorial Sloan Kettering Cancer Center|Bristol-Myers Squibb|M.D. Anderson Cancer Center|City of Hope Medical Center Hodgkin Lymphoma January 25, 2017 Phase 1
NCT00186888 St. Jude Children's Research Hospital|National Cancer Institute (NCI) Retinoblastoma|Retinal Neoplasm February 2005 Phase 3
NCT00742924 Children's Oncology Group|National Cancer Institute (NCI) Sarcoma August 2008 Phase 1
NCT01412879 Southwest Oncology Group|National Cancer Institute (NCI) Lymphoma November 2011 Phase 2
NCT00003311 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Lymphoma March 1999 Phase 2
NCT00392834 AIDS Malignancy Consortium|National Cancer Institute (NCI)|The EMMES Corporation Lymphoma September 2006 Phase 2
NCT01016054 Astellas Pharma Inc|Agensys, Inc. Carcinoma|Ovarian Cancer|Ovarian Diseases|Ovarian Neoplasms October 2009 Phase 1
NCT00343369 Universitätsklinikum Hamburg-Eppendorf|National Cancer Institute (NCI) Leukemia January 2003
NCT01363128 M.D. Anderson Cancer Center|Novartis Pharmaceuticals Leukemia July 12, 2011 Phase 2
NCT00006232 West of Scotland Lymphoma Group|National Cancer Institute (NCI) Multiple Myeloma and Plasma Cell Neoplasm October 1996 Phase 3
NCT00002967 NSABP Foundation Inc|National Cancer Institute (NCI) Breast Cancer May 1997 Phase 3
NCT00005047 Southwest Oncology Group|National Cancer Institute (NCI)|NCIC Clinical Trials Group|University of Southern California Bladder Cancer August 1997 Phase 3
NCT01026220 Children's Oncology Group|National Cancer Institute (NCI) Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma|Stage III Childhood Hodgkin Lymphoma|Stage IV Childhood Hodgkin Lymphoma December 2009 Phase 3
NCT00002529 International Breast Cancer Study Group Breast Cancer May 1993 Phase 3
NCT00123877 Gem Pharmaceuticals Breast Cancer|Metastasis March 2005 Phase 2
NCT00005024 Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI) Unspecified Adult Solid Tumor, Protocol Specific Phase 3
NCT02978495 Barretos Cancer Hospital BRCA1 Hereditary Breast and Ovarian Cancer Syndrome May 17, 2017 Phase 2
NCT00897026 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Breast Cancer July 2008
NCT00036985 Celsion|National Cancer Institute (NCI) Breast Cancer August 2001 Phase 2
NCT01595048 Children's Oncology Group|National Cancer Institute (NCI) Childhood B Acute Lymphoblastic Leukemia|Childhood Burkitt Leukemia|Childhood Diffuse Large Cell Lymphoma|Mediastinal (Thymic) Large B-Cell Lymphoma|Stage III Childhood Large Cell Lymphoma|Stage IV Childhood Large Cell Lymphoma June 2012 Phase 2|Phase 3
NCT00299182 M.D. Anderson Cancer Center|Amgen Lymphoma March 2006 Phase 1|Phase 2
NCT00678327 Cancer Research UK|National Cancer Institute (NCI) Lymphoma August 2008 Phase 3
NCT01871766 St. Jude Children's Research Hospital Rhabdomyosarcoma December 4, 2013 Phase 2
NCT00822120 Southwest Oncology Group|National Cancer Institute (NCI) Lymphoma|Nonneoplastic Condition July 2009 Phase 2
NCT00054158 Roswell Park Cancer Institute|National Cancer Institute (NCI) Multiple Myeloma and Plasma Cell Neoplasm August 2004 Phase 2
NCT00146562 Harold J. Burstein, MD, PhD|Dana-Farber Cancer Institute|Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Lowell General Hospital|Brigham and Women's Hospital|North Shore Medical Center Breast Cancer|Stage I Breast Cancer|Stage II Breast Cancer July 2003 Phase 2
NCT02176967 Children's Oncology Group|National Cancer Institute (NCI) Ganglioneuroblastoma|Localized Resectable Neuroblastoma|Localized Unresectable Neuroblastoma|Recurrent Neuroblastoma|Regional Neuroblastoma|Stage 4 Neuroblastoma July 2014 Phase 3
NCT00002561 NCIC Clinical Trials Group|Eastern Cooperative Oncology Group|Canadian Cancer Trials Group Hodgkin Lymphoma January 1994 Phase 3
NCT00033644 Gynecologic Oncology Group|National Cancer Institute (NCI) Sarcoma March 2002 Phase 2
NCT00002858 Gustave Roussy, Cancer Campus, Grand Paris|National Cancer Institute (NCI) Lung Cancer March 1993 Phase 3
NCT00980460 National Cancer Institute (NCI) PRETEXT Stage 1 Hepatoblastoma|PRETEXT Stage 2 Hepatoblastoma|PRETEXT Stage 3 Hepatoblastoma|PRETEXT Stage 4 Hepatoblastoma September 14, 2009 Phase 3
NCT00005583 Nordic Society for Gynaecologic Oncology|European Organisation for Research and Treatment of Cancer - EORTC|National Cancer Institute (NCI) Endometrial Cancer January 2000 Phase 3
NCT00077389 University of Leicester|National Cancer Institute (NCI) Liver Cancer January 2004 Phase 2
NCT00873093 National Cancer Institute (NCI) B-cell Adult Acute Lymphoblastic Leukemia|B-cell Childhood Acute Lymphoblastic Leukemia|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Lymphoblastic Lymphoma|T-cell Adult Acute Lymphoblastic Leukemia|T-cell Childhood Acute Lymphoblastic Leukemia March 2009 Phase 2
NCT00689845 University Hospital Southampton NHS Foundation Trust|National Cancer Institute (NCI) Lymphoma June 2007
NCT00005977 Children's Oncology Group|National Cancer Institute (NCI) Leukemia|Lymphoma September 2000 Phase 3
NCT02622074 Merck Sharp & Dohme Corp. Triple Negative Breast Neoplasms January 27, 2016 Phase 1
NCT00083551 University of Arkansas|Celgene Corporation Multiple Myeloma August 1998 Phase 3
NCT02986568 Seoul National University Hospital Cervical Cancer|Uterine Cancer May 2016
NCT00103285 Children's Oncology Group|National Cancer Institute (NCI) B-cell Childhood Acute Lymphoblastic Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia April 2005 Phase 3
NCT03017326 University of Birmingham|Fundació Institut Germans Trias i Pujol|University of Padua|University of Newcastle Upon-Tyne|University Hospital Munich|University Hospital, Bonn|University of Kiel|University Hospital Tuebingen|Medical University of Gdansk Hepatoblastoma|Carcinoma, Hepatocellular May 2017 Phase 3
NCT01783535 St. Jude Children's Research Hospital Retinoblastoma June 19, 2013 Phase 2
NCT00002791 Radiation Therapy Oncology Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group Sarcoma February 1997 Phase 2
NCT00055640 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Lymphoma October 2002 Phase 2
NCT00025259 Children's Oncology Group|National Cancer Institute (NCI) Childhood Lymphocyte-Depleted Classical Hodgkin Lymphoma|Childhood Mixed Cellularity Classical Hodgkin Lymphoma|Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma|Childhood Nodular Sclerosis Classical Hodgkin Lymphoma|Stage I Childhood Hodgkin Lymphoma|Stage II Childhood Hodgkin Lymphoma|Stage III Childhood Hodgkin Lymphoma|Stage IV Childhood Hodgkin Lymphoma September 2002 Phase 3
NCT00408005 National Cancer Institute (NCI) Adult T Acute Lymphoblastic Leukemia|Childhood T Acute Lymphoblastic Leukemia|Stage II Adult T-Cell Leukemia/Lymphoma|Stage II Childhood Lymphoblastic Lymphoma|Stage II Contiguous Adult Lymphoblastic Lymphoma|Stage II Non-Contiguous Adult Lymphoblastic Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage III Adult T-Cell Leukemia/Lymphoma|Stage III Childhood Lymphoblastic Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Adult T-Cell Leukemia/Lymphoma|Stage IV Childhood Lymphoblastic Lymp January 22, 2007 Phase 3
NCT02786719 Baylor College of Medicine|Texas Children's Hospital Neuroblastoma June 2016
NCT00028756 European Organisation for Research and Treatment of Cancer - EORTC|National Cancer Institute (NCI)|Groupe D'Etude des Tumeurs Uro-Genitales|Institute of Cancer Research, United Kingdom|NCIC Clinical Trials Group|Arbeitsgemeinschaft Urologische Onkologie Stage III Bladder Cancer|Stage IV Bladder Cancer|Transitional Cell Carcinoma of the Bladder October 2001 Phase 3
NCT00006261 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer May 2000 Phase 2
NCT00027885 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer November 2001 Phase 2
NCT00000703 National Institute of Allergy and Infectious Diseases (NIAID) Lymphoma, Non-Hodgkin|HIV Infections
NCT00148681 Dana-Farber Cancer Institute|Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Brigham and Women's Hospital Breast Cancer|Stage II Breast Cancer|Stage III Breast Cancer May 2001 Phase 2
NCT00335556 Children's Oncology Group|National Cancer Institute (NCI) Childhood Renal Cell Carcinoma|Clear Cell Renal Cell Carcinoma|Clear Cell Sarcoma of the Kidney|Papillary Renal Cell Carcinoma|Rhabdoid Tumor of the Kidney|Stage I Renal Cell Cancer|Stage I Renal Wilms Tumor|Stage II Renal Cell Cancer|Stage II Renal Wilms Tumor|Stage III Renal Cell Cancer|Stage III Renal Wilms Tumor|Stage IV Renal Cell Cancer|Stage IV Renal Wilms Tumor June 2006 Phase 2
NCT00002919 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Bladder Cancer November 1996 Phase 2
NCT01220128 GlaxoSmithKline Neoplasms, Breast April 1, 2011 Phase 2
NCT02502266 National Cancer Institute (NCI) Deleterious BRCA1 Gene Mutation|Deleterious BRCA2 Gene Mutation|Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|Fallopian Tube Transitional Cell Carcinoma|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Seromucinous Carcinoma|Ovarian Serous Adenocarcinoma|Ovarian Transitional Cell Carcinoma|Primary Peritoneal Serous Adenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|R February 5, 2016 Phase 2|Phase 3
NCT00025610 European Infant Neuroblastoma Study Group - 1999|National Cancer Institute (NCI) Neuroblastoma July 1999 Phase 2
NCT00003214 Swiss Group for Clinical Cancer Research Ovarian Cancer July 1996 Phase 3
NCT00002611 Children's Oncology Group|National Cancer Institute (NCI) Kidney Cancer July 1995 Phase 3
NCT01186328 Therapeutic Advances in Childhood Leukemia Consortium|Enzon Pharmaceuticals, Inc. Lymphoblastic Leukemia, Acute|Lymphoblastic Leukemia, Acute, Childhood|Leukemia, Lymphoblastic, Acute, T Cell|Leukemia, Lymphoblastic, Acute August 2010 Phase 1
NCT03020030 Dana-Farber Cancer Institute|Baxalta US Inc. Acute Lymphoblastic Leukemia, Pediatric January 2017 Phase 3
NCT00309881 German CLL Study Group Chronic Lymphocytic Leukemia April 2003 Phase 2
NCT02883049 National Cancer Institute (NCI) B Acute Lymphoblastic Leukemia|Bone Necrosis|Central Nervous System Leukemia|Cognitive Side Effects of Cancer Therapy|Neurotoxicity Syndrome|Pain|Ph-Like Acute Lymphoblastic Leukemia|Testicular Leukemia|Therapy-Related Toxicity|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia February 27, 2012 Phase 3
NCT00002524 M.D. Anderson Cancer Center|National Cancer Institute (NCI) Lymphoma June 1993 Phase 2
NCT00004228 Children's Oncology Group|National Cancer Institute (NCI) Lymphoma June 2000 Phase 3
NCT00075725 Children's Oncology Group|National Cancer Institute (NCI) Leukemia December 2003 Phase 3
NCT00324467 British Columbia Cancer Agency|Hoffmann-La Roche Lymphoma, Non-Hodgkin|Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma August 2006 Phase 2
NCT03007147 Children's Oncology Group|National Cancer Institute (NCI) B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|BCR-ABL1 Fusion Protein Expression|Minimal Residual Disease|Philadelphia Chromosome Positive|T Acute Lymphoblastic Leukemia|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia July 2017 Phase 3
NCT00074490 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Lymphoma|Leukemia|Myeloproliferative Disorders|Multiple Myleoma|Myelodysplastic Syndrome December 11, 2003 Phase 2
NCT00003640 European Organisation for Research and Treatment of Cancer - EORTC Bladder Cancer September 1998 Phase 2
NCT00072007 Swiss Group for Clinical Cancer Research Leukemia June 2002 Phase 2
NCT02911142 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Primary Effusion Lymphoma|B-Cell Lymphoma September 15, 2016 Phase 1|Phase 2
NCT03117751 St. Jude Children's Research Hospital|Bristol-Myers Squibb|Incyte Corporation|Shire Acute Lymphoblastic Leukemia|Acute Lymphoblastic Lymphoma March 29, 2017 Phase 2|Phase 3
NCT00022230 Roger Williams Medical Center Breast Cancer January 2000 Phase 1|Phase 2
NCT00002784 International Breast Cancer Study Group Breast Cancer June 1996 Phase 3
NCT01750073 University of Nebraska|National Cancer Institute (NCI) Estrogen Receptor-negative Breast Cancer|Estrogen Receptor-positive Breast Cancer|HER2-negative Breast Cancer|HER2-positive Breast Cancer|Progesterone Receptor-negative Breast Cancer|Progesterone Receptor-positive Breast Cancer|Stage IA Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Triple-negative Breast Cancer December 2012 Phase 2
NCT00165178 Dana-Farber Cancer Institute|Boston Children’s Hospital|University of Rochester|McMaster University|San Jorge Children's Hospital (Puerto Rico)|St. Justine's Hospital|Maine Children's Cancer Program|Ochsner Health System|Tulane University School of Medicine|Laval University|Columbia University Acute Lymphoblastic Leukemia September 2000 Phase 3
NCT00110006 Case Comprehensive Cancer Center|National Cancer Institute (NCI) Lymphoma December 2004
NCT00003364 London Lung Cancer Group|National Cancer Institute (NCI) Lung Cancer January 1993 Phase 3
NCT01327521 Albert Koong|Accuray Incorporated|Stanford University Carcinoma, Hepatocellular February 2011 Phase 3
NCT00613457 Associazione Italiana Ematologia Oncologia Pediatrica Leukemia September 2000 Phase 3
NCT01309789 Seattle Genetics, Inc.|Millennium Pharmaceuticals, Inc. Lymphoma, Large-Cell, Anaplastic|Lymphoma, NK-cell|Lymphoma, T-cell February 2011 Phase 1
NCT00379340 Children's Oncology Group|National Cancer Institute (NCI) Stage III Wilms Tumor With Loss of Heterozygosity (LOH) for 1p and 16q|Stage IV Wilms Tumor February 2007 Phase 3
NCT02570412 CytRx Sarcoma
NCT01706835 CytRx Advanced Solid Tumors October 2012 Phase 1
NCT00187057 St. Jude Children's Research Hospital|Children's Hospital of Philadelphia|National Cancer Institute (NCI) Ataxia-Telangiectasia September 2002
NCT00003243 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Leukemia|Lymphoma|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Diseases January 1998 Phase 1
NCT00736450 University of Nebraska|National Cancer Institute (NCI)|Genta Incorporated Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Stage I Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma July 2008
NCT00003052 European Organisation for Research and Treatment of Cancer - EORTC|The European Society for Hyperthermic Oncology|National Cancer Institute (NCI) Sarcoma July 1997 Phase 3
NCT00451178 Eli Lilly and Company Lymphoma May 2007 Phase 2
NCT00049036 National Cancer Institute (NCI) AIDS-related Diffuse Large Cell Lymphoma|AIDS-related Immunoblastic Large Cell Lymphoma|AIDS-related Peripheral/Systemic Lymphoma|AIDS-related Small Noncleaved Cell Lymphoma March 2003 Phase 2
NCT00023998 National Cancer Institute (NCI) Metastatic Osteosarcoma July 2001 Phase 2
NCT00003050 University of Southern California|National Cancer Institute (NCI) Breast Cancer April 1997 Phase 2
NCT02845882 Children's Cancer Group, China|Shanghai Children's Medical Center|Tongji Hospital|West China Second University Hospital|Qilu Hospital of Shandong University|Tianjin Medical University Cancer Institute and Hospital|Children’s Hospital of Sochow University, China|Nanjing Children's Hospital|Xiangya Hospital of Central South University Lymphoblastic Lymphoma January 2016 Phase 2|Phase 3
NCT00057811 Children's Oncology Group|National Cancer Institute (NCI) Childhood Burkitt Lymphoma|Childhood Diffuse Large Cell Lymphoma|Childhood Immunoblastic Large Cell Lymphoma|Stage I Childhood Large Cell Lymphoma|Stage I Childhood Small Noncleaved Cell Lymphoma|Stage II Childhood Large Cell Lymphoma|Stage II Childhood Small Noncleaved Cell Lymphoma|Stage III Childhood Large Cell Lymphoma|Stage III Childhood Small Noncleaved Cell Lymphoma|Stage IV Childhood Large Cell Lymphoma|Stage IV Childhood Small Noncleaved Cell Lymphoma|Untreated Childhood Acute Lymphobla June 2004 Phase 2
NCT00025623 European Infant Neuroblastoma Study Group - 1999|National Cancer Institute (NCI) Neuroblastoma July 1999 Phase 2
NCT00025597 European Infant Neuroblastoma Study Group - 1999|National Cancer Institute (NCI) Neuroblastoma July 1999 Phase 2
NCT00006110 UNC Lineberger Comprehensive Cancer Center Breast Cancer December 1998 Phase 2
NCT00002653 Medical Research Council|National Cancer Institute (NCI) Multiple Myeloma and Plasma Cell Neoplasm September 1993 Phase 3
NCT00023738 Radiation Therapy Oncology Group|National Cancer Institute (NCI) Sarcoma August 2001 Phase 1|Phase 2
NCT00309920 Heinrich-Heine University, Duesseldorf|National Cancer Institute (NCI) Breast Cancer January 2004
NCT00005959 Amgen|National Cancer Institute (NCI) Lymphoma December 1999 Phase 2
NCT00004179 European Organisation for Research and Treatment of Cancer - EORTC|Lymphoma Trials Office|Stichting Hemato-Oncologie voor Volwassenen Nederland|Australasian Leukaemia and Lymphoma Group|NCIC Clinical Trials Group|Nordic Lymphoma Group Lymphoma May 1999 Phase 3
NCT00004112 University of Nebraska|National Cancer Institute (NCI) Lymphoma September 1999 Phase 3
NCT00652860 Mayo Clinic|National Cancer Institute (NCI) Metastatic Cancer|Sarcoma August 2001 Phase 2
NCT00381680 Children's Oncology Group|National Cancer Institute (NCI) B-cell Childhood Acute Lymphoblastic Leukemia|L1 Childhood Acute Lymphoblastic Leukemia|L2 Childhood Acute Lymphoblastic Leukemia|Intermediate Risk Recurrent Childhood Acute Lymphoblastic Leukemia March 2007 Phase 3
NCT00533936 Instituto Nacional de Cancerologia, Columbia|National Cancer Institute (NCI) Breast Cancer September 2006 Phase 2
NCT00671034 Children's Oncology Group|National Cancer Institute (NCI) B-cell Adult Acute Lymphoblastic Leukemia|B-cell Childhood Acute Lymphoblastic Leukemia|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia July 2008
NCT00003042 City of Hope Medical Center|National Cancer Institute (NCI) Breast Cancer May 1997 Phase 2
NCT00618813 Children's Oncology Group|National Cancer Institute (NCI) Ewing Sarcoma of Bone|Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor March 2008
NCT03226249 Northwestern University|National Cancer Institute (NCI) Classical Hodgkin Lymphoma|Lymphocyte-Depleted Classical Hodgkin Lymphoma|Lymphocyte-Rich Classical Hodgkin Lymphoma|Mixed Cellularity Classical Hodgkin Lymphoma|Nodular Sclerosis Classical Hodgkin Lymphoma August 15, 2017 Phase 2
NCT00003119 Children's Oncology Group|National Cancer Institute (NCI) Neuroblastoma March 1998 Phase 3
NCT00052351 National Cancer Institute (NCI) Breast Cancer September 2002 Phase 2
NCT00016302 National Cancer Institute (NCI) T-cell Childhood Acute Lymphoblastic Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia April 2001
NCT01190930 Children's Oncology Group|National Cancer Institute (NCI) Adult B Lymphoblastic Lymphoma|Childhood B Acute Lymphoblastic Leukemia|Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1|Childhood B Lymphoblastic Lymphoma|Down Syndrome|Stage I B Lymphoblastic Lymphoma|Stage II B Lymphoblastic Lymphoma|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia August 2010 Phase 3
NCT00022178 The Christie NHS Foundation Trust|National Cancer Institute (NCI) Carcinoma of Unknown Primary December 1998 Phase 3
NCT00003784 Southwest Oncology Group|National Cancer Institute (NCI) Lymphoma May 1999 Phase 2
NCT00637832 University Hospital Southampton NHS Foundation Trust|National Cancer Institute (NCI) Lymphoma April 2008 Phase 2
NCT00009997 New York University School of Medicine|National Cancer Institute (NCI) Breast Cancer March 1999 Phase 1
NCT00567567 Children's Oncology Group|National Cancer Institute (NCI) Localized Resectable Neuroblastoma|Localized Unresectable Neuroblastoma|Recurrent Neuroblastoma|Regional Neuroblastoma|Stage 4 Neuroblastoma|Stage 4S Neuroblastoma November 2007 Phase 3
NCT01004991 Weill Medical College of Cornell University|Celgene Diffuse Large B Cell Lymphoma January 2010 Phase 1|Phase 2
NCT00003701 Eastern Cooperative Oncology Group|National Cancer Institute (NCI) Bladder Cancer|Urethral Cancer March 1999 Phase 3
NCT00004218 Leukemia Research Fund|Medical Research Council|National Cancer Institute (NCI) Leukemia October 1999 Phase 3
NCT02112916 National Cancer Institute (NCI) Adult T Acute Lymphoblastic Leukemia|Childhood T Acute Lymphoblastic Leukemia|Stage II Childhood Lymphoblastic Lymphoma|Stage II Contiguous Adult Lymphoblastic Lymphoma|Stage II Non-Contiguous Adult Lymphoblastic Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage III Childhood Lymphoblastic Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Childhood Lymphoblastic Lymphoma|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia September 30, 2014 Phase 3
NCT00792948 National Cancer Institute (NCI) Adult Acute Lymphoblastic Leukemia in Remission|Adult B Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|Adult L1 Acute Lymphoblastic Leukemia|Adult L2 Acute Lymphoblastic Leukemia|Adult T Acute Lymphoblastic Leukemia|Recurrent Adult Acute Lymphoblastic Leukemia|Untreated Adult Acute Lymphoblastic Leukemia September 1, 2009 Phase 2
NCT03126916 Children's Oncology Group|National Cancer Institute (NCI) Childhood Ganglioneuroblastoma|Childhood Neuroblastoma|NMYC Gene Amplification|Recurrent Neuroblastoma August 2017 Phase 3
NCT00376961 Southwest Oncology Group|National Cancer Institute (NCI) Lymphoma August 2006 Phase 2
NCT00028717 Commissie Voor Klinisch Toegepast Onderzoek|National Cancer Institute (NCI) Lymphoma February 2001 Phase 3
NCT00004039 Hoag Memorial Hospital Presbyterian|Cancer Biotherapy Research Group Lymphoma June 1998 Phase 2
NCT00003150 Eastern Cooperative Oncology Group|National Cancer Institute (NCI)|Cancer and Leukemia Group B|Southwest Oncology Group Lymphoma December 1997 Phase 3
NCT00662233 Mayo Clinic|National Cancer Institute (NCI) Ovarian Cancer|Sarcoma October 1991
NCT00004237 Royal Marsden NHS Foundation Trust|National Cancer Institute (NCI) Breast Cancer October 1998 Phase 2
NCT00003776 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Sarcoma December 1998 Phase 2
NCT00562068 Cancer Research UK|National Cancer Institute (NCI) Lymphoma|Small Intestine Cancer May 2007 Phase 1
NCT00025428 Societe Internationale d'Oncologie Pediatrique|Children's Cancer and Leukaemia Group|National Cancer Institute (NCI) Neuroblastoma December 2000 Phase 3
NCT00019864 National Cancer Institute (NCI) Cardiac Toxicity|Sarcoma March 2000 Phase 2
NCT00004006 St. Jude Children's Research Hospital|National Cancer Institute (NCI) Retinoblastoma November 1997 Phase 2
NCT00003093 Children's Oncology Group|National Cancer Institute (NCI) Neuroblastoma March 1988 Phase 3
NCT00379041 European Organisation for Research and Treatment of Cancer - EORTC Lymphoma September 1993 Phase 3
NCT00002462 European Organisation for Research and Treatment of Cancer - EORTC Lymphoma September 1989 Phase 3
NCT00470223 UNICANCER|Novartis|Chugai Pharmaceutical|National Cancer Institute, France|SFCE|Ligue contre le cancer, France Sarcoma March 2007 Phase 3
NCT00398554 Christine Mauz-Körholz|Martin-Luther-Universität Halle-Wittenberg Lymphoma June 2005 Phase 2
NCT01132807 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lymphoma May 2010 Phase 2
NCT00023868 American College of Radiology Imaging Network|National Cancer Institute (NCI) Colorectal Cancer|Metastatic Cancer November 2001 Phase 3
NCT00020566 University of Leicester|National Cancer Institute (NCI)|Children's Cancer and Leukaemia Group|Societe Francaise Oncologie Pediatrique|European Organisation for Research and Treatment of Cancer - EORTC|Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany|Gesellschaft fur Padiatrische Onkologie und Hamatologie - Austria|Swiss Group for Clinical Cancer Research|EBMT Solid Tumors Working Party|Children's Oncology Group Sarcoma February 2001 Phase 3
NCT00002715 Stanford University|National Cancer Institute (NCI) Lymphoma April 1989 Phase 2
NCT00002714 Stanford University|National Cancer Institute (NCI) Lymphoma April 1995 Phase 2
NCT00666484 University College, London Lymphoma|Neurotoxicity March 2008 Phase 2
NCT00945009 Children's Oncology Group|National Cancer Institute (NCI) Adult Renal Wilms Tumor|Beckwith-Wiedemann Syndrome|Childhood Renal Wilms Tumor|Diffuse Hyperplastic Perilobar Nephroblastomatosis|Hemihypertrophy|Stage I Renal Wilms Tumor|Stage II Renal Wilms Tumor|Stage III Renal Wilms Tumor|Stage IV Renal Wilms Tumor|Stage V Renal Wilms Tumor July 2009 Phase 3
NCT02393833 International Breast Cancer Study Group Breast Cancer June 2002 Phase 3
NCT00030654 Radiation Therapy Oncology Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group|Cancer and Leukemia Group B|Southwest Oncology Group|NRG Oncology Prostate Cancer October 2002 Phase 3
NCT00416832 Christine Mauz-Körholz|Martin-Luther-Universität Halle-Wittenberg Lymphoma November 2002 Phase 2
NCT00002987 Medical Research Council|National Cancer Institute (NCI) Lymphoma January 1997 Phase 3
NCT00416377 Children's Cancer and Leukaemia Group|National Cancer Institute (NCI) Lymphoma
NCT00003262 Centro di Riferimento Oncologico - Aviano|National Cancer Institute (NCI) Lymphoma May 1997 Phase 2
NCT00002905 Centro di Riferimento Oncologico - Aviano|National Cancer Institute (NCI) Lymphoma June 1995 Phase 2
NCT00002516 University Hospital Muenster|Medical Research Council|National Cancer Institute (NCI) Sarcoma July 1992 Phase 3
NCT00024271 Herbert Irving Comprehensive Cancer Center|National Cancer Institute (NCI) Malignant Mesothelioma May 2001 Phase 2
NCT00311636 Gruppo Italiano Mammella (GIM)|National Cancer Institute (NCI) Breast Cancer September 2003 Phase 3
NCT00002582 Institute of Cancer Research, United Kingdom|Cancer Research Campaign Clinical Trials Centre|Scottish Cancer Therapy Network|Yorkshire Regional Clinical Trials Research Unit|National Cancer Institute (NCI) Breast Cancer June 1993 Phase 3
NCT00002542 NCIC Clinical Trials Group|Canadian Cancer Trials Group Breast Cancer July 1993 Phase 3
NCT00041210 Mount Vernon Cancer Centre at Mount Vernon Hospital|National Cancer Institute (NCI) Lymphoma October 2001 Phase 3
NCT00025064 Children's Cancer and Leukaemia Group|National Cancer Institute (NCI) Lymphoma January 2000 Phase 2
NCT00003421 Medical Research Council|National Cancer Institute (NCI) Lymphoma June 1998 Phase 3
NCT00003893 University Hospital Birmingham|National Cancer Institute (NCI) Breast Cancer July 1998 Phase 3
NCT00047138 University of Leicester|Societe Francaise Oncologie Pediatrique|Children's Cancer and Leukaemia Group|Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany|National Cancer Institute (NCI) Kidney Cancer January 2001 Phase 3
NCT00002740 Children's Oncology Group|National Cancer Institute (NCI) Neuroblastoma May 1996 Phase 1
NCT00070200 Children's Oncology Group|National Cancer Institute (NCI) Neuroblastoma March 2004 Phase 1
NCT00060385 European Organisation for Research and Treatment of Cancer - EORTC Lymphoma March 2003 Phase 2|Phase 3
NCT00032019 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lymphoma February 2002 Phase 2
NCT00002643 National Cancer Institute (NCI)|Children's Cancer Group Neutropenia|Sarcoma April 1995 Phase 2
NCT00361621 Dana-Farber Cancer Institute|Brigham and Women's Hospital|Millennium Pharmaceuticals, Inc. Non-Hodgkin's Lymphoma July 2006 Phase 2
NCT00014222 NCIC Clinical Trials Group|North Central Cancer Treatment Group|Southwest Oncology Group|Cancer and Leukemia Group B|Canadian Cancer Trials Group Breast Cancer December 2000 Phase 3
NCT00025103 Children's Cancer and Leukaemia Group|National Cancer Institute (NCI) Kidney Cancer May 2001 Phase 2
NCT00041327 AIDS Malignancy Consortium|National Cancer Institute (NCI) Lymphoma October 2002 Phase 2
NCT00002634 Memorial Sloan Kettering Cancer Center Neuroblastoma February 1995 Phase 2
NCT00002757 Children's Oncology Group|National Cancer Institute (NCI)|Societe Francaise Oncologie Pediatrique|Children's Cancer and Leukaemia Group Leukemia|Lymphoma June 2001 Phase 3
NCT00513188 University of Miami Lymphoma February 2007
NCT00379457 European Paediatric Soft Tissue Sarcoma Study Group|Italian Association for Pediatric Hematology Oncology|Children's Cancer and Leukaemia Group|Dutch Childhood Oncology Group|National Cancer Institute (NCI) Sarcoma June 2006 Phase 3
NCT00040690 Medical Research Council|National Cancer Institute (NCI) Leukemia|Lymphoma November 2008 Phase 2
NCT00002755 Scottish Cancer Therapy Network|National Cancer Institute (NCI) Breast Cancer November 1995 Phase 3
NCT00002610 Children's Oncology Group|National Cancer Institute (NCI) Kidney Cancer January 1996 Phase 3
NCT00002822 Medical Research Council|National Cancer Institute (NCI) Lung Cancer March 1996 Phase 3
NCT01796197 Dana-Farber Cancer Institute Breast Cancer March 2013 Phase 2
NCT00006455 Gustave Roussy, Cancer Campus, Grand Paris|National Cancer Institute (NCI) Lymphoma December 1999 Phase 3
NCT00629278 Azienda Ospedaliera - Universitaria di Modena|National Cancer Institute (NCI) Breast Cancer December 2007 Phase 3
NCT00006669 Washington Hospital Center|National Cancer Institute (NCI) Lymphoma September 1999 Phase 2
NCT00137111 St. Jude Children's Research Hospital|National Cancer Institute (NCI) Lymphoblastic Leukemia, Acute June 2000 Phase 3
NCT01005758 Ohio State University Comprehensive Cancer Center|National Cancer Institute (NCI) Leukemia January 2009 Phase 2
NCT00669812 Cancer Research UK|National Cancer Institute (NCI) Lymphoma|Small Intestine Cancer February 2008 Phase 2
NCT00002494 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Leukemia|Lymphoma May 1992 Phase 2
NCT02235688 CytRx Metastatic Solid Tumors August 2014 Phase 1
NCT02014844 CytRx Glioblastoma March 2014 Phase 2
NCT00030381 National Cancer Institute (NCI) Primary Systemic Amyloidosis December 2001 Phase 1
NCT00003853 National Cancer Institute (NCI) Multiple Myeloma and Plasma Cell Neoplasm April 1999 Phase 2
NCT00003217 Children's Oncology Group|National Cancer Institute (NCI) Leukemia|Lymphoma March 1998 Phase 1
NCT00002676 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lymphoma July 1995 Phase 2
NCT00028886 Commissie Voor Klinisch Toegepast Onderzoek|National Cancer Institute (NCI) Multiple Myeloma and Plasma Cell Neoplasm March 2001 Phase 3
NCT00025441 Societe Internationale d'Oncologie Pediatrique|Children's Cancer and Leukaemia Group|Societe Francaise Oncologie Pediatrique|National Cancer Institute (NCI) Ovarian Cancer|Sarcoma|Small Intestine Cancer November 1998 Phase 2
NCT00003541 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Lymphoma June 1998 Phase 1|Phase 2
NCT00002548 Southwest Oncology Group|National Cancer Institute (NCI)|Cancer and Leukemia Group B|Eastern Cooperative Oncology Group Multiple Myeloma January 1994 Phase 3
NCT00002489 Memorial Sloan Kettering Cancer Center Extragonadal Germ Cell Tumor|Ovarian Cancer October 1991 Phase 2
NCT00558519 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Leukemia November 2007 Phase 2
NCT00005945 Children's Oncology Group|National Cancer Institute (NCI) Leukemia June 2000 Phase 3
NCT00049595 European Organisation for Research and Treatment of Cancer - EORTC|Lymphoma Trials Office|Lymphoma Study Association|Grup per l'Estudi dels Limfomes de Catalunya i Balears|NCIC Clinical Trials Group|Australasian Leukaemia and Lymphoma Group|Nordic Lymphoma Group Lymphoma August 2002 Phase 3
NCT00024193 Children's Cancer and Leukaemia Group|Societe Francaise Oncologie Pediatrique|National Cancer Institute (NCI) Neuroblastoma April 1999 Phase 2
NCT00004197 University of Nebraska|National Cancer Institute (NCI) Lymphoma June 1999 Phase 2
NCT00755313 University of California, San Francisco|National Cancer Institute (NCI) Breast Cancer|Chemotherapeutic Agent Toxicity|Cognitive/Functional Effects|Fatigue|Long-term Effects Secondary to Cancer Therapy in Adults|Neurotoxicity|Psychosocial Effects of Cancer and Its Treatment May 2007
NCT00077285 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Sarcoma October 2003 Phase 2
NCT00025649 European Infant Neuroblastoma Study Group - 1999|National Cancer Institute (NCI) Neuroblastoma July 1999 Phase 2
NCT00002802 Children's Hospital Medical Center, Cincinnati|National Cancer Institute (NCI) Neuroblastoma July 1990 Phase 3
NCT00002590 Children's Oncology Group|National Cancer Institute (NCI) Lymphoma July 1994 Phase 2
NCT01415765 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Lymphoma, Diffuse Large-Cell B-cell|Diffuse, Large B-cell Lymphoma|Lymphoma, Diffuse Large-Cell|Large-Cell Lymphoma, Diffuse July 15, 2011 Phase 1|Phase 2
NCT00417053 Children's Cancer and Leukaemia Group|National Cancer Institute (NCI) Neuroblastoma Phase 3
NCT00003815 Scotland and Newcastle Lymphoma Group|National Cancer Institute (NCI) Lymphoma June 1994 Phase 3
NCT00003578 Lymphoma Trials Office|National Cancer Institute (NCI) Lymphoma January 1993 Phase 3
NCT00003215 Swiss Group for Clinical Cancer Research Lymphoma April 1997 Phase 3
NCT00002657 Southwest Oncology Group|National Cancer Institute (NCI)|Eastern Cooperative Oncology Group Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm May 1995 Phase 2
NCT00920153 French Innovative Leukemia Organisation Lymphoma May 2008 Phase 3
NCT00974792 Cancer Research UK|National Cancer Institute (NCI) Lymphoma January 2006 Phase 2
NCT00018954 National Institutes of Health Clinical Center (CC)|National Cancer Institute (NCI) Leukemia|Lymphoma October 1992 Phase 2
NCT00002865 Wake Forest University Health Sciences|National Cancer Institute (NCI) Leukemia April 1995 Phase 2
NCT00002599 Medical Research Council|National Cancer Institute (NCI) Multiple Myeloma and Plasma Cell Neoplasm September 1994 Phase 3
NCT00764907 University Hospital, Motol|National Cancer Institute (NCI) Leukemia November 2002 Phase 3
NCT00430118 University of Schleswig-Holstein Leukemia July 2000 Phase 3
NCT00005603 Children's Oncology Group|National Cancer Institute (NCI) Leukemia March 2000 Phase 3
NCT00002665 Southwest Oncology Group|National Cancer Institute (NCI) Leukemia|Neutropenia|Thrombocytopenia July 1995 Phase 2
NCT00002531 Johann Wolfgang Goethe University Hospital|National Cancer Institute (NCI) Leukemia January 1993 Phase 2
NCT03206671 University Hospital Muenster|Deutsche Krebshilfe e.V., Bonn (Germany) Mature B-cell Non-Hodgkin Lymphoma July 2017 Phase 3
NCT00003437 Medical Research Council|National Cancer Institute (NCI) Leukemia January 1997 Phase 3
NCT00002812 Children's Oncology Group|National Cancer Institute (NCI) Leukemia September 1996 Phase 3
NCT00040872 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Neuroblastoma June 2000 Phase 2
NCT01175356 Children's Oncology Group|National Cancer Institute (NCI) Disseminated Neuroblastoma|Ganglioneuroblastoma|Localized Resectable Neuroblastoma|Localized Unresectable Neuroblastoma|Regional Neuroblastoma|Stage 4S Neuroblastoma October 2010
NCT00049569 National Cancer Institute (NCI) L1 Childhood Acute Lymphoblastic Leukemia|L2 Childhood Acute Lymphoblastic Leukemia|Non-T, Non-B Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Lymphoblastic Leukemia|T-cell Childhood Acute Lymphoblastic Leukemia January 2003
NCT00017225 Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany|National Cancer Institute (NCI) Neuroblastoma May 1997 Phase 2
NCT00723658 Southwest Oncology Group|National Cancer Institute (NCI) Lymphoma September 2008 Phase 2
NCT01117441 University of Schleswig-Holstein|Deutsche Krebshilfe e.V., Bonn (Germany) Leukemia June 2010 Phase 3
NCT00526318 Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany|National Cancer Institute (NCI) Neuroblastoma January 2007
NCT00410631 Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany|National Cancer Institute (NCI) Neuroblastoma October 2004 Phase 3
NCT00048893 National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) Breast Neoplasms|Metastases, Neoplasm November 2002 Phase 1|Phase 2
NCT00020943 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) Lymphoma June 2001 Phase 2
NCT00017368 Children's Oncology Group|National Cancer Institute (NCI) Neuroblastoma April 2001 Phase 2
NCT00012311 Herbert Irving Comprehensive Cancer Center|National Cancer Institute (NCI) Breast Cancer January 2000 Phase 2
NCT00003086 Feist-Weiller Cancer Center at Louisiana State University Health Sciences|National Cancer Institute (NCI) Breast Cancer March 1997 Phase 1|Phase 2
NCT01156883 Gruppo Italiano Malattie EMatologiche dell'Adulto Leukemia April 2010
NCT00400946 Dana-Farber Cancer Institute|National Cancer Institute (NCI) Drug/Agent Toxicity by Tissue/Organ|Leukemia April 2005 Phase 3
NCT00275106 Children's Cancer and Leukaemia Group|European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma|National Cancer Institute (NCI) Lymphoma September 2004 Phase 3
NCT00003728 European Organisation for Research and Treatment of Cancer - EORTC|National Cancer Institute (NCI) Leukemia|Lymphoma December 1998 Phase 3
NCT00002744 Children's Oncology Group|National Cancer Institute (NCI) Leukemia May 1996 Phase 3
NCT00002700 European Organisation for Research and Treatment of Cancer - EORTC|Acute Leukemia French Association Leukemia|Lymphoma August 1995 Phase 3
NCT00238368 Sidney Kimmel Comprehensive Cancer Center|National Cancer Institute (NCI) Lymphoma February 2004 Phase 2
NCT00004231 Northwestern University|National Cancer Institute (NCI) Lymphoma October 1999 Phase 2
NCT00002766 Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) Leukemia|Lymphoma March 1996 Phase 3
NCT00080925 National Institutes of Health Clinical Center (CC)|National Cancer Institute (NCI) Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms February 2004 Phase 1
NCT00022126 Children's Oncology Group|National Cancer Institute (NCI) Leukemia November 2002 Phase 2
NCT00476190 Dana-Farber Cancer Institute|Massachusetts General Hospital|Boston Children’s Hospital|NCIC Clinical Trials Group Acute Lymphoblastic Leukemia April 2007 Phase 2
NCT01358253 Ruijin Hospital Acute Lymphoblastic Leukemia December 2010 Phase 4
NCT00136435 Dana-Farber Cancer Institute|Brigham and Women's Hospital|Massachusetts General Hospital|Queen Elizabeth II Health Sciences Centre Acute Lymphoblastic Leukemia June 2002 Phase 2
NCT01659099 The Lymphoma Academic Research Organisation|Hoffmann-La Roche Diffuse Large B Cell Lymphoma CD20 Positive September 2012 Phase 3
NCT01569204 University of Cologne Hodgkin Lymphoma October 2012 Phase 2
NCT00440726 Therapeutic Advances in Childhood Leukemia Consortium Acute Lymphoblastic Leukemia June 2006 Phase 1|Phase 2
NCT02723994 Incyte Corporation|Children's Oncology Group B-cell Acute Lymphoblastic Leukemia August 2016 Phase 2
NCT03150693 Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) B Acute Lymphoblastic Leukemia June 1, 2017 Phase 3
NCT00131027 Japan Adult Leukemia Study Group Lymphoblastic Leukemia, Acute September 2002 Phase 3
NCT02894645 National University Hospital, Singapore Acute Lymphoblastic Leukemia (ALL) October 2008 Phase 4
NCT02235701 CytRx Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma August 2014 Phase 1|Phase 2
NCT02486952 Hoffmann-La Roche|Serbian Lymphoma Group Lymphoma, Lymphoma, Large B-Cell, Diffuse, Non-Hodgkin's Lymphoma, Lymphoma, Non Hodgkin, Relapsed or Refractory Diffuse Large B-Cell Lymphoma August 2005
NCT00646854 Aarhus University Hospital|GCP-unit at Aarhus University Hospital, Aarhus, Denmark|University of Aarhus Lymphoma, T-Cell, Peripheral June 2008 Phase 3
NCT01724021 Hoffmann-La Roche Diffuse Large B-Cell Lymphoma, Non-Hodgkin's Lymphoma December 2012 Phase 3
View MoreCollapse
References
Preparing Stock Solutions
Concentration Volume (DMSO) Mass 1 mg 5 mg 10 mg
1 mM 1.7242 mL 8.6210 mL 17.2420 mL
5 mM 0.3448 mL 1.7242 mL 3.4484 mL
10 mM 0.1724 mL 0.8621 mL 1.7242 mL
Cell Assay
[2]

Doxorubicin hydrochloride is dissolved in stock solutions (1 mM) and serially diluted with RPMI 1640 media (0.1, 1, and 2 μM)[2].

160 μL of Hela cells suspension (3×104 cell/mL) is dispensed into three 96-well U-bottom microplates and incubated for 24 h at 37°C in a fully humidified atmosphere of 5% CO2. In plate 1, serial dilutions of Doxorubicin (20 μL; final concentration, 0.1-2 μM) and Simvastatin (20 μL; final concentration, 0.25-2 μM) are added to a final volume of 200 μL and incubated for another 72 h. In plates 2 and 3 serial dilutions of each drug (Simvastatin or Doxorubicin, 40 μL) are added. After an incubation period of 24 h, the medium is aspirated and the cells are washed in PBS. Then, serial dilutions of other drug (40 μL) are added and supplemented with culture medium to a final volume of 200 μL, and incubated for 48 h. Doxorubicin and Simvastatin are used individually as positive controls (40 μL in each well), and the cells treated only with solvent are considered as negative controls. To evaluate cell survival, 20 μL of MTT solution (5 mg/mL in PBS) is added to each well and incubated for 3 h. Then the media is replaced with 150 μL of DMSO, and complete solubilization of formazan crystals is achieved by repeated pipetting of the solution. Absorbance is then determined at 540 nm by an ELISA plate reader. Each drug concentration is assayed in 4 or 8 wells and repeated 3 times. The cytotoxic/cytostatic effect of Doxorubicin is expressed as the relative viability (% control) and calculated. Percentage of cell survival in the negative control is assumed as 100. Relative viability=(experimental absorbance-background absorbance)/ (absorbance of untreated controls-background absorbance)×100 %[2]. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Administration
[3][4]

Doxorubicin is prepared in PBS (containing 0.1% BSA) (Mice)[3].

Mice[3]
Athymic male nude mice (3-4 weeks old) are used. PC3 cells (4×106) are injected subcutaneously into the flanks of mice. Animals bearing tumors are randomly assigned to treatment groups (five or six mice per group) and treatment initated when xenografts reached volumes of about 100 mm3. Tumors are measured using digital calipers and volume calculated using the formula: Volume=Width2×Length×0.52, where width represents the shorter dimension of the tumor. Treatments are administered as indicated using vehicle (PBS containing 0.1% BSA), Doxorubicin (2-8 mg/kg), Apo2L/TRAIL (500 μg/animal), or a combination of 4 mg/kg Doxorubicin followed by 500 μg Apo2L/TRAIL. Doxorubicin is administered systemically whereas Apo2L/TRAIL is given either intra-tumorally or systemically. All treatments are given once. Mice are monitored daily for signs of adverse effects (listlessness and scruffy apparance). Treatments seemed to be well tolerated. The mean±SEM is calculated for each data point. Differences between treatment groups are analyzed by the student t-test. Differences are considered significant when P<0.05.
Rat[4]
Thirty male Sprague-Dawley rats weighing 250 to 300 g are randomly assigned to 1 of 3 experimental groups: Doxorubicin schedule 1 (Doxorubicin 1, n=10), Doxorubicin schedule 2 (Doxorubicin 2, n=10), or Doxorubicin schedule 3 (Doxorubicin 3, n=10). For all Doxorubicin treatment schedules, the cumulative dose of Doxorubicin is 10 mg/kg. Schedule 1 involves a single bolus intraperitoneal injection of Doxorubicin at 10 mg/kg. Schedule 2 involves 10 intraperitoneal injections of Doxorubicin at 1 mg/kg for 10 consecutive days. Schedule 3 involves 5 intraperitoneal injections of Doxorubicin at 2 mg/kg, once each week, for 5 wk. Immediately before the first Doxorubicin treatment and at weekly intervals after beginning Doxorubicin treatment, blood pressure and cardiac function are assessed in all surviving animals as long as there are at least 3 rats per group. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

References
Molecular Weight

579.98

Formula

C₂₇H₃₀ClNO₁₁

CAS No.

25316-40-9

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Shipping

Room temperature in continental US; may vary elsewhere

Solvent & Solubility

DMSO: ≥ 30 mg/mL

* "<1 mg/mL" means slightly soluble or insoluble. "≥" means soluble, but saturation unknown.

Purity: 99.47%

Inquiry Online

Your information is safe with us. * Required Fields.

Product name

 

Salutation

Applicant name *

 

Email address *

Phone number

 

Organization name *

Country *

 

Requested quantity *

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Doxorubicin hydrochloride
Cat. No.:
HY-15142
Quantity: